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ABSTRACT 
 
The overall goal of my thesis research is to produce four-carbon alcohols such as 1-butanol 
and 2,3-butanediol, and isobutanol as advanced biofuels and chemicals from microorganisms 
through metabolic engineering, systems biology, and synthetic biology approaches. Biobutanol is 
an attractive renewable biofuel and intermediate chemical that has been produced from the ABE 
(acetone-butanol-ethanol) fermentation by solventogenic clostridia such as Clostridium 
beijerinckii. Although the ABE fermentation is considered as a promising process for butanol 
production, current drawbacks in the ABE fermentation include low titer, yield, and productivity 
of solvent production that needs to be improved to achieve an economically viable process. 
Therefore, the first goal of my thesis study was to improve the ABE fermentation by C. beijerinckii 
for production of butanol and its derivatives. This first objective involved four approaches. First, 
optimization of ABE fermentation condition was conducted to maximize butanol production in a 
small-scale standard platform. Second, product diversification in the ABE fermentation producing 
butyl esters was carried out through simultaneous ABE fermentation, condensation, and extraction 
to compensate the low yield of butanol. Third, oxygen-independent fluorescence reporter protein 
(FbFP) was employed for evaluating protein expression in C. beijerinckii under strict anaerobic 
conditions. With the FbFP reporter, screening of mutant, analysis of cell population, and metabolic 
engineering of C. beijerinckii were achieved. Lastly, evolutionary engineering of C. beijerinckii 
was performed to increase cell growth on lignocellulosic hydrolysate which is a potential feedstock 
for industrial butanol production. The second goal of my thesis study was to produce butanol 
isomers including 2,3-butanediol (2,3-BD) and isobutanol by industrial yeast S. cerevisiae strain. 
For this purpose, evolutionary engineering and metabolic engineering of pyruvate decarboxylase 
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(Pdc)-negative S. cerevisiae were performed to increase the production of butanol isomers by 
eliminating ethanol production. The metabolically engineered Pdc-negative S. cerevisiae 
containing heterologous 2,3-BD biosynthetic pathway successfully produced 2,3-BD at high titer, 
yield and productivity without ethanol production. Isobutanol production was also significantly 
increased through identification of metabolic limitations and optimization of metabolic pathways 
in the recombinant Pdc-negative S. cerevisiae harboring a cytosolic isobutanol biosynthetic 
pathway. Overall, this study has broad implications for the sustainable biological production of 
higher-chain alcohols as advanced biofuels and chemicals which can replace the use of fossil fuel 
and petroleum. Moreover, findings and tools obtained in this study can be applied to synthetic 
biology and metabolic engineering of other solventogenic clostridia and yeast strains toward 
increased production of value-added bioproducts. 
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CHAPTER I      INTRODUCTION TO BIOLOGICAL PRODUCTION OF 1-BUTANOL 
AND BUTANOL ISOMERS AS ADVANCED BIOFUELS AND CHEMICALS 
 
1.1. Needs and motivation: biological production of 1-butanol and butanol isomers 
Second-generation biofuels, 1-butanol and butanol isomers, are considered as advanced 
biofuels which can substitute for gasoline. Butanol has similar properties to gasoline, thereby 
applying for direct replacement or as a fuel additive. Butanol has many advantages over ethanol 
that is the first-generation biofuel. Butanol has higher energy content, lower volatility, not as 
hygroscopic as is ethanol, and is less corrosive thereby allowing it to be transported and stored 
using existing facilities. Other butanol isomers such as isobutanol, 2-methayl-1-butanol, and 3-
methyl-1- butanol can also be used as biofuels because of their higher octane numbers when 
compared to 1-butanol. In addition to its use as a biofuel, butanol has been used for manufacturing 
lacquers, enamels and coating materials. Butanol is also an industrial solvent widely used for the 
production of antibiotics, vitamins, and drugs. Industrial production of 1-butanol has been 
achieved through the ABE fermentation using the solventogenic clostridia. However, biological 
production of butanol has been dominated by a chemical process using petroleum which is much 
cheaper and more efficient. Recently, increasing concerns over climate change and global warming 
have fostered research toward alternative biofuel and biochemical production. Considering its 
broad scope of applications as a chemical feedstock and alternative transportation fuel, sustainable 
production of butanol has garnered particular industrial interest. Regarding this, many types of 
research have been conducted to increase titer, yield, and productivity of the biological production 
of butanol. In this thesis, I investigated several biological routes to produce 1-butanol and butanol 
isomers by metabolically engineered microorganisms (Fig. 1.1). 
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1.2. Production of 1-butanol from ABE fermentation by solventogenic clostridia 
The acetone-butanol-ethanol (ABE) fermentation by solventogenic clostridia has a long 
history going back to Pasteur. There has been renewed interest in the ABE fermentation for 
sustainable biofuel and biochemical production [1]. There are two predominant solventogenic 
clostridia used for ABE fermentation: Clostridium acetobutylicum and Clostridium beijerinckii. 
C. beijerinckii is phenotypically similar to C. acetobutylicum, but it has significant advantages 
over C. acetobutylicum. First, C. beijerinckii does not contain a mega-plasmid in which the 
solvent-production genes reside, but rather these genes are located on the chromosome, thereby it 
is more stable [2]. The genome of C. beijerinckii is 50% larger than C. acetobutylicum and 
demonstrates a multiplicity of gene families and is thereby less subject to degeneration [3]. C. 
beijerinckii can utilize a broader range of substrates including starch, sugarcane juice, and tropical 
maize stalk juice [4-6]. Also, it has a broader pH optimum for growth and solvent production, and 
it is more tolerant to acetate, formate, furfural and hydroxymethylfurfural that is present in 
lignocellulosic hydrolysates [7].  
Like other solvent-producing clostridia, C. beijerinckii has some common characteristics such 
as rod-shaped morphology, gram-positive cell wall, anaerobic metabolism, a formation of heat-
resistant endospore and biphasic ABE fermentation [1]. The ABE fermentation by solventogenic 
clostridia consists of two distinct phases, acidogenesis and solventogenesis, and is coupled with a 
unique life cycle and cell differentiation (Fig. 1.2). The acidogenic phase is coupled with 
vegetative cell growth and produces acetate and butyrate from sugar as main products. 
Acidogenesis is followed by solventogenesis coupled with an initiation of sporulation during 
which the formed acids are converted to solvents.  
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As a result of the biphasic ABE fermentation by C. beijerinckii, butanol is produced as a major 
end-product among the produced solvents. Butanol is an attractive renewable liquid biofuel and 
large-volume, intermediate chemical [8]. Butanol has favorable physical and chemical properties 
for blending with or directly substituting for gasoline such as higher energy content, lower 
miscibility with water [9]. Although butanol can be produced by a chemical conversion process 
from petroleum, the biological production of butanol by the ABE fermentation is preferable due 
to the finite nature of fossil fuel and the concern about climate change and global warming. Also, 
the ABE fermentation process can be compatible with the chemical conversion process since the 
value of butanol is sufficiently high for investing into commercialization [8]. However, to claim a 
significance of the biological butanol production to the markets, the ABE fermentation process by 
clostridia requires further exploration to overcome the current limitations in yield and productivity. 
 
1.2.1. Challenges in the ABE fermentation for industrial production 
To make the ABE fermentation economically feasible, current issues in the ABE fermentation 
need to be addressed. First, the clostridial ABE fermentation has inherent drawbacks including 
low titer, yield, and productivity of solvents compared to its theoretical levels [8, 10]. The low 
solvent production is also related to low sugar uptake caused by product inhibition [11]. These 
intrinsic limitations are applied to all of solventogenic clostridia, and it prevents a cost effective 
ABE fermentation at a large-scale [12]. Second, due to the unique cell cycle and complex biphasic 
process consisting of a metabolic shift coupled with cellular differentiation, the ABE fermentation 
is less predictable, and the fermentation profile is difficult to reproduce over repeated runs. This 
complexity and systems nature of the ABE fermentation process results in challenges in optimizing 
the bioprocess and prevents a stable manufacturing process at a large-scale [13]. Either bioprocess 
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optimization or strain engineering can be applied to increase the titer, yield, and productivity of 
solvent produced from the ABE fermentation.  
 
1.2.2. Improvement of solvent production through bioprocess engineering 
To achieve increased titer, yield, and productivity of solvents from the ABE fermentation, 
bioprocess optimization can be applied first. Previous research attempted to optimize the ABE 
fermentation conditions for C. beijerinckii using a new feedstock, tropical maize stalk juice [4]. 
However, the optimized conditions are specific to the feedstock containing mixed sugars. 
Optimization of solvent production by C. beijerinckii using glucose as a sole carbon source has 
not yet been systematically investigated. As mentioned above, the ABE fermentation is a very 
complex biological process that is influenced by many factors (Fig. 1.3). The extrinsic factors 
involved in fermentation include such conditions as medium, temperature, pH value and inoculum 
can provide significant variations in results. The variation can be minimized by standardization 
and tight control of the fermentation process. The intrinsic factors such as stochastic gene 
expression and cell differentiation can also result in product fluctuations that cannot be easily 
controlled. 
There is one canonical example showing huge variations on the ABE fermentation. One of 
the mutant strains, C. beijerinckii BA101, which was constructed using a chemical mutagen in the 
presence of 2-deoxyglucose was able to consume glucose faster than the parent C. beijerinckii 
NCIMB8052 wild-type (WT) and produced solvent with a higher titer and yield [14, 10]. However, 
under certain fermentation conditions, the BA101 strain performed worse than the WT strain. 
These results suggested that the ABE fermentation depends on the fermentation conditions, and 
each strain may have different optimal conditions for the best solvent production. Therefore, I 
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investigated the impact of variable factors involved in ABE fermentation using both C. beijerinckii 
8052 WT and BA101 strains in order to determine the optimal conditions for stable and maximal 
solvent production. 
 
1.2.3. Diversification of the ABE products to value-added biochemicals 
The ABE fermentation products can be diversified to other value-added chemicals that have 
higher market value in order to compensate for the low yield of solvent. Another reason to convert 
ABE products to other chemicals is due to butanol inhibition and the associated recovery cost. The 
recovery of butanol from the fermentation broth is energy-intensive and requires high downstream 
processing costs [15]. If butanol is converted to other chemicals that can be easily separated from 
fermentation broth during the ABE fermentation, both production cost and butanol inhibition can 
be reduced. 
Recent research described the integration of biological and chemical catalytic routes to 
convert the ABE fermentation products efficiently into ketones [16]. This bioprocess engineering 
approach provides a means to selectively produce petrol, jet and diesel fuel from the ABE 
fermentation at yields near their theoretical maximum [17]. Another study looked at producing 
butyl esters instead of butanol [15]. This work focused on butyl butyrate production through a 
simultaneous clostridial fermentation, esterification of the formed butanol with butyrate, and 
extraction of the butyl butyrate by hexadecane. The high partition coefficient of butyl butyrate can 
facilitate product recovery from the broth. Moreover, butyl butyrate as a final product is a value-
added chemical that has numerous uses in the flavor and fragrance industry [18], and it is also 
compatible with Jet A-1 aviation kerosene for liquid fuel [19]. Overall, product diversification will 
help to make the ABE fermentation economically feasible by: i) increasing the value of the final 
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product, ii) decreasing product recovery costs, and iii) increasing the yield of the product by 
eliminating butanol inhibition during the ABE fermentation. 
 
1.2.4. Metabolic engineering of clostridia for enhanced strain properties 
To economically produce value-added chemicals from the ABE fermentation by C. 
beijerinckii, the metabolic performance of the strain needs to be significantly improved [20]. 
Metabolic engineering can be applied to overcome the drawbacks by improving strain 
characteristics toward increased solvent production and tolerance by solventogenic clostridia to 
the produced solvents [20-24]. To enable the metabolic engineering of C. beijerinckii, 
comprehensive understanding of cellular physiology and gene regulation as well as reliable genetic 
engineering tools are needed. Recently, the CRISPR/Cas9-based genome editing tool for C. 
beijerinckii has been constructed and applied to engineer this microorganism [25]. The CRISPR 
technology uses a short guide RNA to target DNA and a CRISPR-associated (Cas) nuclease to 
cleave DNA, with a DNA editing template, leading to precise genome editing [26]. Although it 
still needs further optimization for C. beijerinckii, the Cas9 system enables a more precise approach 
to re-direct the C. beijerinckii metabolic flux to solvents or set of other products by knocking 
down/knocking out or overexpressing specific genes [27, 28]. Despite the development of an 
efficient genetic engineering tool, the lack of basic genetic information for C. beijerinckii such as 
promoter strength, gene regulation, and protein stability has hindered metabolic engineering of 
this microorganism. Also, the available E. coli-clostridia shuttle vectors used for delivery of 
engineering tools into C. beijerinckii is limited. Moreover, heterologous protein overexpression in 
C. beijerinckii that is a prerequisite for metabolic engineering has not been confirmed. 
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In order to gain knowledge of gene expression and regulation in C. beijerinckii, an in vivo 
fluorescent reporter system can be employed. Also, stability and efficiency of protein 
overexpression in C. beijerinckii can be investigated by expressing fluorescent reporter and 
measuring the intensity. In general, green fluorescence protein (GFP) and relative analogs have 
been widely used as real-time reporters in prokaryotes and eukaryotes [29]. However, GFP-family 
proteins require molecular oxygen for fluorescence maturation [30]. Considering the strict 
anaerobic growth conditions of the clostridia, an oxygen-independent flavin mononucleotide-
based fluorescent protein (FbFP) can be used as an alternative fluorescence reporter. After 
collecting essential genetic information using the oxygen-independent fluorescence reporter, both 
the Cas9 toolbox and a gene overexpression system can be further explored and employed for the 
metabolic engineering of C. beijerinckii. 
 
1.3. Production of 1-butanol and butyl isomers in other microorganisms  
Due to the difficulty of engineering solventogenic clostridia, other conventional model 
microorganisms such as Escherichia coli and Saccharomyces cerevisiae have been employed to 
produce butanol. First, the engineered E. coli containing the solvent-producing genes from C. 
acetobutylicum was able to produce 552 mg/L of 1-butanol from 2% glycerol as a carbon source 
[31]. Another engineered E. coli produced 1.18 g/L (16 mM) of 1-butanol from 4% glucose [32]. 
Later, significant improvement has been achieved by introduction of reverse β-oxidation pathway 
into E. coli, resulting in more than 15 g/L butanol titer [33, 34]. 
S. cerevisiae has also been engineered to produce 1-butanol by introducing the metabolic 
genes from C. beijerinckii, but the titer was limited to 2.5 mg/L [35]. The butanol titer was further 
increased up to 6.6 mg/L by replacing one of the enzymes in the pathway, the NADH-dependent 
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trans-enoyl-CoA [36]. Later, several other enzymes were overexpressed in S. cerevisiae resulting 
in increased butanol production to 20 mg/L [37]. To overcome the limitation of cytosolic acetyl-
CoA, the pyruvate dehydrogenase (Pdh) bypass pathway was employed together with butanol 
production pathway, resulting in 120 mg/L butanol in S. cerevisiae. The butanol titer was further 
increased to 242.8 mg/L through endogenous pathway involved in threonine metabolism in S. 
cerevisiae [38]. By optimizing the enzyme and substrate supply, 1-butanol production with 
engineered yeast was improved up to 0.86 g/L [39]. Overall, 1-butanol production in yeast using 
heterologous butanol biosynthetic pathway from solventogenic clostridia was limited due to many 
aspects such as the availability of coenzyme A and cytosolic acetyl-CoA, cofactor imbalance as 
well as the toxicity of 1-butanol.  
Other than 1-butanol, branched-chain alcohols such as isobutanol, 2-methyl-1-butanol, 3-
methyl-1-butanol have been produced from E. coli and S. cerevisiae through the Ehrlich pathway 
using an amino acid intermediate as a substrate for alcohol production [40, 41]. Many different 
keto acid intermediates derived from the amino acid biosynthetic pathway can be converted to 
fusel alcohols by the keto acid decarboxylase (Kdc) and the alcohol dehydrogenase (Adh). Using 
this strategy, butanol and butanol isomers have been produced by engineered non-solventogenic 
clostridia [42-44] as well as other microorganisms [45-47].  
 
1.3.1. Production of 2,3-butanediol by engineered yeast 
2,3-Butanediol (2,3-BD) is butanol isomer which is a platform chemical with wide industrial 
applications and is naturally produced from S. cerevisiae. To increase 2,3-BD production, 
metabolic engineering of S. cerevisiae has been applied. First, the heterologous 2,3-BD 
biosynthetic pathway was introduced into S. cerevisiae (Fig. 1.4) [48]. Second, byproduct 
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pathways such as ethanol and glycerol were eliminated from S. cerevisiae [48, 49]. Third, cofactor 
imbalance problem derived from the stoichiometry of 2,3-BD biosynthesis was alleviated by 
introducing additional electron acceptors and adjusting respiration rate [50-52]. The resulting 
recombinant S. cerevisiae was able to produce up to 154.3 g/L 2,3-BD from glucose which is 
comparable with native 2,3-BD producing bacteria [52]. Other than glucose, various carbon 
sources including xylose [53], cellobiose [54], and galactose [51] were investigated for 2,3-BD 
production by the engineered yeast. 
 
1.3.2. Production of isobutanol by engineered yeast 
Isobutanol can be produced via the Ehrlich pathway involved in fusel alcohol production in 
yeast. 2-Ketoisovalerate (KIV) which is an intermediate of valine biosynthesis pathway is 
decarboxylated to isobutyraldehyde by ketoisovalerate decarboxylase (Kivd) and further 
converted to isobutanol by Adh. In yeast, the valine biosynthesis pathway (upstream) is located in 
mitochondria, but the alcohol production pathway (downstream) is located in the cytosol (Fig. 
1.6). To produce isobutanol in the cytosol, KIV produced in the mitochondria needs to be 
transported to the cytosol. Overexpressing the upstream pathway in the mitochondria [55] and the 
cytosol [56] were carried out to enhance isobutanol production in S. cerevisiae. Later, the 
downstream pathway was integrated into the mitochondria to connect two pathways in the same 
compartment, and this approach yielded isobutanol up to 635 mg/L [57]. The isobutanol 
production was further improved by 1.62 g/L when the full cytosolic upstream pathway with 
parallel mitochondrial pathway were overexpressed in the engineered S. cerevisiae lacking the 
pyruvate dehydrogenase complex gene LPD1 [58]. This titer is the maximum isobutanol titer that 
has been achieved by S. cerevisiae in academic research. Previous studies suggested that the 
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reasons for the low production of isobutanol are the limitation of biogenesis of Fe-S cluster in the 
cytosol which is essential for enzyme activity of the dihydroxyacid dehydratase (Dhad) in the 
amino acid biosynthesis pathway [59]. Several attempts have been made to enhance the Dhad 
activity, but it is a challenge in S. cerevisiae due to the complexity of Fe-S assembly [60]. Also, 
cofactor imbalance between glycolysis (NADH) and the enzyme acetohydroxyacid 
reductoisomerase (Ahar) (NADP+) in the upstream pathway has resulted in low cell growth and 
inefficient biosynthesis of isobutanol. Overall, the production of isobutanol in S. cerevisiae still 
has room for improvement and requires further investigation of metabolic limitations.        
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1.4. Figures and tables 
 
Figure 1.1. Metabolic pathways to produce 1-butanol and butanol isomers by metabolically 
engineered Clostridium beijerinckii and Saccharomyces cerevisiae investigated in this thesis. 
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Figure 1.2. The life cycle of Clostridium beijerinckii and its metabolism. (A) Spore, (B) 
Vegetative cell, (C) Clostridial form, (D) Forespore.   
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Figure 1.3. The metabolic pathway for ABE fermentation by Clostridium beijerinckii. The 
figure is adapted from the previous review [61]. 
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Figure 1.4. The metabolic pathway for 2,3-BD production in yeast. AlsS, acetolactate synthase; 
AlsD, acetolactate decarboxylase; BDH1, 2,3-butanediol dehydrogenase; PDC, pyruvate 
decarboxylase; ADH, alcohol dehydrogenase; GPD, glycerol-3-phosphate dehydrogenase. 
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Figure 1.5. The metabolic pathway for isobutanol production in yeast. ILV2, acetolactate 
synthase; ILV5, acetohydroxyacid reductoisomerase; ILV3, dihydroxyacid dehydratase, BAT1, 
branched-chain amino-acid aminotransferase isozyme 1; Kivd, ketoisovalerate decarboxylase; 
ADH2, alcohol dehydrogenase isozyme 2; TDH3, Glyceraldehyde-3-phosphate dehydrogenase; 
PDC, pyruvate decarboxylase; PDA1, a subunit of pyruvate dehydrogenase complex.  
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CHAPTER II       UNDERSTANDING AND OPTIMIZATION OF 1-BUTANOL 
PRODUCTION BY CLOSTRIDIUM BEIJERINCKII WILD TYPE AND ITS MUTANT 
 
The content of this chapter will be submitted to Bioresource technology.  I am the first author of the 
paper. I performed the research and Drs. Yong-Su Jin and Hans Blaschek are the directors of the research. 
 
2.1. Introduction 
Increasing concerns over climate change, global warming, and the finite nature of fossil fuels 
have induced the research toward alternative biofuel and biochemical production from renewable 
biomass [62]. Biobutanol is an attractive renewable liquid biofuel commonly produced from the 
ABE (acetone, butanol, and ethanol) fermentation by solventogenic clostridia that has a long 
history going all the way back to Pasteur [63]. With an eye toward maximizing solvent production 
for economic industrial ABE fermentation, several mutants of solventogenic clostridia with an 
increased solvent yield and titer have been constructed [64, 20]. Previously, the Clostridium 
beijerinckii BA101 mutant was generated in the presence of the glucose analogue, 2-deoxyglucose 
(2-DG), using a chemical mutagen to increase the amylolytic activity when grown in a starch 
medium [14]. The 2-DG resistant mutant BA101 demonstrated 1.8-fold higher amylolytic activity 
than that of the C. beijerinckii NCIMB 8052 wild-type strain grown in starch. In glucose medium, 
BA101 produced more solvents with a higher butanol titer than the wild-type strain by consuming 
glucose more completely. Owing to the hyper-butanol producing phenotype, the BA101 strain has 
been widely studied and employed to produce solvents from various carbon sources [65-71, 10, 
72-79]. However, under certain conditions, BA101 did not demonstrate the superior solvent-
producing phenotype and sometimes exhibited an “acid crash” phenotype, resulting in large 
variations of butanol titer and yield when compared to previous studies (Table 2.1). The acid crash 
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phenotype is caused by rapid glucose uptake and acid production during the early phase of growth 
resulting in the failure of solvent production [80]. However, in the presence of proper fermentation 
conditions for relieving the acid toxicity, the BA101 strain was able to produce high concentration 
of solvents resulting from improved acid production and sugar uptake [81]. To control the 
performance of the BA101 mutant by minimizing variations from run to run, there is a demand for 
investigating environmental factors influencing the ABE fermentation. Also, the fermentation 
conditions need to be optimized to have the BA101 mutant constantly outperform the wild type 
strain as the previous studies exhibited. To investigate the effect of environmental factors on the 
ABE fermentation profiles, I first selected three factors including agitation, inoculum age, and 
yeast extract supplementation [82-84]. The environmental factors were optimized toward 
increasing butanol production using the one-factor-at-a-time approach. 
The first environmental factor to be investigated was the agitation rate since agitation of the 
medium has a dramatic effect on the overall fermentation results by C. beijerinckii (Fig. 2.1) [4]. 
Agitation can enhance the distribution of nutrients, the microbial cells and fermented products 
secreted by the cells throughout the fermentation vessel. In the absence of agitation, C. beijerinckii 
cells are precipitated at the bottom of fermentation vessel over time. If the fermentation products 
and intermediates are toxic to the cell, uniform distribution of products may increase the inhibition 
of cell growth, while the distribution of nutrients may enhance cell growth. Also, gas production, 
accumulation, and reassimilation by the cells may be affected by the continuous mixing that 
releases the gas out of the medium [82]. Agitation can also attenuate the natural movement of the 
cells such as chemotaxis that responds to a chemical stimulus in the environment. Usually, the 
small-scale ABE fermentation in an anaerobic chamber has been performed in a tube or bottle in 
the absence of agitation, while fermentation in a bioreactor has employed the agitation by impellers 
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together with purging the nitrogen gas bubbles. This may be the reason why there have been large 
variations in solvent production among various fermentation runs with different working volumes 
and experimental settings (Table 2.1).  
Next, the effect of the age of inoculum employed for the main fermentation was investigated 
and optimized considering its importance for contributing to the heterogeneity of the culture (Fig. 
2.1). Since solventogenic clostridia have unique properties such as cell differentiation and biphasic 
metabolism, the ABE fermentation consists of a heterogeneous cell population with a high degree 
of complexity [1]. The cell differentiation process during the course of the fermentation 
demonstrates four different forms of the clostridial cell including the vegetative state, clostridial 
form, forespore, and free spore. Each of the cell types has a different metabolism, and the acids 
and solvents produced are the products resulting from the unique life cycle of solventogenic 
clostridia [85]. Thus, the different initial population in the inoculum affects the overall profile of 
metabolites accumulated during the fermentation [83].  
Yeast extract supplementation was also considered for investigation since yeast extract is a 
good source of nitrogen and nutrients that increase the growth rate and biomass concentration [84]. 
In the solventogenic clostridia, the rapid cell growth and metabolism by increasing nutrients 
sometimes resulted in dramatic acid production and a corresponding decrease in pH, causing the 
acid crash phenotype (Fig. 2.1) [80]. However, a sufficient amount of yeast extract also has a 
buffering capacity by maintaining the pH of the medium above 5.0 that helps to relieve acid 
toxicity [86, 87]. Considering both beneficial and detrimental effects of the yeast extract, the 
amount of yeast extract supplemented to the medium may be an important factor in determining 
the performance of C. beijerinckii. During this investigation, the major environmental factors were 
optimized for increasing solvent production by both the wild-type and the BA101 mutant using a 
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one-factor-at-a-time approach in the small-scale fermentation platform using the bottle in an 
anaerobic chamber. Finally, the selected conditions were further employed for large-scale batch 
fermentations in a bioreactor with the pH control above 5.5 to alleviate acid toxicity [88].  
In this study, I developed a scaled down evaluation fermentation platform, evaluated three 
major environmental factors (agitation, inoculum age, and yeast extract) with optimization of 
conditions toward increasing butanol production, and then scaled up the fermentation process in 
the presence of pH control. The framework and dataset presented in this study advances our 
understanding of complex clostridial ABE fermentation, and can also be used as a guideline for 
strain development, optimization, and computational metabolic model development.    
 
2.2. Materials and methods 
2.2.1. Bacterial strains, media, and growth conditions 
Laboratory spore stocks of C. beijerinckii NCIMB 8052 wild-type strain and the C. 
beijerinckii BA101 mutant were stored in double-distilled and autoclaved H2O at 4°C. For pre-
culture, spore solutions were heat-shocked at 80°C for 10 min, followed by cooling on ice for 5 
min. The heat-shocked spores were inoculated at an 1% (v/v) inoculum level and grown 
anaerobically at 35ºC in the TGY medium containing the following compounds: 30 g/L tryptone, 
20 g/L glucose, 10 g/L yeast extract and 1 g/L L-cysteine [81]. The growing cultures were 
inoculated into the P2 or P2YE medium containing sugars in BioFlo® 115 benchtop bioreactors 
(New Brunswick Scientific Co., CT, USA) at a 5% (v/v) inoculum level. The P2 medium contained 
the following compounds: 0.5 g/L KH2PO4; 0.5 g/L K2HPO4; 2.2 g/L CH3COONH4; 0.2 g/L 
MgSO4·7H2O; 0.01 g/L MnSO4·H2O; 0.01 g/L FeSO4·7H2O; 0.01 g/L NaCl; 1 mg/L p-
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aminobenzoic acid; 1 mg/L thiamin-HCl; 10 µg/L biotin. For the P2YE medium, 1 g/L yeast exact 
was additionally added to the P2 medium.  
 
2.2.2. Fermentation experiments 
For investigating the effect of environmental factors involved in the ABE fermentation, batch 
fermentations were performed in a small-scale fermentation platform using a 100 ml Pyrex glass 
bottle without pH control in an anaerobic chamber. The fermentation bottle was kept in an 
anaerobic chamber for over 8 hours to initiate an anoxic condition before inoculation. A battery-
powered portable magnetic stirrer (Cole-Parmer, IL, USA) was employed to investigate the effect 
of agitation. For the effect of age of inoculum, a growing culture in the TGY medium was 
transferred to the P2 medium at three different time points (12 h, 24 h, and 48 h). For the effect of 
yeast extract supplementation, three different concentrations of yeast extract (at final 
concentrations of 0, 1, and 5 g/L) were added into the P2 medium. The batch fermentations in a 
bioreactor with 1.5 L working volume were performed at 35°C with pH control above 5.5 using 
2M KOH. Oxygen-free nitrogen was purged through the culture to make an anaerobic 
environment. For the wild-type strain, agitation was employed at 55 rpm. During the fermentation, 
samples were collected for measurement of cell growth and fermentation products. 
 
2.2.3. Analysis of cell growth, pH, and fermentation products 
Cell growth was measured by optical density (OD) in the fermentation broth at A600 using a 
BioMate3 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). The pH profiles of each 
fermentation in a bioreactor were recorded using the NBS BioCommand® software (New 
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Brunswick Scientific Co., Enfield, CT). ABE products and butyric acid concentrations were 
quantified using gas chromatography (GC) (Agilent Technologies, CA, USA) equipped with a 
flame ionization detector (FID), while sugar and acetic acid concentrations were quantified using 
high-performance liquid chromatography (HPLC) (Agilent Technologies, Santa Clara, CA) 
equipped with an RI detector using a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex 
Inc., CA, USA) as previously reported [89].  
 
2.2.4. Genomic DNA isolation, library construction, and sequencing  
Genome sequencing of BA101 mutant and wild-type strain was performed to identify genetic 
variations involved in the phenotypic difference using Illumina sequencing. The shotgun genomic 
library was prepared with the Hyper Library construction kit from Kapa Biosystems. The library 
was quantitated by qPCR and sequenced on a HiSeq 2500 using a HiSeq Rapid SBS sequencing 
kit version 2 in the Roy J. Carver Biotechnology Center. The Illumina sequences were generated 
and demultiplexed with the bcl2fastq v2.17.1.14 conversion software (Illumina). Adaptor was 
trimmed from the 3'-end of the reads. The sequence reads of low-quality data were trimmed with 
a quality score limit of 0.05 in CLC Genomics Workbench 9.5 (CLC Bio, Aarhus, Denmark, 
http://www.clcbio.com) and reads of less than 15 bp were discarded. The trimmed sequences were 
assembled by the reference-guided assembly (map reads to reference) against the published C. 
beijerinckii NCIMB 8052 genome sequence in CLC Genomics Workbench. Probabilistic variants 
were detected with the following factors: minimum coverage = 10 and probability = 90 and a filter 
ignoring non-specific matches and broken pairs. The variants were filtered against reference 
variants from the wild-type strain [2]. Annotation and amino acid change analysis were carried out 
with the following short-read parameters: mismatch cost = 2, insertion cost = 3, deletion cost = 3.  
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2.3. Results and discussion 
2.3.1. Development of the small-scale fermentation platform for systematic investigation of 
optimal conditions for butanol production 
To investigate the effect of the various environmental factors on the ABE fermentations, a 
small-scale fermentation platform allowing high throughput evaluation and process optimization 
was developed and used as a single standard platform to minimize variations between runs. The 
platform was set up using a 250 ml screw-cap Pyrex glass bottle and battery-powered portable 
magnetic stirrer to allow agitation of the culture in an anaerobic chamber. To check if the small 
scale platform is suitable for ABE fermentation evaluation, batch fermentation of C. beijerinckii 
wild-type strain in the small-scale platform was performed and compared with the fermentation 
result in a bioreactor under the same conditions (Fig. 2.2). The ABE fermentation in the small-
scale platform demonstrated the typical ABE fermentation profile without significant 
discrepancies with the fermentation profile in a bioreactor. The result suggests that the small-scale 
platform was suitable for performing the ABE fermentation and can be scaled up with a similar 
expectation of performance. Therefore, I used the small-scale fermentation platform for systematic 
investigation of various environmental factors and optimization toward increasing butanol 
production. I first selected three variable factors including agitation, inoculum age, and yeast 
extract supplementation that may impact the ABE fermentation profile (Fig. 2.1). Using the one-
factor-at-a-time approach, three sets of batch fermentations of both the BA101 and the wild-type 
strains were performed sequentially using the small-scale fermentation platform (Fig. 2.3-2.5). The 
fermentation conditions for each strain were optimized toward increasing butanol titer and glucose 
uptake.     
 
23 
 
2.3.2. Effect of agitation on butanol production 
The first environmental factor I investigated was agitation of the culture. The batch 
fermentation of the C. beijerinckii wild-type strain and the BA101 strain were performed with and 
without agitation using the small-scale fermentation platform (Fig. 2.3). I first used a baseline 
fermentation condition with P2 medium containing 60 g/L glucose and a TGY pre-culture that was 
previously used for the ABE fermentation of each strain [90, 89, 91]. As shown in Fig. 2.6, with 
the agitation, the butanol titer for the C. beijerinckii wild-type strain increased from 8.7 g/L to 10.4 
g/L. The glucose uptake by the wild-type was also enhanced from 29.7 g/L to 40.8 g/L. However, 
the butanol titer by the BA101 mutant significantly decreased from 9.6 g/L to 4.8 g/L in the 
presence of agitation. The initial glucose uptake rate of the BA101 mutant increased in the presence 
of agitation, but the total amount of glucose uptake was reduced by agitation because the BA101 
strain stopped consuming glucose after 24 h (Fig. 2.3). These results suggest that agitation of the 
culture is beneficial to the wild-type strain with respect to butanol production and glucose uptake, 
while it is detrimental to the BA101 mutant. When the agitation rate was increased up to 300 rpm 
in the same medium, the BA101 strain demonstrated the acid crash phenotype, exhibiting severe 
inhibition of glucose uptake at the early stage of the fermentation (Data not shown due to no cell 
growth). In the batch fermentation of the 8052 wild-type strain, acetone production significantly 
increased in the presence of agitation from 2.5 g/L to 5.6 g/L. This was more than twice as high as 
that without agitation (Fig. 2.3). This result agreed with the previous study for the C. beijerinckii 
wild-type strain which reported that the butanol/acetone ratio dramatically decrease with an 
increase in agitation [4]. Overall, the batch fermentation of the BA101 strain in the presence of 
agitation yielded lower solvent production but accumulated more acids when compared to the 
fermentation without agitation. In particular, butyrate produced during the early stage of 
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fermentation was not re-assimilated, thereby decreasing the pH of the culture below 5.0. These 
results suggest that cell growth and acid production by the BA101 strain that was drastically 
enhanced by the agitation may be the cause of acute acid toxicity. Based on this result, another set 
of batch fermentations were carried out with agitation for the wild-type strain and without agitation 
for the BA101 mutant strain in order to investigate the subsequent environmental factor and 
optimize the conditions for increased butanol production. 
 
2.3.3. Effect of different inoculum age on butanol production 
The age of inoculum can effect the heterogeneity of the cells employed for the main 
fermentation. A short period of pre-culture has a large population of vegetative cells of C. 
beijeirnckii and a longer period of pre-culture will include more differentiated cell types such as 
clostridial form and pre-spore forms (Fig. 2.1). Also, the number of cells inoculated into the main 
fermentation will be different with varying harvest times as demonstrated by a pre-culture that has 
different optical density values at different time points. Thus, the status of inoculum is an important 
environmental factor to maintain fermentation quality and consistency. To evaluate the impact of 
different inoculum age on the main fermentation profile, I simply used three different ages of the 
inoculum, 12 h, 24 h, and a 48 h-old TGY preculture. Figure 2 shows the effect of the inoculum 
age on the butanol production and glucose uptake of both the wild-type 8052 strain and the BA101 
strain in the small-scale fermentation platform. In the case of the wild-type strain, the highest 
butanol titer was achieved when the 48 h-old pre-culture was used (Fig. 2.6B). However, the 
BA101 strain produced more butanol when the 12 h-old pre-culture was used. Glucose uptake also 
demonstrated a similar pattern with the butanol production (Fig. 2.6E). These results suggest that 
a younger age of the inoculum is beneficial to the BA101 fermentation, while an older age of the 
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inoculum is beneficial to the wild-type strain with respect to butanol production and glucose 
uptake. The wild-type and the BA101 mutant also demonstrated a different response to the 
inoculum age for overall fermentation profile (Fig. 2.4). Successful butyrate re-assimilation of the 
BA101 mutant at the late growth phase was observed only when the 12 h-old inoculum was used. 
For the one-factor-at-a-time approach to maximize butanol production and investigate the next 
factor, I fixed two environmental factors for each strain as follows: i) agitation and, ii) the 48h-old 
inoculum for the wild-type strain, and, i) no agitation and ii) the 12 h-old inoculum for the BA101 
strain.  
  
2.3.4. Supplementation of the medium with yeast extract.  
To examine the effect of yeast extract supplementation to the main culture medium, I used 
three different concentrations, 0 g/L, 1 g/L and 5 g/L of yeast extract. The batch fermentations in 
P2 medium with different yeast extract concentrations were carried out in the small-scale 
fermentation platform under the condition in which two previous environmental factors were fixed 
for each strain. As a result, the highest butanol titers were achieved from both strains when 5 g/L 
yeast extract was added to the P2 medium (P2YE5) (Fig. 2.6C). The BA101 mutant strain produced 
more butanol (up to 13.4 g/L) than the wild-type strain from less glucose (Fig. 2.6C and 2.6F). 
However, 1 g/L of yeast extract did not demonstrate significant increases in butanol production 
and glucose consumption for both strains. The results suggest that a sufficient amount of yeast 
extract supplementation helps to increase butanol titer regardless of the strain being used. Cell 
growth, glucose uptake and acetone production of both strains were also enhanced in the presence 
of 5 g/L of yeast extract supplementation to the medium (Fig. 2.5 and 2.6F). Yeast extract provides 
not only nutrients for cell growth but also provides a buffering effect which can alleviate acid 
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toxicity [92]. At 12 h of culture, the external pH was maintained at 6.0 when yeast extract was 
added to the medium, while the pH value decreased to 5.1 when no yeast extracted was added, 
although similar amounts of butyrate and acetate were produced (Fig. 2.5). The effect of the yeast 
extract on butanol titer was more dramatic in the BA101 mutant. This may be because the BA101 
mutant may get more benefit from the yeast extract supplementation than the wild-type strain due 
to the effect of buffering on acid toxicity. I further investigated the effect of pH control on the 
fermentation to see whether butanol production can be improved by maintaining a high pH value 
of the culture.   
 
2.3.5. Effect of pH control 
Since it is not easy to control the pH of the culture in the small-scale fermentation platform, I 
carried out the batch fermentations in a bioreactor employing pH control under the optimized 
conditions for each strain (Fig. 2.7). In a bioreactor with 1.5 L culture volume, the wild-type strain 
produced 11.4 g/L butanol without pH control which was the similar amount to that (11.5 g/L) in 
the small-scale fermentation platform under the same condition. The BA101 strain produced 13.3 
g/L butanol in a bioreactor without pH control which was also similar to that of the small-scale 
fermentation (13.4 g/L) under the same conditions. These results suggest that optimization and 
fermentation results from the small-scale fermentation platform can be scaled-up to the bioreactor 
scale without significant variation if the environmental factors are controlled. In the presence of 
pH control above 5.5, butanol production by the wild-type strain increased from 11.4 g/L to 12.4 
g/L. The BA101 mutant strain achieved the highest butanol titer (14.5 g/L) with the pH control 
from among all the conditions I investigated. Also, glucose uptake of both strains was enhanced 
in the presence of pH control which may have resulted in the increased butanol titer. Overall, 
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maintaining the pH of the culture above 5.5 was beneficial to both the wild-type strain and the 
BA101 mutant for glucose uptake and butanol production. Once the culture pH was controlled, the 
BA101 outperformed the wild-type strain by consuming more glucose and producing more butanol 
at a faster rate than the 8052 wild-type strain under the optimized fermentation conditions. 
 
2.3.6. Genome sequencing and analysis of genetic mutations in BA101 
To identify the genetic factor involved in the differences in phenotypes and responses to the 
environmental changes between the 8052 wild-type and the BA101 mutant, I performed genome 
sequencing of both the wild-type and the BA101 strains. For the BA101 strain, two different cell 
stocks were stored separately at different times to sort out any spontaneous mutations occurred 
during the passage of the culture in the lab. Through the comparative analysis of the wild-type 
strain and the BA101 strains, several genetic variations were detected and confirmed by Sanger 
sequencing (Table 2.2). Most of the genomic variations were also present in the sibling strains, 
BA105 and SA1 that were constructed from the same 8052 parental strain as the BA101 mutant 
[5, 14, 2]. One single nucleotide polymorphism (SNP) unique to the BA101 strain was found in 
the genome of both BA101 cell stocks. This SNP may be the responsible mutation affecting the 
phenotype of the BA101 mutant. The SNP was located at the 2,113 bp (G to T) position of the 
Cbei_3078 gene encoding PAS/PAC sensor hybrid histidine kinase in the BA101 strain (Fig. 2.8). 
The point mutation introduced the stop codon at the 705th codon in a response regulator receiver 
domain of the protein, resulting in expression of the truncated histidine kinase. The truncated form 
of histidine kinase without the complete response regulator receiver domain may not be functional 
in the BA101 mutant. The malfunction of histidine kinase in the BA101 mutant may explain the 
phenotype of the BA101 mutant including the increased sugar uptake, acid overproduction, delay 
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of solventogenesis, high solvent production and sometimes demonstrating the acid crash 
phenotype. The sensory histidine kinase is involved in an initiation of sporulation in solventogenic 
clostridia by directly controlling the phosphorylation status of Spo0A which is a master regulator 
of sporulation [93]. In solventogenic clostridia, the Spo0A is involved in the metabolic switch 
from acidogenesis to solventogenesis [94]. Histidine kinase also controls sugar uptake and the acid 
production pathway of the solventogenic clostridia by repressing metabolic proteins [95]. 
Regarding these regulations, the mutant histidine kinase in BA101 mutant may cause an 
upregulation of sugar uptake and acid biosynthetic pathways and a delay in the solventogenenic 
switch, thereby accumulating high amounts of acids. Also, the increased sugar uptake and acid 
accumulation may accelerate the acid crash phenotype of the BA101 mutant under certain 
fermentation conditions. However, these phenotypes of the BA101 mutant can be advantageous 
for solvent production if the fermentation condition successfully alleviates acid toxicity. A 
previous study reported the similar observation that the C. acetobutylicum strain containing a 
mutation in histidine kinase significantly altered the acid and solvent producing phenotype and 
cell growth [96]. The mutant strain produced the higher amounts of solvent when compared to the 
wild-type strain. The effect of the mutation on the global regulator was also proven in other 
solventogenic clostridia. Thus, a further study can be performed to investigate the effect of the 
mutant histidine kinase found in the BA101 mutant through reverse engineering of wild-type C. 
beijerinckii. Also, the mutation may be introduced into the histidine kinase of other clostridia to 
generate similar phenotypes of BA101 mutant for increasing sugar uptake and solvent production. 
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2.4. Conclusions 
Overall, the responses to environmental factors by the C. beijerinckii BA101 mutant are quite 
different with the wild-type strain. Both strains have their own optimum fermentation conditions 
allowing increased solvent production. For the wild-type strain, the highest butanol production 
(12.4 g/L) was achieved with the 48 h-old inoculum and 5 g/L yeast extract in the presence of 
agitation with pH control above 5.5. For the BA101 strain, the highest butanol production (14.5 
g/L) was achieved when the 12 h-old inoculum and 5 g/L yeast extract without agitation were 
employed with pH control above 5.5. Thus, following strain development, it is necessary to 
understand mutants by evaluating the strains and optimizing the fermentation conditions in order 
to guide them for their best performance rather than using standard fermentation conditions. Based 
on previous reports demonstrating a high concentration of butanol produced by BA101, the current 
fermentation conditions are not fully optimized. Nevertheless, this work advances our 
understanding of complex clostridial ABE fermentations in general, as well as by the hyper-
butanol producing mutant of C. beijerinckii. The identified genetic mutation (i.e. histidine kinase) 
in the BA101 mutant may be applied to other solventogenic clostridia to increase butanol 
production under optimized fermentation conditions. 
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2.5. Figures and tables 
 
Figure 2.1. The rationale for selection of three factors involved in the ABE batch 
fermentation with a focus on maximizing butanol production. (A) Agitation, (B) Inoculum 
age, (C) Yeast extract supplementation.  
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Figure 2.2. The batch fermentation profile of the Clostridium beijerinckii NCIMB 8052 
wild-type strain in the small-scale platform in P2 medium with agitation (A) and a 2L 
bioreactor under the same condition (B). 
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Figure 2.3. The effect of agitation on the ABE batch fermentations by C. beijerinckii 
NCIMB 8052 wild-type (A) and the mutant BA101 (B). This figure represents the one 
fermentation profile from duplicate experiments.   
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Figure 2.4. The effect of inoculum age on ABE batch fermentations by C. beijerinckii 
NCIMB 8052 wild-type (A) and the mutant BA101 (B). This figure represents the one 
fermentation profile from duplicate experiments.   
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 Figure 2.5. The effect of yeast extract supplementation on the ABE batch fermentations by 
C. beijerinckii NCIMB 8052 wild-type (A) and the mutant BA101 (B). This figure represents 
the one fermentation profile from duplicate experiments.   
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Figure 2.6. The effect of agitation, inoculum age, and yeast extract supplementation on the 
butanol titer and glucose uptake by C. beijerinckii NCIMB 8052 wild-type and the BA101 
mutant in a small-scale fermentation platform. All results are the average of duplicate 
experiments, and the error bars represent standard deviations. 
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Figure 2.7. The batch fermentation profiles of the C. beijerinckii NCIMB 8052 wild-type (A 
and B) and the BA101 mutant (C and D) under the optimized conditions for each strain in 
a bioreactor without pH control and with the pH control above 5.5. The environmental 
factors used for the fermentation of each strain are indicated at the bottom of the profiles.  
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Figure 2.8. Identification of a single nucleotide polymorphism (SNP) in the PAS/PAC sensor 
hybrid histidine kinase (Cbei_3078) in the C. beijerinckii BA101 mutant. In BA101, the 
introduced stop codon at 705 bp of the open reading frame will result in the truncated version of 
the protein without the complete response receiver domain.  
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Table 2.1. Batch fermentation results for butanol production by the C. beijerinckii mutant 
BA101 from previous studies 
 
a P2YE medium is designated for the P2 medium containing 1 g/L yeast extract 
b CSW medium contains only FeSO4-7H2O beside the carbon source 
c MP2 medium is designated for the P2 medium replacing sodium acetate with ammonium sulfate 
d LCS medium contains the P2 buffer solution and FeSO4-7H2O 
 
  
Carbon source Base medium 
Working 
volume (L) 
Butanol yield 
(g/g sugar) 
Butanol 
titer (g/L) Reference 
6% Glucose P2YEa 20 0.32 18.6 [65] 
6% STAR-DRI 5 maltodextrins P2YE 20 0.35 18.6 [65] 
5% Glucose/corn steep water CSWb 20 NA 16.0 [68] 
6% Glucose/corn steep water CSW 200 0.30 17.8 [68] 
8% Glucose / 60 mM sodium acetate MP2c 1 0.30 20.9 [66] 
6% Glucose / 60 mM sodium acetate MP2 1 NA 18.6 [66] 
6% Glucose P2YE 0.8 0.34 19.7 [70] 
6% Glucose P2YE 1.6 0.27 11.9 [75] 
6% Glucose P2YE 0.1 0.30 13.7 [97] 
6% Liquefied corn starch LCSd 1 0.30 13.4 [97] 
Model agricultural waste (96.4 g/L starch) - 1 0.22 13.0 [98] 
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Table 2.2. All single nucleotide polymorphisms (SNPs) and genome arrangements detected in 
C. beijerinckii BA101 compared to the wild-type of C. beijerinckii NCIMB 8052  
 
*The BA105 strain is a sibling strain of BA101 that was constructed from the same parental strain at the 
same time. (The sequencing result of BA105 will be published in Biotechnology Journal) 
 
  
Genome 
position Gene Protein name 
Nucleotide 
change 
Amino acid 
change 
Shared by 
other 
siblings 
935449 cbei_0769 extracellular solute-binding protein C to T 
CAA (Gln) to 
UAA (Stop) 
SA-1[2], 
BA105* 
1099983 cbei_0917 hypothetical protein TAAATA to T frameshift 
SA-1, 
BA105 
2149286 cbei_1854 peptidase S8/S53 subtilisin kexin sedolisin T to C 
GUU (Val) to 
GCU (Ala) 
SA-1, 
BA105 
2234607 cbei_1935 PucR transcriptional regulator C to A CAU (His) to AAU (Asn) 
SA-1, 
BA105 
2295776 cbei_1975 adenine deaminase G to T GCU (Ala) to UCU (Ser) 
SA-1, 
BA105 
2611044 89 bp upstr. cbei_2247 hypothetical protein C to T - 
SA-1, 
BA105 
3591468 cbei_3078 PAS/PAC sensor hybrid histidine kinase G to T 
GAA (Glu) to 
UAA (Stop) BA101 EM 
5075403 cbei_4400 serine/threonine protein phosphatase-like protein G to T 
CGG (Arg) to 
CUG (Leu) 
SA-1, 
BA105 
5556196 cbei_4761 cell wall binding repeat-containing protein T to C 
GUU (Val) to 
GCU (Ala) 
SA-1, 
BA105 
5769732 441 bp upstr. cbei_R0121 16s ribosomal RNA T to C - 
SA-1, 
BA105 
2073338 25 bp upstr. cbei_1789 deacetylase 
Large 
insertion - 
SA-1, 
BA105 
5770364 41 bp dwstr. Cbei_R0122 5s ribosomal RNA 
Duplication, 
Tandem - BA101 EM 
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CHAPTER III       PRODUCTION OF BUTYL BUTYRATE BY METABOLICALLY 
ENGINEERED CLOSTRIDIUM BEIJERINCKII 
 
The content of this chapter has been published in Biotechnology and Bioengineering Journal (Volume 114, 
Issue 1, January 2017, Pages 106–112). Permission to the reprint of the contents in this thesis was obtained 
from the publisher John Wiley and Sons (License number, 4090850080064). I was the first author of the 
paper and Yi Wang, Ting Lu, Yong-Su Jin, and Hans Blaschek were co-authors. I performed the research 
with help from the co-authors and Drs. Yong-Su Jin and Hans Blaschek were the directors of the research.  
 
3.1. Introduction 
Spo0A is a master regulator involved in sporulation, colony morphology, motility and 
chemotaxis in spore-forming Gram-positive bacteria such as Bacillus and Clostridium species [99-
101, 95, 102]. Particularly in the solventogenic clostridia including Clostridium acetobutylicum 
and C. beijerinckii which can produce a mixture of acetone, butanol, ethanol from sugars, Spo0A 
is also involved in the metabolic shift from acidogenesis to solventogenesis by controlling the 
expression of metabolic enzymes that are essential for solvent production [103-105, 13, 94]. To 
investigate the effect of spo0A gene disruption in C. beijerinckii, I constructed a C. beijericnkii 
spo0A mutant involving deletion of 262 bp genomic DNA fragment including the promoter region 
and an initial part of the spo0A ORF using CRISPR/Cas9-based genome engineering [25]. In this 
study, I characterized the fermentative behavior of the C. beijerinckii spo0A mutant in batch 
fermentations. 
In a batch fermentation with pH control, the spo0A mutant accumulated both butyrate and 
butanol over the course of the fermentation unlike a typical fermentation profile by wild-type C. 
beijerinckii. The wild-type strain produces acetate and butyrate first in the acidogenic phase and 
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later converts the formed acids into acetone, butanol, and ethanol in the solventogenic phase [1]. 
As the solventogenic shift occurs when a critical butyrate concentration is reached (usually less 
than 2 g/L), the wild-type strain does not accumulate butyrate to a high level in the medium [1, 
106, 107]. However, the spo0A mutant produced significant amounts of butyrate as well as butanol 
in a pH-controlled batch fermentation in this study, suggesting that the transition from acidogenic 
to solventogenic phases of the spo0A mutant is disrupted. 
Based on the unique phenotype, i.e., accumulating butyrate and butanol, of the C. beijerinckii 
spo0A mutant, I considered utilizing this strain to produce butyl butyrate that can be formed by the 
condensation of butyrate and butanol in the presence of lipase. For efficient butyl butyrate 
production, it is necessary to provide both butanol and butyrate simultaneously during the 
fermentation. However, the wild-type C. beijerinckii strain generates butyrate and butanol with 
unfavorable concentrations for the condensation reaction to occur. Therefore, butyl butyrate 
production can be limited if the wild-type C. beijerinckii is used. Consequently, the spo0A mutant 
is considered an advantageous solventogenic strain for in situ butyl butyrate production. 
Butyl butyrate is a value-added chemical that has numerous applications, for example, in the 
food and fragrance industry as a flavor compound and solvent [108, 18, 109, 110]. Also, butyl 
butyrate as a biofuel is compatible with Jet A-1 aviation kerosene and can be used for enrichment 
of biodiesels [17, 19]. Moreover, there is a growing interest in upgrading the ABE fermentation 
products to jet and diesel fuels via catalysis [16, 111]. Thus, butyl butyrate that can be produced 
from the ABE fermentation may be a promising target chemical. The production of butyl butyrate 
by simultaneous esterification and extraction during the ABE fermentation using C. 
acetobutylicum wild-type strain has been reported [15]. In situ extraction was applied to the 
process since butyl butyrate is more hydrophobic than other ABE products and can be concentrated 
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into the organic solvent phase. However, additional butyrate was fed into the system to overcome 
the substrate imbalance between butyrate and butanol produced by the wild-type strain.  
In this study, I eliminated the need for butyrate feeding since the C. beijerinckii spo0A mutant 
already accumulated a high level of butyrate along with butanol. To reduce the initial butyrate 
toxicity due to the accumulation of butyrate by the spo0A mutant, I maintained the pH of the 
medium using a calcium carbonate (CaCO3) buffer and supplemented the medium with butanol to 
initiate the esterification of butyl butyrate. As soon as butyrate is produced, the produced butyrate 
in the presence of the supplemented butanol is converted to butyl butyrate by the lipase CalB and 
extracted into the hexadecane layer. Continuous agitation was also performed to enhance the 
enzymatic esterification and extraction process of butyl butyrate production during the 
fermentation. 
 
3.2. Materials and methods 
3.2.1. Bacterial strains, media and growth conditions 
C. beijerinckii NCIMB 8052 wild-type strain and the spo0A mutant [25] constructed by 
CRISPR/Cas9-based marker-less genome engineering were used for this study. Laboratory spore 
stocks of C. beijerinckii 8052 were heat-shocked at 80oC for 10 min and inoculated into tryptone–
glucose–yeast extract (TGY) medium containing 30 g/L tryptone, 20 g/L glucose, 10 g/L yeast 
extract and 1 g/L L-cysteine with a 1% (v/v) ratio as previously described [107]. For the spo0A 
mutant, frozen cell stock stored at -80oC was inoculated into TGY medium. The TGY culture was 
incubated at 35oC for 12 h in an anaerobic chamber under N2:CO2:H2 (volume ratio of 85:10:5) 
atmosphere and was then inoculated into the main fermentation medium at a 5% inoculum level. 
C. beijerinckii strains were grown anaerobically at 35ºC in a model solution containing 60 g/L 
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glucose, 5 g/L yeast extract and filter-sterilized P2 medium (and thus the fermentation broth was 
designated as a P2YE5 medium). The P2 medium contained the following compounds: 0.5 g/L 
KH2PO4; 0.5 g/L K2HPO4; 2.2 g/L CH3COONH4; 0.2 g/L MgSO4·7H2O; 0.01 g/L MnSO4·H2O; 
0.01 g/L FeSO4·7H2O; 0.01 g/L NaCl; 1 mg/L p-aminobenzoic acid; 1 mg/L thiamin-HCl; 10 µg/L 
biotin [91]. 
 
3.2.2. Fermentation experiments 
For investigating the fermentation characteristics of the spo0A mutant, batch fermentations 
were performed with or without pH control. The growing culture of the spo0A mutant was 
inoculated into the P2YE5 medium in BioFlo® 115 benchtop bioreactors (New Brunswick 
Scientific Co., Enfield, CT) at a 5% inoculum level. The pH of the medium was controlled at 6.5 
by the addition of 2M HCl and 2M NaOH for the pH-controlled batch fermentation. High-purity 
nitrogen gas was purged through the medium until the OD600 of culture was reached at 2.0 which 
makes media under anaerobic condition by own gas productions, CO2 and H2. Temperature was 
controlled at 35oC and agitation was carried out at 55 rpm. For carrying out the butyl butyrate 
production in a small-scale extractive fermentation platform, a biphasic medium was prepared by 
adding 30 ml of P2YE5 and 30 ml of hexadecane (a volume ratio of 1:1) into a 100 ml Pyrex glass 
bottle. 10 g/L CaCO3 was added into the medium as a supplementation of the buffering capacity. 
For testing the effect of butanol supplementation on butyl butyrate production, 5 g/L butanol was 
added into the medium. The fermentation bottle was kept in an anaerobic chamber for more than 
8 hours to initiate an anoxic condition before inoculation. The TGY pre-culture of the C. 
beijerinckii spo0A mutant was inoculated into the small-scale platform at an inoculum of 5% of 
the medium volume. Subsequently, 0.25 g acrylic resin of lipase CalB (Sigma-Aldrich, MO, USA) 
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was added to the fermentation. A battery-powered portable magnetic stirrer (Cole-Parmer, IL, 
USA) was employed to maintain a continuous agitation of ~200 rpm through the fermentation 
process. Cell growth, pH, glucose and product concentrations in both the aqueous and organic 
phase were monitored throughout the course of the fermentation. 
 
3.2.3. Analysis of cell growth, pH, and fermentation products 
Cell growth was measured by following optical density (OD) at A600 using a BioMate 3 
spectrometer (Thermo, New York, USA). The pH of the medium was analyzed by a Beckman 
Coulter Φ390 pH meter (Beckman Coulter, Inc., CA, USA). Glucose, acetone, butanol, ethanol, 
acetate and butyrate in the aqueous medium were quantified by a high-performance liquid 
chromatography (HPLC) (Agilent Technologies 1200 Series) system equipped with a refractive 
index detector (RID) using Biorad Aminex HPX-87H column (300 x 7.8 mm). The column was 
eluted with 0.005 N of H2SO4 at a flow rate of 0.6 mL/min at 30°C. Butyl butyrate and fermentation 
products contained in the hexadecane layer were analyzed by a gas chromatography (GC) (Agilent 
Technologies 7890A) equipped with a flame ionization detector (FID) and auto-injector. An HP-
INNOWax (30 m length, 0.53 mm diameter, 1.00 µm film thickness) (Agilent Technologies) 
column was used for this analysis purpose. The GC oven temperature was initially held at 40°C 
for 3 min and was then increased at a rate of 45°C/min until 235°C and held for 4 min. The injector 
temperature was held at 225°C, and the FID detector was held at 330°C. An injection volume of 
0.6 µl and a split ratio of 15:1 was used for the analysis. Helium was used as the carrier gas. 
 
3.3. Results and discussion 
3.3.1. Phenotypic characterization of the C. beijerinckii spo0A mutant during batch 
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fermentation 
To investigate the fermentative behavior of the C. beijeirinckii spo0A disruption mutant as 
compared to the parental strain, I performed batch fermentations with or without pH control. In 
the absence of pH control, glucose uptake and cell growth of the spo0A mutant were severely 
inhibited and ceased at the early stage of the fermentation because of butyrate accumulation 
(mainly the undissociated acid form), which is known as the “acid crash” phenomenon [112] (data 
not shown). However, by maintaining the pH at 6.5, cell growth and glucose uptake of the spo0A 
mutant were maintained, and butyrate and butanol were accumulated up to 8.96 g/L and 3.32 g/L, 
respectively from 60 g/L glucose in less than 30 hours (Fig. 3.1A). The results suggested that the 
pH-controlled fermentation condition rescues the growth and glucose uptake of the spo0A mutant 
by alleviating butyrate toxicity. Also, these results agree with the previous studies that the spo0A-
inactivated C. acetobutylicum and C. beijerinckii cultured in a pH-controlled bioreactor 
demonstrated good cell growth, sugar uptake and acid accumulations [105, 103, 113, 94].   
Under the same condition, the wild-type strain accumulated a maximum of 1.85 g/L butyrate 
which was reassimilated later, resulting in a final concentration of 0.3 g/L butyrate. Butanol 
concentration by the wild-type strain reached up to 8.87 g/L at the end of the fermentation (Fig. 
3.1B). Based on the unique phenotype of the spo0A mutant accumulating substantial amounts of 
butyrate and butanol during the fermentation, I considered the spo0A mutant as a promising host 
strain for butyl butyrate production. Therefore, I next employed the spo0A mutant to produce butyl 
butyrate during the ABE fermentation. 
 
3.3.2. Butyl butyrate production in batch fermentation by the spo0A mutant 
To test butyl butyrate production by the spo0A mutant and lipase, I performed batch 
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fermentations in a biphasic medium containing the P2YE5 medium and a hexadecane phase 
containing the CalB lipase (Fig. 3.2). As a result, the spo0A mutant produced only 98 mg/L of 
butyl butyrate in the hexadecane phase (Fig. 3.3A). In the aqueous medium, the spo0A mutant 
accumulated 2.94 g/L butyrate after consuming 6.8 g/L glucose, but butanol was not detected (Fig. 
3.3B and 3.3C). The primary reasons for the negligible butyl butyrate production by the spo0A 
mutant were as follow: First, the acid crash during the fermentation resulted in incomplete sugar 
utilization and metabolic abolishment [112, 114]. Second, butanol produced by the spo0A mutant 
from the fermentation was insufficient to serve as a co-substrate for butyl butyrate conversion by 
the CalB lipase. I thus addressed the both aspects in the following studies. 
 
 3.3.3. CaCO3 supplementation to prevent acid crash 
To prevent the acid crash phenotype of the spo0A mutant in batch fermentation without pH 
control, I supplemented CaCO3 in the fermentation medium. As it is not easy to control pH in the 
small-scale fermentation using a 100 ml Pyrex bottle, 10 g/L of CaCO3 was added to the medium 
to maintain a high pH of the medium and alleviate butyrate toxicity [115, 116]. I reasoned that pH 
increase of the medium would decrease the amount of the undissociated form of butyrate which is 
overproduced by the spo0A mutant [117, 13]. Therefore, the acid crash phenotype of the spo0A 
mutant can be overcome by supplementing the medium with CaCO3. As expected, butyl butyrate 
production by the spo0A mutant increased to 1.68 g/L in the hexadecane phase (Fig. 3.3A). 
Meanwhile, glucose uptake and butanol concentration in the aqueous medium also increased (Fig. 
3.3B and 3.3C). The results suggested that adding CaCO3 into the medium can allow the spo0A 
mutant to sustain glucose consumption in the presence of butyrate, thereby enhancing butyl 
butyrate production. 
Although CaCO3 supplementation prevented the acid crash phenotype of the spo0A mutant, 
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there remains an imbalance in the amounts of butyrate and butanol produced from the spo0A 
mutant for the optimal production of butyl butyrate. The spo0A mutant accumulated 5 g/L of 
butyrate, but only 1.5 g/L of butanol was produced from the consumption of 26 g/L glucose (Fig. 
3.3B and 3.3C). Under the same conditions, the parental strain was able to consume 39.3 g/L 
glucose and produce 8.6 g/L butanol (Fig. 3.3E and 3.3F). The results indicate that butyrate toxicity 
was not completely eliminated by the addition of CaCO3. Even though the parental wild-type strain 
consumed more glucose than the spo0A mutant, only 0.21 g/L butyl butyrate was produced by the 
wild-type strain (Fig. 3.3D), which is much less amount compared to the concentration (1.68 g/L) 
by the spo0A mutant (Fig. 3.3A). This result suggests that the spo0A mutant becomes an 
advantageous strain for butyl butyrate production than the wild-type strain once the growth of the 
spo0A mutant is maintained by buffering the medium with CaCO3.   
 
3.3.4. Butanol supplementation for enhanced butyl butyrate production  
The limitation of available butanol for the condensation reaction of butyrate and butanol also 
needs to be resolved in order to improve butyl butyrate production by the spo0A mutant. To provide 
an ample supply of butanol for the condensation reaction, I added exogenous butanol into the 
medium at the beginning of the fermentation. I hypothesized that the added butanol could serve as 
a sink of butyrate through the esterification reaction, thereby preventing accumulation of butyrate 
in the medium during the early phase of the fermentation. The abatement of butyrate accumulation 
in the medium should enhance glucose uptake and solventogenesis of the spo0A mutant by 
preventing the acid crash [112], resulting in enhanced butyl butyrate production. As expected, a 
batch fermentation containing a 5 g/L of butanol supplementation resulted in enhanced glucose 
uptake by the spo0A mutant (Fig. 3C). As a result, butyl butyrate production increased to 2.73 g/L 
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in the hexadecane phase (Fig. 3.3A). These results demonstrated that butanol supplementation 
could enhance butyl butyrate production by playing dual roles in the system by: 1) providing the 
necessary component for esterification of butyl butyrate, and 2) alleviating butyrate toxicity by 
participating in the esterification reaction with butyrate resulting in lower concentrations of 
butyrate in the aqueous medium. 
During the production of butyl butyrate in the biphasic medium, I observed an apparent delay 
of butyl butyrate production in the hexadecane layer as compared to the substrate (butyrate and 
butanol) formation in the aqueous phase. The maximum production of butyrate and butanol was 
observed before 58 h of fermentation, while the maximum butyl butyrate production was achieved 
after 150 h of the fermentation (Fig. 3.4A). Also, the spo0A mutant accumulated a high level of 
butanol even in the presence of sufficient butyrate in the medium (Fig. 3.4A). The results suggested 
that the esterification and extraction of butyl butyrate into the hexadecane layer may be a rate-
limiting step which resulted in the accumulation of butanol and butyrate in the aqueous medium.  
 
3.3.5. Effect of continuous agitation on butyl butyrate production 
I further examined the effects of agitation on the enzymatic esterification and extraction of 
butyl butyrate through the adequate mixing of substrates and the CalB lipase in the biphasic 
medium. With a continuous agitation at 200 rpm, the butyl butyrate production by the spo0A 
mutant increased to 3.32 g/L (Fig. 3.3A). Furthermore, the maximum titer of butyl butyrate could 
be achieved within 48 h during the fermentation. The rate of butyrate production with continuous 
agitation was three-fold higher than that in the absence of continuous agitation (158 h) (Fig. 3.4B). 
This rapid production of butyl butyrate with continuous agitation indicated that mixing of the 
biphasic medium in the presence of buffer and butanol supplementation enhanced both the titer 
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and productivity of butyl butyrate. However, I also observed that continuous agitation decreased 
the glucose uptake by the spo0A mutant (Fig. 3.3C), although the yield of butyl butyrate from 
glucose was increased. Thus, further optimization needs to be performed to increase both sugar 
uptake and butyl butyrate production for sustainable bioprocess. For this purpose, a pH-controlled 
bioreactor fermentation can be performed since the spo0A mutant completely consumed glucose 
in the pH-controlled bioreactor even with continuous agitation (Fig 3.1A).   
Meanwhile, continuous agitation with supplementation of CaCO3 and butanol also helped the 
wild-type strain increase butyl butyrate production up to 1.08 g/L (Fig. 3.3D). This result 
demonstrated that continuous agitation has a beneficial effect on butyl butyrate production 
regardless of the host strain by increasing the enzymatic esterification and extraction of butyl 
butyrate into the hexadecane layer. Nevertheless, the wild-type strain was not able to generate 
more than 1.08 g/L butyl butyrate because this strain had an inherent substrate imbalance issue 
under all the conditions I investigated (Fig. 3.3D and 3.3E). Similarly, in a previous study, butyl 
butyrate production using C. acetobutylicum wild-type strain in shake flask batch fermentations 
achieved 0.96 g/L butyl butyrate in 25 ml of organic phase coupled with 25 ml of aqueous medium 
[15]. To overcome the substrate imbalance of the wild-type strain, they continuously fed butyrate 
with glucose in a pH-controlled fed-batch bioreactor fermentation and achieved maximum 4.9 g/L 
butyl butyrate in 250 ml of the organic phase coupled with 1.5 L of the aqueous medium. In this 
case, the organic solvent phase has six times less volume than the aqueous medium; thus butyl 
butyrate was concentrated into the organic phase. Compared to the previous study, I achieved 3.32 
g/L butyl butyrate using the spo0A mutant with a 1:1 ratio between the organic and the aqueous 
phases in a small-scale batch fermentation without the bioreactor operation and continuous 
feeding, which allows high-throughput evaluation and process optimization. 
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3.4. Conclusions 
In this study, I characterized the fermentative behavior of the C. beijerinckii spo0A mutant 
and utilized this mutant to produce butyl butyrate during the ABE fermentation. The spo0A mutant 
accumulating both butyrate and butanol may be a promising strain for the production of butyl 
butyrate under further-optimized conditions. The supplementation of the medium with CaCO3 and 
butanol enhanced butyl butyrate production. Continuous agitation further improved the butyl 
butyrate production regarding titer, rate, and yield. 
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3.5. Figures and tables 
 
Figure 3.1. Characterization of the fermentative behavior of the C. beijerinckii spo0A mutant 
(A) compared to the wild-type strain C. beijerinckii NCIMB 8052 (B) in the P2YE5 medium 
in batch fermentation with constant pH control at 6.5. 
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Figure 3.2. Schematic diagram of butyl butyrate production during the ABE fermentation 
using the C. beijerinckii spo0A mutant in the biphasic medium with three key aspects of the 
fermentation condition manipulation: (A) Supplementation of CaCO3 buffer to alleviate 
butyrate toxicity, (B) Supplementation of butanol to initiate the esterification of butyl butyrate, (C) 
Continuous agitation to enhance the esterification and extraction of butyl butyrate. 
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Figure 3.3. Extractive batch fermentation results for butyl butyrate production by the C. 
beijerinckii spo0A mutant and the parental strain C. beijerinckii NCIMB 8052 in the biphasic 
medium with the manipulations (Supplementation of CaCO3, butanol, and agitation). (A) 
Butyl butyrate production by the spo0A mutant in the hexadecane phase, (B) Butyrate and butanol 
production by the spo0A mutant in the aqueous phase (Aq), (C) Glucose uptake by the spo0A 
mutant, (D) Butyl butyrate production by the parental strain in the hexadecane phase, (E) Butyrate 
and butanol production by the parental strain in the aqueous phase, (F) Glucose uptake by the 
parental strain (at the time point of maximum butyl butyrate production) 
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Figure 3.4. Batch fermentation profiles of the C. beijerinckii spo0A mutant for butyl butyrate 
production in the biphasic medium supplemented with a 5 g/L butanol and 10 g/L CaCO3 
buffer without continuous agitation (A) and with continuous agitation (B). Aq: in the aqueous 
phase (medium), Org: in the organic phase (hexadecane) 
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CHAPTER IV       DEVELOPMENT OF AN OXYGEN-INDEPENDENT 
FLUORESCENCE REPORTER SYSTEM IN CLOSTRIDIUM BEIJERINCKII AND ITS 
APPLICATIONS 
 
The content of this chapter will be submitted to Journal of Biotechnology. I am the first author of the paper. 
I performed the research, and Drs. Yong-Su Jin and Hans Blaschek were the directors of the research. 
 
4.1. Introduction 
Clostridium beijerinckii is a predominant clostridia host strain for ABE fermentation as it has 
a broad substrate range of utilization and a broader pH optimum for growth and solvent production 
as well as a higher tolerance to acetate, formate, furfural and hydroxymethylfurfural than other 
solventogenic clostridia [118, 119]. However, there is still a need for strain improvement since it 
has considerable drawbacks which are inherent in all of solventogenic clostridia such as low titers, 
yield, and productivity of solvent preventing a cost effective industrial ABE fermentation. 
Metabolic engineering has been applied to overcome some of the drawbacks by improving 
strain characteristics toward desirable phenotypes with systematic and combinatorial strategies. To 
manipulate and optimize a metabolic pathway precisely, genetic information and genetic 
engineering tools for clostridia are a prerequisite. Several genetic engineering tools such as 
ClosTron mutagenesis and modular plasmid system, Targetron based gene knockout system, gene 
allele exchange and inducible gene expression system for clostridia have been developed and 
successfully demonstrated by several research groups. However, essential genetic information for 
metabolic engineering such as promoter and terminator strength, gene regulation circuits and 
conditional gene expression of clostridia still needs to be obtained.  
To gain knowledge of gene expression and regulation in clostridia, several reporter systems 
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based on enzyme activity have already been developed [120-122]. However, enzymatic assay 
based reporter systems have potential limitations such as a high background if there is endogenous 
enzymatic activity in the cell and the additional labor involved in disrupting cells for real-time 
measurement if there is no secretion of the enzyme. 
For these reasons, a fluorescence reporter system is widely used for understanding the 
complex physiological bioprocesses and quantitative analysis of gene expression in living 
microorganisms. The most variable and popular fluorescence in vivo reporter in microbiology is 
the green fluorescence protein (GFP). GFP and relative analogs can be expressed in a broad host 
range of different organisms and can be used as real-time reporters to monitor protein expression, 
localization, folding, and interactions in living cells. However, the GFP-family proteins require 
molecular oxygen for fluorescence maturation, which hampers their application in a strict 
anaerobic microorganism such as Clostridium.  
The oxygen independent fluorescence reporter, flavin mononucleotide-based fluorescent 
protein (FbFP) has been developed and used as an alternative of GFP for oxygen-limited 
environment [123, 124, 30, 125, 126, 29]. The engineered blue-light photoreceptors from Bacillus 
subtilis and Pseudomonas putida having light, oxygen or voltage-sensing (LOV) domain were 
successfully employed as FbFP reporters in both aerobic and anaerobic biological systems [127, 
124, 128, 129]. Also, FbFPs have been further engineered for optimization of brightness and 
stability in each host strain[130, 131]. Among them, EcFbFP which is truncated and optimized 
version of B. subtilis YtvA-derived BsFbFP exhibited substantially greater in vivo fluorescence 
compared to wild type YtvA and other variants in E. coli [30].  
To investigate and understand physiological bioprocesses and complex gene regulation in C. 
beijerinckii under strict anaerobic growth conditions, I constructed and tested the codon optimized 
57 
 
version of EcFbFP for clostridia (CbFbFP) in C. beijerinckii NCIMB 8052 wild-type strain. The 
CbFbFP reporter can be adapted for comparison experiments of gene expression levels among 
different promoters by quantification of fluorescence in C. beijerinckii. The various applications 
of CbFbFP reporter will play an important role to provide valuable information for better 
understanding of the genetic and physiological events taking place in the solventogenic clostridia 
and help to generate desirable recombinants. Also, the CbFbFP reporter can be used for synthetic 
biology tool for clostridia and other anaerobes to aid a gene circuit design and build artificial 
metabolic pathways for desirable phenotypes. 
 
4.2. Materials and methods 
4.2.1. Bacterial strains and growth conditions 
Escherichia coli TOP10 (Invitrogen, Grand Island, NY) was used for gene cloning and 
propagation of plasmids. Following transformations, E. coli TOP10 transformants were grown 
aerobically at 37ºC in Lysogeny Broth (LB) medium, supplemented with 50 µg/ml ampicillin. For 
pre-culture, C. beijerinckii NCIMB 8052 transformants were grown anaerobically at 35ºC in 
tryptone–glucose–yeast extract (TGY) medium containing 30 g/L tryptone, 20 g/L glucose, 10 g/L 
yeast extract and 1 g/L L-cysteine [107], supplemented with 75 µg/ml erythromycin as needed. 
For the main culture, C. beijerinckii NCIMB 8052 transformants were grown anaerobically at 35 
ºC in P2 medium containing 60 g/L glucose or P2YE50 medium which is a modified P2 medium 
containing 50 g/L glucose and 1 g/L yeast extract, supplemented with 75 µg/ml erythromycin as 
needed. The P2 medium contained the following compounds: 0.5 g/L KH2PO4; 0.5 g/L K2HPO4; 
2.2 g/L CH3COONH4; 0.2 g/L MgSO4·7H2O; 0.01 g/L MnSO4·H2O; 0.01 g/L FeSO4·7H2O; 0.01 
g/L NaCl; 1 mg/L p-aminobenzoic acid; 1 mg/L thiamin-HCl; 10 µg/L biotin. For making agar 
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plate media, 20 g/L agar was additionally added into the liquid media compositions. All strains 
used in this study are listed in Table 1. 
 
4.2.2. Plasmid construction  
A plasmid map is described in Fig. 4.1. The gene encoding FbFP for C. beijerinckii (CbFbFP) 
was optimized to the codon usage bias of C. beijerinckii based on nucleotide sequence of EcFbFP 
(411 bp, GenBank accession number EF418615) and synthesized as a gBlock from IDT. The 
nucleotide and amino acid sequences of CbFbFP with stop codon are shown in Fig. 4.2A. The 
synthesized gene of CbFbFP was amplified by PCR using primers F_CbFbFP and R_CbFbFP 
(Table 1). The amplified gene encoding CbFbFP was introduced into the multi-cloning site (MCS) 
of the E. coli-C. beijerinckii shuttle vector pTJ1-Pthl by SacI and BamHI enzyme sites (Fig. 4.1A). 
The pTJ1-Pthl vector was constructed by introducing Thiolase (Cbei_0411) promoter (spanning 
from -120 to the start codon ATG) and terminator (spanning from the stop codon TAA to +100) 
regions into the pTJ1 vector which was modified from phagemid pYL102E [132, 133]. The Pthl-
CbFbFP cassette was amplified from pTJ1-Pthl-CbFbFP and transferred to pIMP1 plasmid to 
construct pIMP1-Pthl-CbFbFP plasmid. Also, the pIMP1m-Pthl-CbFbFPm was isolated from the 
bright cells sorted by FACS. The pIMP1m plasmid was constructed by eliminating Pthl-CbFbFP 
mutant cassette using EcoRI and self- ligated. The sADH operon was amplified from C. 
beijerinckii NRRL B593 genomic DNA and introduced into pIMP1 and pIMP1m to construct 
pIMP1-sADH593 and pIMP1m-sADH593. All plasmids and oligonucleotides used in this study 
are listed in Table 1. 
 
 
59 
 
4.2.3. Transformation 
The CbFbFP expression plasmids were chemically transformed into competent E. coli TOP10 
cells. Plasmids isolated from the right clones were then transformed into C. beijerinckii NCIMB 
8052 using electroporation by following procedures. Laboratory spore stock of C. beijerinckii 
NCIMB 8052 was heat-shocked at 80oC for 10 minutes and inoculated into TGY medium with a 
1% (v/v) ratio as previously described [107]. The culture was grown anaerobically at 35oC until 
the optical density of the culture reached 0.6-0.8 (A600). Cells were harvested by centrifugation at 
4000 rpm for 10 minutes at 4°C. The cell pellet was washed with one volume of ice-cold 15% 
glycerol (v/v in H2O, Sigma-Aldrich, St. Louis, MO) and centrifuged down. The cell pellet was 
re-suspended with 5% initial culture volume of ice-cold 15% glycerol and used immediately for 
electroporation. For each transformation, 1.0 µg of plasmid DNA mixed with 400 µl of electro-
competent C. beijerinckii cell suspension and transferred to a 0.2 cm pre-chilled electroporation 
cuvette and incubated for 10 min on ice. A Gene Pulser Xcell Electroporation System (Bio-Rad 
Laboratories, CA, USA) was used for electroporation with the parameters 1.8 kV, 25 µF and 200 
Ω. The transformation mixture in the cuvette was then transferred to into 1 ml TGY and incubated 
at 35oC for recovery. The resulting cells were plated onto TGY agar plates containing 25 µg/ml 
erythromycin and incubated at 35oC under anaerobic conditions. The erythromycin-resistant 
colonies were picked for colony PCR to confirm transformed vectors using primers F_pTJ1-Seq, 
R_pTJ1-Seq, F_pIMP1, and R_Thlt-Seq (Table 1).  
 
4.2.4. Expression of CbFbFP 
The positive colony of the C. beijerinckii transformant was inoculated into TGY medium and 
incubated at 35oC for 12 hours in an anaerobic chamber under N2:CO2:H2 (ratio of 85:10:5) 
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atmosphere. The TGY culture was then transferred to P2YE medium containing 50 g/L glucose. 
Cell growth was measured by following optical density (OD) at A600 using a BioMate 3 
spectrometer (Thermo, New York, USA).  
 
4.2.5. Detection of fluorescence 
C. beijerinckii transformants grown in P2YE medium containing 50 g/L glucose were 
harvested during the late exponential growth phase, and stored at -80oC when necessary. Cell 
cultures of both recombinants were normalized to the equal OD600 and centrifuged at 13,000 rpm 
for 2 minutes at 4oC. The cell pellets were resuspended in PBS or phosphate buffer and used 
immediately for detection of fluorescence in dark reader transilluminator (Clare Chemical 
Research). The CbFbFP fluorescence in C. beijerinckii was imaged by using an EVOS FL 
fluorescence microscope (AMG, Bothell, WA) with a GFP light cube having an excitation 
wavelength of 470 nm and emission wavelength 525 nm. 
 
4.2.6. SDS-PAGE analysis 
The protein expression analysis by SDS-PAGE was performed to confirm the expression of 
CbFbFP and sADH in C. beijerinckii. The cell pellet stored at −20 °C was re-suspended in PBS 
buffer (pH 7.4). All samples were normalized to the same OD600 with PBS buffer, and equal 
volumes of cell suspension were boiled with Laemmli sample buffer (Bio-Rad) for 10 minutes. 
After disruption of the cell, the resulting suspensions were analyzed by SDS–PAGE with 12% 
precast polyacrylamide gel (Bio-Rad). 
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4.2.7. Quantitative measurement of fluorescence 
C. beijerinckii transformants grown in TGY medium were inoculated into P2YE medium 
containing 50 g/L glucose supplemented with 75 µg/ml erythromycin. The harvested cells from 
growing culture in P2YE medium containing 50 g/L glucose were inoculated into 200 µl of P2 
medium containing 60 g/L glucose supplemented with 125 µg/ml erythromycin in an optically 
clear round bottom 96-well plates with same initial OD600. The incubation and measurement of 
fluorescence were conducted in a Spectramax M5 spectrofluorometer (Molecular Devices). 
Mineral oil was applied on the top of each culture well in the plate to create anaerobic like 
condition by preventing the surface contact with oxygen. The CbFbFP fluorescence was monitored 
at an excitation wavelength of 460 nm and an emission wavelength of 492 nm with an auto cutoff 
at 475 nm. The optical density of cell culture in the plate was measured by the spectrofluorometer 
at A600. The fluorescence intensity of cell culture was calculated by subtraction of the background 
media noise and normalization against the optical density values to obtain the fluorescence per 
optical density. 
 
4.2.8. Fermentation and product analysis 
Batch fermentations of C. beijerinckii recombinant strain containing the sADH expressing 
plasmid were carried out in 50 ml falcon tube with 20 ml of TGY medium containing erythromycin 
in an anaerobic chamber. Cell growth was measured by optical density (OD) in the fermentation 
broth at A600 using a BioMate3 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). 
ABE products and isopropanol concentrations were quantified using gas chromatography (GC) 
(Agilent Technologies, Santa Clara, CA) equipped with a flame ionization detector (FID). Glucose 
concentration was quantified by a high-performance liquid chromatography (HPLC) (Agilent 
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Technologies 1200 Series) system equipped with a refractive index detector (RID) using Biorad 
Aminex HPX-87H column (300 x 7.8 mm). 
 
4.3. Results and discussion 
4.3.1. Construction of CbFbFP expression vectors and recombinants 
The nucleotide sequence of the gene encoding EcFbFP which is truncated and E. coli-codon 
optimized version of BsFbFP was used as a template to synthesize the CbFbFP with optimization 
of codon usage for C. beijerinckii. As a result of codon optimization, the synthesized CbFbFP gene 
displayed low GC contents (26%) but no change in the encoded amino acid (Fig. 4.2A). The 
CbFbFP gene was then introduced into the multi-cloning site (MCS) of E. coli-C. beijerinckii 
shuttle vectors pTJ1-Pthl containing endogenous thiolase promoter and terminator (Fig. 4.1A). 
The resulting vector pTJ1-Pthl-CbFbFP and control vector pTJ1-Pthl were introduced into the C. 
beijerinckii NCIMB 8052 wild-type strain by electroporation. The individual colonies grown on 
TGY agar plates containing erythromycin were confirmed by colony PCR to select positive 
transformants harboring the corresponding vectors. The positive recombinant strains were 
designated to C. beijerinckii TCF (pTJ1-Pthl-CbFbFP) and C. beijerinckii CON (pTJ1-Pthl), 
respectively. 
 
4.3.2. Confirmation of CbFbFP expression in C. beijerinckii 
C. beijerinckii cell cultures were carried out in P2YE medium containing 50 g/L glucose under 
a strict anaerobic condition in an anaerobic chamber. The growth curves of recombinant strains 
were shown in Fig. 4.3A. Both C. beijerinckii CON and TCF strains displayed similar growth 
kinetics. The fluorescence of recombinant strain was first detected in a dark reader transilluminator 
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after centrifugation of cells in 1.7 mL tube (Fig. 4.3A). C. beijerinckii CON did not show the 
fluorescence while the TCF strain showed fluorescence from the cells at the bottom. To measure 
the fluorescence level and CbFbFP expression, both cell cultures harvested at 12 h were normalized 
to same OD600 after washing the cells twice with phosphate buffer. The fluorescence level in cell 
suspensions was measured by a spectrofluorometer (Fig. 4.3B). The TCF strain showed more than 
twice higher fluorescence than did the CON strain. Compared to CON strain, the fluorescence 
intensity of TCF strain was increased in proportion to increase of OD600, indicating TCF cells 
emitted the fluorescence, but CON cells did not show a significant increase. 
The recombinant strains were further imaged and investigated by a fluorescence microscope. 
As shown in Figure 4.3C, TCF strain showed the fluorescence from an individual cell while CON 
strain did not have any cells exhibiting fluorescence. This results suggested that the CbFbFP was 
successfully expressed in C. beijerinckii and exhibited a fluorescence in the cell under strict 
anaerobic condition. The expressed CbFbFP of an apparent 15.7 kDa molecular weight appeared 
in SDS–PAGE analysis of cell extract from C. beijerinckii TCF (Fig. 4.3D). When compared to 
TCF strain, CON strain did not have the corresponding strong band of 15.7 kDa in size. 
Supernatant fractions from both cell cultures did not have the corresponding protein band of 
CbFbFP which means CbFbFP was not secreted outside the cell (data not shown). The overall 
expression level of CbFbFP was not high according to the relative band thickness, but fluorescence 
level was measurable and distinguishable.  
 
4.3.3. Increased expression and fluorescence intensity of CbFbFP by replacing the backbone 
vector from Phagemid to Plasmid 
Although I confirmed the expression and fluorescence of CbFbFP in C. beijerinckii, 
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fluorescence intensity needs to be improved to apply CbFbFP as in vivo fluorescence reporter 
against background fluorescence of cell culture. Thus, I employed the plasmid shuttle vector 
(pIMP1) instead of the previous phagemid vector (pTJ1) to possibly increase copy number and 
stability of the CbFbFP expression cassette (Fig. 4.1B). The CbFbFP expression cassette was 
transferred to the pIMP1 empty plasmid, and the resulting plasmid pIMP1-Pthl-CbFbFP was 
introduced into C. beijerinckii wild-type. The recombinant strain harboring the plasmid was 
designated to the C. beijerinckii ICF strain and cultured under strict anaerobic condition. The ICF 
strain also showed fluorescence in a single cell that was much strong when compared to the TCF 
strain (Fig. 4.4A). CbFbFP protein expression level was also significantly increased and confirmed 
by a thick corresponding band of CbFbFP in size of 15.7 kDa (Fig. 4.4B). These results suggested 
that plasmid expression system helps to increase CbFbFP expression level in the cell, thereby 
increasing fluorescence intensity. However, during microscopic observation, I noticed that not all 
the cells of the ICF strain displayed the strong fluorescence in the cell population (Fig. 4.4C). The 
few specific cells of ICF strain exhibited significantly strong fluorescence. Thus, I further 
examined cell population of both the CON2 containing the empty plasmid and the ICF strain 
containing the CbFbFP expression plasmid by flow cytometry to check if the specific outstanding 
cell population showing high intensity exists in the cell culture of ICF strain (Fig. 4.4D). Compared 
to CON2 strain, ICF strain demonstrated a peak of the cell population in the high-intensity region. 
This result agreed with our microscopic observation that confirmed the outstanding single cells. I 
speculated that the recombinant cells exhibiting strong fluorescence might have genetic mutations 
responsible for increased intensity and stability of CbFbFP in the cell. Therefore, I isolated 5% of 
single cell population exhibiting higher intensity by fluorescence-activated cell sorting (FACS) 
(Fig. 4.5).   
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4.3.4. Identification of genetic mutations in the CbFbFP expression cassette and backbone 
plasmid 
To identify genetic mutation may present in the high fluorescent cells of ICF strain, single 
colonies were isolated from cell suspensions sorted by FACS. The colonies were cultured and 
extracted to isolate CbFbFP expression plasmid which is more likely involved in the increase of 
CbFbFP expression. The isolated plasmids were sequenced together with the original plasmid that 
was initially introduced into C. beijerinckii to find out genetic mutations newly occurred. Plasmid 
full sequencing results found several mutations in the isolated plasmid (Fig. 4.1C and Table 2). 
The mutations included two single nucleotide polymorphisms (SNPs) and one insertion in the 
region of the CbFbFP expression cassette. One SNP (A to G) was in the open reading frame of 
CbFbFP, but it was a synonymous mutation which it does not change the encoded amino acid. 
Another SNP (T to C) was in the terminator region which might affect terminator binding on DNA. 
The large insertion (233 bp) at the end of the ORF was a partial sequence of CbFbFP gene, but it 
contained interesting structural variations (Fig. 4.6). This insertion was after the TAA stop codon, 
thereby not being translated. However, it may have an important function for mRNA stability as a 
3’-untranslational region (3’-UTR). The unique orientation of DNA sequences with forward and 
reverse homologous regions of CbFbFP gene may have resulted in the hairpin structure of mRNA 
which is known to affect the stability after transcription (Fig. 4.6C). The increased stability of 
CbFbFP transcript may increase translation efficiency, resulting in high protein level and intensity. 
This complicated mutation might be generated during PCR reaction due to low GC contents and 
similarity when the CbFbFP expression cassette was amplified to transfer from the pTJ1 to the 
pIMP1 plasmid.  
Additionally, one SNP in MCS site and two SNPs in the Gram-positive origin of replication 
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region found in the isolated plasmid. The SNP (C to G) made the XmaI enzyme site move one base 
pair backward because previous nucleotide (C) could still support the XmaI site (CCCGGG). The 
two SNPs in the Gram-positive origin were in the ORF of replication protein (RepL). One SNP (T 
to G) caused amino acid change at 127th of RepL from lysine to asparagine, but another SNP (C 
to A) did not make amino acid change. The change in the amino acid of replication protein may 
affect its replication efficiency in C. beijerinckii cell. Since the Gram-positive replicon pIM13 in 
the pIMP1 plasmid was isolated from Bacillus subtilis, the pIMP1 plasmid might be evolved to 
increase replication efficiency in C. beijerinckii for survival in antibiotics.  
To confirm if mutations in the plasmid are directly involved in the increased fluorescence, I 
reintroduced the isolated mutant plasmid (pIMP1m-Pthl-CbFbFPm) into C. beijerinckii wild-type 
strain. After transformation, several colonies were selected and cultured to test the fluorescence of 
cells. The cell culture of colonies showed strong fluorescence on the transilluminator (Fig. 4.6D). 
This result suggested that the isolated mutant plasmid was responsible for increased CbFbFP 
expression in C. beijerinckii. 
 
4.3.5. Applications of the CbFbFP reporter system in C. beijerinckii as examples 
I successfully developed the CbFbFP anaerobic fluorescence report system in C. beijerinckii. 
Thus, I applied CbFbFP reporter for other studies. First, in vivo fluorescence quantitative 
measurements can be employed for screening of promoter strength and expression profile [134]. 
Also, CbFbFP can be integrated into genome location and tracked regulator or protein expression 
profile in the cells during fermentation. To test the feasibility of using CbFbFP as a screening tool, 
small-scale batch fermentation was carried out in a spectrofluorometer (Fig. 4.7A). The C. 
beijerinckii CON2 containing empty plasmid pIMP1 and the ICFm strain containing CbFbFP 
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expressing plasmid were inoculated into the P2 medium with same initial OD600 in a 96-microwell 
plate covered with mineral oil and film. The plate was then incubated in a spectrofluorometer at 
35oC with intermittent shaking. The fluorescence intensity of ICFm strain was increased over time 
in 96-well plate, reflecting the expression of CbFbFP. However, CON2 strain did not significantly 
increase fluorescence intensity. This result indicated that CbFbFP expressing strain ICFm showed 
trackable and distinguishable fluorescence level during the fermentation in 96-well plate. 
Therefore, CbFbFP reporter system can be applied for high throughput investigation of the 
expression profile of different promoters in C. beijerinckii by culturing the cells in 
spectrofluorometer equipped with 96-well plate. 
Second, CbFbFP reporter can be simply used as a selection tool. To confirm if the positive 
colony expressing CbFbFP reporter can be selected by fluorescence detection, I mixed two strains 
(CON2 and ICFm) and spread onto TGY agar plate with erythromycin. Then, several colonies 
randomly picked and cultured in small tubes. In the transilluminator, I was able to find the positive 
colony of ICFm exhibiting the fluorescence without disruption of cells or colony PCR (Fig. 4.7B). 
The CbFbFP reporter can also be used for analysis of cell population of C. beijerinckii under 
different fermentation conditions by flow cytometry (Fig. 4.7C). Batch fermentations of ICFm 
strain was carried out under two different conditions with and without erythromycin regarding the 
effect of selection pressure. The cell cultures were analyzed by flow cytometry to check if cell 
population can be distinguished under two different culture conditions. As a result, I was able to 
confirm the different cell population under two different conditions by fluorescence intensity 
profile of single cells. Without antibiotic pressure, the population of ICFm cells (I) showed the 
same profile with control strain CON2 (III) containing empty plasmid, indicating that ICFm strain 
did not express the CbFbFP probably due to loss of expression plasmid (Fig. 4.7C). However, with 
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antibiotics, the cell population expressing CbFbFP (II) was significantly increased. This result 
suggested that the CbFbFP reporter can be employed for analysis of cell population. The 
fluorescence reporter can be further used to harvest desirable cell population by FACS as I isolated 
the mutant plasmid.  
The isolated mutant plasmid which led the overexpression of CbFbFP was further applied for 
metabolic engineering of C. beijerinckii (Fig. 4.8). Since the isolated plasmid harboring mutations 
in Gram-positive replicon may result in high copy number or stability in C. beijerinckii, I used the 
plasmid backbone to introduce another expression cassette that is secondary alcohol 
dehydrogenase (sADH_B593) from C. beijerinckii NRRL B593 strain. In the previous study, the 
introduction of sADH_B593 operon increased isopropanol production in C. acetobutylicum [135]. 
The sADH_B593 operon was introduced into the pIMP1 original plasmid as well as pIMP1 mutant 
plasmid after CbFbFP cassette was removed from pIMP1m-Pthl-CbFbFPm. The resulting 
plasmids pIMP1-sADH593 and pIMP1m-sADH593 were introduced into C. beijerinckii wild-
type, and several colonies from each plate were picked for batch fermentation. C. beijerinckii 
recombinant strains containing the mutant plasmid pIMP1m-sADH593 (#3, #4, and #5) showed a 
significant increase in isopropanol production when compared to the control strain containing 
pIMP1 empty plasmid and the strain containing the original pIMP1-sADH593 plasmid (Fig. 4.8B). 
The SDS-PAGE analysis also suggested that protein expression of sADH was significantly 
increased in the strains harboring the mutation plasmid pIMP1m-sADH593 (Fig. 4.8C). This result 
demonstrated the use of fluorescence reporter to isolate mutant plasmid that helps to increase 
protein expression in C. beijerinckii. The isolated mutant plasmid backbone by the CbFbFP 
reporter with the sADH expression cassette were successfully employed to engineer C. beijerinckii 
strain toward increased isopropanol production.   
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4.4. Conclusions 
Considering a strict anaerobic growth condition of clostridia, the anaerobic fluorescence 
reporter system was constructed in C. beijerinckii based on an oxygen-independent flavin 
mononucleotide-based fluorescent protein (FbFP). The protein expression and in vivo fluorescence 
of CbFbFP in C. beijeirnckii were confirmed under anaerobic growth condition. I identified a 
heterogeneity of the cell population exhibiting a variety range of fluorescence intensity and sorted 
the high fluorescent cells by FACS. Sequencing of the isolated plasmid revealed several mutations 
in the plasmid which may be responsible for the high level and stable expression of CbFbFP in C. 
beijerinckii. The isolated oxygen-independent CbFbFP reporter cassette and plasmid were 
successfully applied for quantitative real-time measurement of fluorescence, selection of positive 
colonies, population analysis as well as metabolic engineering in this study.  
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4.5. Figures and tables 
 
 
Figure 4.1. The CbFbFP expression vectors constructed and isolated in this study. (A) The 
phagemid vector pTJ1 containing the CbFbFP expression cassette under thiolase promoter. (B) 
The plasmid vector pIMP1 containing the CbFbFP expression cassette under thiolase promoter. 
(C) The mutant version of pIMP1-Pthl-CbFbFP isolated by FACS exhibiting a high level of 
CbFbFP expression.   
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Figure 4.2. DNA nucleotide sequence and corresponding amino acid of the synthesized 
CbFbFP gene (A) and the mutant CbFbFP gene with additional insertion identified in this 
study.   
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Figure 4.3. Confirmation of CbFbFP expression and fluorescence in C. beijerinckii. (A) Batch 
fermentation profiles of the C. beijerinckii CON and TCF strains in P2YE medium containing 50 
g/L glucose. The arrow indicates the sampling point for comparison of in vivo fluorescence of cell 
suspension. The data is from duplicate experiments for each strain. (B) Quantitative measurement 
of fluorescence from cell suspension of C. beijerinckii recombinants. (C) Microscopic observation 
of fluorescence in C. beijerinckii recombinants. (D) SDS-PAGE analysis of cell extracts. The 
arrow indicates the corresponding protein band of CbFbFP reporter. 1: C. beijerinckii CON, 2: C. 
beijerinckii TCF.  
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Figure 4.4. Confirmation of CbFbFP expression using pIMP1 plasmid. (A) Microscopic 
observation of fluorescence in C. beijerinckii recombinants. (B) SDS-PAGE analysis of cell 
extracts. The arrow indicates the corresponding protein band of CbFbFP reporter. (C) Microscopic 
observation of fluorescence in C. beijerinckii ICF strain with high cell numbers. (D) Flow 
cytometry analysis of C. beijerinckii recombinants. 1: C. beijerinckii CON2, 2: C. beijerinckii ICF. 
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Figure 4.5. Isolation of sub-population of cells exhibiting higher fluorescence intensity by 
FACS. Single cell population analysis of (A) C. beijerinckii CON2 and (B) C. beijerinckii ICF. 
The gate was adjusted for isolation of 5% cell population with higher intensity shown in purple. 
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Figure 4.6. Identification of mutations in the CbFbFP expression cassette. (A) CbFbFP 
expression cassette designed in this study, (B) the mutant CbFbFP expression cassette containing 
the insertion of partial ORF sequence of CbFbFP in the pIMP1m-Pthl-CbFbFPm plasmid. (C) 
Possible structure variation of CbFbFP mRNA transcripts caused by the insertion. (D) 
Confirmation of fluorescence from recombinant strains after re-transformation of the pIMP1m-
Pthl-CbFbFPm plasmid containing the mutant CbFbFP cassette into C. beijerinckii wild-type. The 
CON2 strain containing pIMP1 empty plasmid and the recombinant strain colonies (1 to 6) were 
cultured in TGY medium with erythromycin.      
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Figure 4.7. Application of CbFbFP reporter system. (A) Quantitative fluorescence 
measurement of C. beijerinckii recombinants cultured in a spectrofluorometer. (B) Selection of 
positive colonies exhibiting fluorescence on transilluminator after culturing in small tubes. (C) 
Flow cytometry analysis of C. beijerinckii recombinants under different culture conditions with 
and without erythromycin (ERM). 
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Figure 4.8. Use of the mutant plasmid isolated by FACS with CbFbFP reporter for metabolic 
engineering study. (A) Construction of plasmids for expression of secondary alcohol 
dehydrogenase from C. beijerinckii NRRL B593 producing isopropanol rather than acetone. (B) 
The fermentation profiles of the recombinant strains with empty plasmid (#1), the original pIMP1 
plasmid containing sADH593 operon (#2) and the mutant plasmid containing sADH593 operon 
(#3, #4 and #5). (C) The SDS-PAGE analysis of cell extracts of the recombinant strains. 
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Table 4.1. List of strains, plasmids, and primers used in this study 
a ampR : ampicillin resistant 
b ermR : erythromycin resistant 
Underlined nucleotide sequence: restriction enzyme site 
Name Description Reference 
Strain 
C. beijerinckii NCIMB 8052 
 
Wild-type, Donker emend. Keis et al. 
 
ATCC® 51743™ 
C. beijerinckii CON C. beijerinckii NCIMB 8052 / pTJ1-Pthl This study 
C. beijerinckii TCF C. beijerinckii NCIMB 8052 / pTJ1-Pthl-CbFbFP This study 
C. beijerinckii CON2 C. beijerinckii NCIMB 8052 / pIMP1 This study 
C. beijerinckii ICF C. beijerinckii NCIMB 8052 / pIMP1-Pthl-CbFbFP This study 
C. beijerinckii ICFm C. beijerinckii NCIMB 8052 / pIMP1m-Pthl-CbFbFPm  This study 
E. coli Top10 For gene cloning experiments Invitrogen 
Plasmid   
pTJ1 ColE1 ori, ampRa, CAK1 ori, ermRb Li Y et al. (2002) 
pTJ1-Pthl pTJ1, Pthl-MCS-Tthl This study 
pTJ1-Pthl-CbFbFP pTJ1-Pthl, CbFbFP gene This study 
pIMP1 pBR322 ori, ampRa, pIM13 ori, ermRb Mermelstein L et 
al. (1992) 
pIMP1-Pthl-CbFbFP pIMP1, Pthl-CbFbFP cassette from pTJ1-Pthl-CbFbFP This study 
pIMP1m-Pthl-CbFbFPm The mutant version of pIMP1-Pthl-CbFbFP isolated from 
high fluorescent cells sorted by FACS 
This study 
pIMP1-sADH593 pIMP1, sADH operon from C. beijerinckii NRRL B593 This study 
pIMP1m-sADH593 pIMPm constructed by eliminating Pthl-CbFbFPm cassette 
from pIMP1m-Pthl-CbFbFPm, and sADH593 operon  
This study 
Primer   
F_CbFbFP CGAGCTCATGGCATCATTTC  
F_CbFbFP CGGGATCCTTATTCTAATAATTTTTCATA  
F_pTJ1_Seq AGGGTTTTCCCAGTCACGACGTTGT  
R_pTJ1_Seq CTGGAGCATAACAACTGGTATTAGTAATAC  
R_Pthl_Seq CATGAGAATTATCATAGTAACCTTTTTAAATC  
F_Thlp GAATTCAGTTTGTTTAAATTTTAACAAT  
R_Thlt GAATTCTTCTATTTTCTTCTTTTAACTTTATTTTATAC  
F_pIMP1_Seq GGGTTTTCCCAGTCACGACGTTG  
F_sADH593 CCCGGGACATGTATGAAAATACAACACTGGCGG  
R_sADH593 CGCTGCAGCCTTCTACACATTTAGGATTCTTAC  
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Table 4.2. Nucleotide sequences of the CbFbFP expressing plasmid  
> pIMP1m-Pthl-CbFbFPm (5,599 bp) 
 
TGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCA
GGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGT
TTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACC
CGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCT
GCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGT
AGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTG
GCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCT
TCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTT
GCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTG
ACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCT
AGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAG
TTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGAC
TCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGC
GAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGA
AGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTT
CGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTG
GTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAA
AAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGG
TTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTA
CTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGA
TAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACT
CTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCA
TCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAAT
AAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGT
TATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACA
TTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGC
GTATCACGAGGCCCTTTCGTCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCC
CGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGC
GGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACC
ATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCCATTCGCCATTC
AGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGG
GGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGA
CGGCCAGTGAATTCAGTTTGTTTAAATTTTAACAATTTATGCTTGATAAAAGAAATAATAAAAGGTATAA
TTTAGTTATGTTAATAATTTAACAAAAGTTAATAAAATAATCTATAAAATTTTAGGAGGCCAAAGAGCTC
ATGGCATCATTTCAATCATTTGGAATACCAGGACAATTAGAAGTTATAAAAAAAGCATTAGATCATGTTA
GAGTTGGAGTTGTTATAACAGATCCAGCATTAGAAGATAATCCAATAGTTTATGTTAATCAAGGATTTG
TTCAAATGACAGGATATGAAACAGAAGAAATATTAGGAAAAAATGCAAGATTTTTACAAGGAAAACAT
ACAGATCCAGCAGAGGTTGATAATATAAGAACAGCATTACAAAATAAAGAACCAGTTACAGTTCAAATA
CAAAATTATAAAAAAGATGGAACAATGTTTTGGAATGAATTAAATATAGATCCAATGGAAATAGAAGAT
AAAACATATTTTGTTGGAATACAAAATGATATAACAAAACAAAAAGAATATGAAAAATTATTAGAATAA 
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Table 4.2. (Continued) 
CGGGATCCCGTTCTAATAATTTTTCAAACAGATCCAGCAGAAGTTGATAATATAAGAACAGCATTACAAAATAAA
GAACCAGTTACAGTTCAAATACAAAATTATAAAAAAGATGGGACAATGTTTTGGAATGAATTAAATATAGATCC
AATGGAAATAGAAGATAAAACATATTTTGTTGGAATACAAAATGATATAACAAAACAAAAGGAATATGAAAAA
TTATTAGAACGGGATCCCTCGAGGGTACCGCGGCCGCTATAAATTAAGATTTAAAAAGGTTACTATGATAATTC
TCATGGTAACCTTTTTTTACTAAATAAGAGTATAAAATAAAGTTAAAAGAAGAAAATAGAAGAATTCCCGGGGG
ATCCGTCGACCTGCAGCCAAGCTTAATCGCATTTCATAGATTGACCTCCCAATAACTACGTGGTGTTATTGGGAG
GTCAATCTATTTCATTTGCCTCTTGCTCAAAGTTACCAAATTCGAGTAAGAGGTATTTTTGGTTTTGGTCGTCGCC
TCTCATTAGTAGTTCAGGGTTTAACATTAATACTCCAGTTTTTCTTTTTATAATATTTCCTTCTTCTAAGATTTTAA
GTGTTGTTATTACTGTTTGTAGACTTGTTCCTGTAGCTTTTGCTATTTCTCTTGTTGTAGCTATCATTGTATTGTTA
CTTAAGTGGACATTATCTAGGATATAGTTAACGATTTTAAGTTTTTTTCCGCCAATCATATCTAACATACTTATTA
ATTGCACTATATATGCCTTTACGAAGTTACCAGACGTTTGTTTACGGTATAACTTGTCTACCTCTATGACTTCTCC
ACTTTCTTCGTCTATGAGCCTCTGAGAGCCTTTATAGACTGTTCCATATCTTTCTTTCATCTTTTTCTCACTCCTTAT
TTTAAACTATTCTAACTATATCATAACTGTTCTAAAAAAAAAAGAACATTTGTTAAAAGAAATTAGAACAAAATG
AGTGAAAAATTAGAACAAACAAATTCCTTATAAACCTTATCATCTCAACCTATATTAAGATTTTACCTAGTTGAAT
CTTCTTTTCTATATAAAGCGTCGGAGCATATCAGGGGGTTATCTAACGTAAATGCTACCCTTCGGCTCGCTTTCG
CTCGGCATTGACGTCAGATACTGCACCCCCTGAACCCCCATGCTCCAACAGCAAAAAGGAAACTTTTTGCTGCTT
TTCCGACGCTTATTCGCTTCGCTCATATTTATATAGAAAAGAAGTGAATGCGCAAAAGACATAATCGATTCACAA
AAAATAGGTACACGAAAAACAAGTTAAGGGATGCAGTTTATGCATCCCTTAACTTACTTATTAAATAATTTATAG
CTATTGAAAAGAGATAAGAATTGTTCAAAGCTAATATTGTTTAAATCGTCAATTCCTGCATGTTTTAAGGAATTG
TTAAATTGATTTTTTGTAAATATTTTCTTGTATTCTTTGTTAACCCATTTCATAACGAAATAATTATACTTCTGTTTA
TCTTTGTGTGATATTCTTGATTTTTTTCTATTTAATCTGATAAGTGAGCTATTCACTTTAGGTTTAGGATGAAAAT
ATTCTCTTGGAACCATACTTAATATAGAAATATCAACTTCTGCCATTAAAAATAATGCCAATGAGCGTTTTGTATT
TAATAATCTTTTAGCAAACCCGTATTCCACGATTAAATAAATCTCATCAGCTATACTATCAAAAACAATTTTGCGT
ATTATATCCGTACTTATGTTATAAGGTATATTACCAAATATTTTATAGGATTGGTTTTTAGGAAATTTAAACTGCA
ATATATCCTTGTTTAAAACTTGGAAATTATCGTGATCAACAAGTTTATTTTCTGTAGTTTTGCATAATTTATGGTC
TATTTCAATGGCAGTTACGAAATTACACCTCTGTACTAATTCAAGGGTAAAATGCCCTTTTCCTGAGCCGATTTC
AAAGATATTATCATGTTCATTTAATCTTATATTTGTCATTATTTTATCTATATTATGTTTTGAAGTAATAAAGTTTT
GACTGTGTTTTATATTTTTCTCGTTCATTATAACCCTCTTTATTTTTTCCTCCTTATAAAATTAGTATAATTATAGCA
CGAGCTCTGATAAATATGAACATGATGAGTGATCGTTAAATTTATACTGCAATCTGATGCGATTATTGAATAAA
AGATATGAGAGATTTATCTAGTTTCTTTTTTTACAAGAAAAAAGAAAGTTCTTAAAGGTTTTATACTTTTGGTCGT
AGAGCACACGGTTTAACGACTTAATTACGAAGTAAATAAGTCTAGTGTGTTAGACTTTAATGTTTTTTTAAGGCA
TTAGTGCATTTAAGCGTCAGAGCATGGCTTTATGCCGAGAAAACTATTGGTTGGAATGGCGTGTGTGTTAGCCA
AAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACG
AGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCG
GTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGC 
 
Underlined sequences in italics and red: mutations found in the isolated mutant plasmid pIMP1m-Pthl-
CbFbFPm when compared to the original plasmid construct pIMP1-Pthl-CbFbFP 
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CHAPTER V       EVOLUTIONARY ENGINEERING OF CLOSTRIDIUM 
BEIJERINCKII WITH LIGNOCELLULOSIC HYDROLYSATE 
 
The content of this chapter will be submitted to Biotechnology and Bioengineering. I am the first author 
of the paper. I performed the research, and Drs. Yong-Su Jin and Hans Blaschek were the directors of the 
research. 
 
5.1. Introduction 
Clostridium beijerinckii is gram-positive, spore-forming, anaerobic clostridia used for the 
fermentative production of industrial solvents such as acetone, butanol, and ethanol (ABE). For 
cost-effective and sustainable production of the solvents, lignocellulosic biomass is attractive and 
renewable feedstock since it is abundant and relatively cheap. Moreover, C. beijerinckii can 
naturally utilize a wide range of sugars including xylose, arabinose, cellobiose, glucose and 
mannose present in lignocellulosic biomass hydrolysate. Thus, many studies have investigated the 
feasibility of solvent production by C. beijerinckii wild type and mutants from lignocellulosic 
biomass hydrolysate [136-145]. Many factors such as harvest, transportation and storage of 
biomass, pretreatment cost, low sugar and solvent yield hinder economically feasible solvent 
production from lignocellulosic biomass. Among them, the inhibitory compounds generated 
during pretreatment of lignocellulosic biomass are the most challenging and important factor since 
the inhibitors severely decrease microbial growth and solvent yield by causing physical damage to 
the cell and disrupting metabolism. Even though some inhibitors such as furfural and HMF can be 
detoxified by clostridial strains during fermentation, the mixture of various inhibitors present in 
pretreated hydrolysate eventually impedes the fermentation if the concentration of the hydrolysate 
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increases in the medium [136].  
To overcome the inhibitor problem, many research groups in diverse fields have tried two 
major strategies: 1) Improving the quality of lignocellulosic biomass hydrolysate [146, 147] and 
2) Engineering the strain [148, 149]. For the first effort, the pretreatment process has been 
optimized to minimize generation of inhibitors. Also, the inhibitors in the hydrolysate have been 
detoxified or eliminated after the pretreatment process. For the later strategy, several microbial 
strains have been developed to have a higher tolerance to the hydrolysate inhibitors or increased 
lignocellulosic sugar uptake through rational metabolic engineering, random mutagenesis, and 
adaptation. This study focused on the strain improvement to enhance cell growth and solvent yield 
of C. beijerinckii in the presence of hydrolysate using evolutionary engineering strategy.   
Evolutionary engineering approach has been widely used for improving industrial strain 
properties including carbon source utilization [150, 151], increased production capabilities [152, 
153], and tolerance to stress conditions [154, 155]. Short-term laboratory evolution followed by 
genome sequencing provides desirable phenotype as well as insight into the mechanism behind 
the adaptive evolution [156]. To develop the inhibitor-tolerant C. beijerinckii strain, I first 
performed laboratory evolution by serial batch fermentations with increased hydrolysate 
concentration in the medium. The pretreated Miscanthus giganteus (MG) hydrolysate generated 
by National Renewable Energy Laboratory (NREL) was used as a model hydrolysate in this study. 
During the evolutionary engineering process, the culture consistently exhibited the 
degeneration or the acid crash phenotype such as ceasing cell growth, acid accumulation, and no 
solvent production. Both the degeneration and the acid crash phenotypes are featured with an 
excess of acid production without the solventogenic switch, but they can be distinguished. Here, I 
defined the degeneration phenotype that is likely caused by loss of solventogenic genes or 
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permanent failure of the solventogenic switch [157]. Compared to the degeneration, the acid crash 
phenotype is more likely caused by particular fermentation run which is usually performed without 
pH control. In the case of the acid crash phenotype, the disrupted metabolic switch and 
solventogenesis will be recovered once the fermentation condition becomes supportive for the cell 
growth of the strain. Some genetic mutations causing a delay of the solventogenic switch or/and 
overproduction of acids can also facilitate the generation of the acid crash phenotype. The acid 
crash mutant exhibits poor cell growth and acid accumulation even under the typical fermentation 
conditions in which the wild-type strain does not exhibit the acid crash phenotype. In this case, 
simple pH control can rescue the growth defect and solventogenesis of the acid crash mutant by 
alleviating the acid toxicity.  
To confirm whether the evolved acid crash strain isolated from the culture of Miscanthus 
hydrolysate represents the degeneration phenotype (loss of solventogenesis or switch) or the acid 
crash phenotype (acute acid toxicity), I performed the batch fermentations of the evolved strain 
with and without pH control together with the wild-type strain. Genome sequencing of the isolated 
mutants was further carried out to identify the genetic mutations involved in the particular 
phenotype obtained during the evolutionary engineering in the presence of lignocellulosic 
hydrolysate.  
 
5.2. Materials and methods 
5.2.1. Bacterial strains, media and growth conditions 
Laboratory spore stock of C. beijerinckii NCIMB 8052 was heat-shocked at 80oC for 10 min 
and inoculated into the TGY medium (30 g/L tryptone, 20 g/L glucose, 10 g/L yeast extract and 1 
g/L L-cysteine) with a 1% (v/v) ratio as previously described [81]. The TGY culture was incubated 
at 35oC in an anaerobic chamber and inoculated into the main fermentation with 5% inoculum. C. 
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beijerinckii strain was grown anaerobically at 35ºC in the filter-sterilized P2YE5 medium with 
various concentrations of hydrolysate if necessary. The P2YE5 medium contained the following 
compounds: 0.5 g/L KH2PO4; 0.5 g/L K2HPO4; 2.2 g/L CH3COONH4; 0.2 g/L MgSO4·7H2O; 0.01 
g/L MnSO4·H2O; 0.01 g/L FeSO4·7H2O; 0.01 g/L NaCl; 1 mg/L p-aminobenzoic acid; 1 mg/L 
thiamin-HCl; 10 µg/L biotin and 5 g/L yeast extract. The modified P2 (MP2) medium used in this 
study contained the same compounds with the P2 medium except replacing CH3COONH4 to 
(NH4)2SO4. For agar medium, 18 g/L Bacto agar was added to the medium.  
 
5.2.2. Analysis of the Miscanthus hydrolysate 
The pretreated Miscanthus giganteus hydrolysate (MGh) was generated at the National 
Renewable Energy Lab (NREL) pretreatment pilot plant (Golden, CO) using a 25% (w/w) solid 
loading, 1.5% (w/w) sulfuric acid and a rapid steam-driven heating ramp to 190oC with 1 min 
holding followed by subsequent rapid pressure release and cooling. The solids were removed by 
filtration, and the liquid fraction of the Miscanthus hydrolysate was adjusted to pH 6.5 using 
Ca(OH)2. Sugars and inhibitors were measured and quantified by high-performance liquid 
chromatography (HPLC) 1200 series (Agilent Technologies, Inc, CA, USA) equipped with a 
refractive index (RI) detector using Aminex HPX-87H column (300 x 7.8 mm) (Bio-Rad 
Laboratories, Inc, Hercules, CA). The column was eluted with 0.005 N of H2SO4 at a flow rate of 
0.6 mL/min at 30°C. The liquid fraction of the hydrolysate contained approximately 20 g/L 
glucose, 50 g/L xylose, 5 g/L arabinose, 10 g/L acetate, 1 g/L HMF, and 2 g/L furfural.  
 
5.2.3. Directed evolution of C. beijerinckii  
Evolutionary engineering of C. beijerinckii was performed by serial cultivations in batch 
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mode using 15 mL screw cap Corning tube (Sigma-Aldrich, St. Louis, MO) containing total 9.5 
mL of the MP2 medium and the Miscanthus hydrolysate. The C. beijerinckii culture (0.5 ml) was 
transfer to fresh medium at 24 h time interval with increasing the concentration of the hydrolysate. 
Cell growth was measured by optical density (OD) in the fermentation broth at A600 using a 
BioMate3 Spectrophotometer (Thermo, New York, USA). The un-inoculated hydrolysate medium 
was used as a blank for OD measurement of the samples. The concentration of hydrolysate in the 
medium was increased only when the culture showed a good growth compared to previous batch 
(OD 2 to 3) at 24 h. The culture with a good growth was then transferred to a higher hydrolysate 
concentration. The cell stock of final evolved culture and intermediate cultures during evolutionary 
engineering process were prepared with 30% glycerol and 5% DMSO and stored at –80 oC.      
 
5.2.4. Isolation of the tolerant mutants 
The final evolved culture was plated onto the MP2 hydrolysate agar plates containing the MP2 
medium, 1 % (w/v) Bacto agar and the Miscanthus hydrolysate. The several fast-growing colonies 
on MP2 hydrolysate agar plate were picked and re-streaked onto the same MP2 agar plate. Total 
three single colonies were picked and inoculated into MP2 medium containing the hydrolysate. 
The single colony cultures were incubated at 35 oC in an anaerobic chamber and stored as a 
glycerol stock. Three evolved mutants isolated from the evolutionary engineering were named as 
DG1, DG2, and DG3. 
 
5.2.5. Genome sequencing and comparative analysis 
Genomic DNA of the parental strain and seven evolved strains were extracted using a Qiagen 
DNeasy kit (Qiagen, Valencia, CA). The DNA samples were sent to the Biotechnology Center 
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(University of Illinois, Urbana-Champaign, IL) for genome sequencing. The shotgun DNAseq 
libraries were prepared with TruSeq DNAseq Sample Prep kit (Illumina). Average DNA fragment 
sizes were 660 base pairs (bp), range from 530 to 930 bp. The libraries were quantitated by qPCR 
and sequenced on one lane for 101 cycles from each end of the fragments on a HiSeq2000 using a 
TruSeq SBS sequencing kit and processed with Casava 1.8.2 in the Biotechnology Center. The 
sequence reads were trimmed of low-quality data with a quality score limit of 0.05 and adaptor 
sequence in CLC Genomics Workbench 6.0.2 (CLC Bio, Aarhus, Denmark) and reads of less than 
15 bp in length were discarded. Trimmed short-read sequences were assembled using reference-
guided assembly (reads to reference) against a published C. beijerinckii NCIMB 8052 reference 
genome in CLC Genomics Workbench. Probabilistic variants were detected with the following 
factors: minimum coverage = 10 and probability = 90 and a filter ignoring non-specific matches 
and broken pairs. The variants were filtered against known variants from wild-type C. beijerinckii. 
Annotation and amino acid change analysis were carried out with the following short-read 
parameters: mismatch cost = 2, insertion cost = 3, deletion cost = 3. Match mode was random to 
allow for assembly of both inverted repeat regions and repetitive elements. Further analysis was 
carried out using the Quality-based Variant Detection toolbox in the CLC Genomics Workbench 
using the following factors: neighborhood radius = 5, maximum gap and mismatch count = 5, 
minimum neighborhood quality = 30, minimum central quality = 30, minimum coverage = 10, 
minimum variant frequency = 10, maximum expected alleles = 5.  
 
5.2.6. PCR amplification and Sanger sequencing 
Genome sequencing results were validated by PCR amplification of the genomic region 
containing mutations and Sanger sequencing. The primers were designed and used for the PCR 
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amplification (Table 1). Around 500 bp of the regions containing the mutations were amplified 
using Phusion High-Fidelity DNA Polymerase (NEB, Ipswich, MA). The DNA fragments were 
purified using Qiagen PCR purification kit (Qiagen, Valencia, CA) and sent to the Biotech Center 
(UIUC) for Sanger sequencing.    
 
5.2.7. Fermentation and metabolite analysis 
The wild-type C. acetobutylicum ATCC824 spore lab stock was heat-shocked for 10 min at 
80°C, followed by cooling for 5 min on ice. The heat-shocked spores were inoculated at a 1% 
inoculum level into TGY medium. The TGY culture was incubated at 37oC for 12-14 h in an 
anaerobic chamber. The growing culture was inoculated into the MP2 medium containing the 
Miscanthus hydrolysate in BioFlo® 115 benchtop bioreactors (New Brunswick Scientific Co.,  CT, 
USA) at 5% inoculum level. Oxygen-free nitrogen was purged through the medium until the 
culture OD was reached at 1.0. The temperature was controlled at 35oC with agitation at 55 rpm. 
Cell growth and fermentation products were measured throughout the fermentation. The pH 
profiles of each fermentation were recorded using the NBS BioCommand® software (New 
Brunswick Scientific Co., CT, USA). Cell growth was measured by OD at A600 using a BioMate3 
Spectrophotometer (ThermoFisher Scientific, NY, USA). Acetone, butanol, ethanol, acetate, and 
butyrate were measured and quantified by HPLC.  
 
5.3. Results and discussion 
5.3.1. Investigation of the growth tolerance of C. beijerinckii to Miscanthus hydrolysate 
Acetic acid, furfural, and HMF are well-known inhibitors found in lignocellulosic 
hydrolysates [145]. These compounds inhibit the cell growth, sugar uptake, thereby affecting 
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fermentation profiles. The Miscanthus giganteus (MG) hydrolysate used in this study contains 
10 g/L acetic acid, 1 g/L HMF, and 2 g/L furfural which may significantly limit the growth of C. 
beijerinckii. To determine the inhibitory effect of the MG hydrolysate, several batch fermentation 
of the wild-type (WT) strain of C. beijerinckii were performed in the P2YE5 medium with various 
concentrations of the hydrolysate from 10 to 50% (v/v) (Fig. 1A). The sugar concentrations in the 
tested medium were maintained at the same levels in the original hydrolysate (20 g/L glucose and 
50 g/L xylose) to avoid the secondary effect of a change in sugar concentrations in the medium 
from different hydrolysate contents. When the MG hydrolysate was added to the medium at 10% 
(v/v) level, the cell growth of the wild-type strain was reduced to 70% when compared to the 
control medium containing sugars without hydrolysate. The WT strain showed enhanced solvent 
production probably because of the assimilation of acetic acid additionally provided from the 
hydrolysate. The cell growth was further reduced by 30% in the 20% (v/v) MG hydrolysate 
medium. Although cell growth was limited, the WT strain demonstrated solvent production around 
9 g/L although cell. With 25% (v/v) MG hydrolysate, the cell growth of WT strain was further 
reduced below 20% and demonstrated marginal solvent production around 3 g/L. When 50% (v/v) 
MG hydrolysate medium was used, no active cell growth and solvent production were observed. 
To provide the proper selection pressure which should not be either too harsh or too mild, I selected 
the 20% (v/v) MG hydrolysate as the initial condition for directed evolution of C. beijerinckii 
against growth inhibition by MG hydrolysate.  
 
5.3.2. Evolutionary engineering of C. beijerinckii to Miscanthus hydrolysate 
The directed evolution process performed in this study is summarized in Figure 1. The 
repeated batch fermentation was carried out by transferring the culture to fresh medium at 24 h 
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intervals. The growth rate of each subculture was plotted as optical density (OD) versus time (Fig. 
5.1B). The initial OD at first 24 h in 20% MG hydrolysate medium was around OD=1.5, but it 
gradually increased up to OD=2.9 during serial cultivation. When growth rate was no longer 
increased, hydrolysate concentration increased from 20% to 25% (v/v). After transferring to the 
25% MG hydrolysate, the OD of the culture was significantly decreased due to increased inhibitory 
effect by 5% increase in MG hydrolysate content. Then, the growth rate gradually increased again 
with each serial transfer, but suddenly decreased after the 5th transfer in 25% MG hydrolysate 
medium. Finally, the culture showed no sign of growth after the last transfer, indicating 
degeneration of culture. Although I repeated the same process of directed evolution three times, 
the cultures were consistently degenerated after a couple of serial transfers. To determine the 
reason for the degeneration, I measured fermentation products of the subculture exhibiting the 
maximum growth (17th transfer) in 25% MG hydrolysate. The culture accumulated 5.6 g/L acetate 
and 1.98 g/L butyrate and did not produce solvents, while the starting culture (1st transfer) 
accumulated the low amount of acids and successfully produced acetone and butanol (Fig. 1B). 
These results suggested that accumulation of acids without solvent production might affect the 
condition of cells, thereby decreasing the growth rate over time after transfer. Regarding the acid 
accumulation followed by limited cell growth which is a typical acid crash phenotype, I speculated 
that the evolved strain might contain genetic mutations responsible for the acid crash phenotype, 
which may be beneficial for growth under the hydrolysate medium conditions. Consequently, due 
to the acquired mutation during directed evolution, the evolved strain may demonstrate the acid 
crash phenotype even under when fed the typical batch fermentation medium. Thus, I isolated 
single colonies from the degeneration culture (at 19th transfer) and further investigated the mutant 
isolates by fermentation and genome sequencing. 
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5.3.3. Characterization of fermentation phenotype of the evolved mutants 
Batch fermentations of three single colony isolates (C. beijerinckii DG1, DG2, and DG3) from 
directed evolution and the WT strain were carried out in the P2YE5 standard medium containing 
60 g/L glucose as a carbon source (Fig. 5.2). As I expected, all three evolved mutant isolates 
showed the acid crash phenotype including limited cell growth and glucose uptake, acid 
accumulations (Fig. 5.2B, C, and D). The produced acetate and butyrate by evolved mutants were 
not reassimilated throughout fermentation, resulting in no solvent production. These phenotypes 
agree with product analysis result of the last subculture in 25% MG hydrolysate medium (Fig. 
5.1B). The results suggested that the evolved mutant has a clear phenotypic difference which is an 
acid crash. This acid crash phenotype may have resulted in the culture degeneration that 
consistently occurred during directed evolution. Under the same condition, the WT strain 
demonstrated normal cell growth and produced 10 g/L butanol from 39 g/L glucose (Fig. 5.2A). 
All the evolved mutants had a long lag phase until 12 h, but after that, the growth was significantly 
increased. At that point, the DG1 has faster growth rate than WT strain, and other two evolved 
isolates showed similar growth rate with WT strain (Fig. 5.2F). However, the cell growth was 
dramatically inhibited at 24 h which was correlated well with acid production profiles. These 
results support the earlier literature that reported that the acid crash was caused by drastic acid 
production to a toxic level, resulting in inhibition of sugar uptake and solventogenic switch. Since 
cell growth was closely connected to acidogenic metabolism, fast cell growth rate may facilitate 
acid crash phenotype of the evolved mutant which was selected for increased cell growth. 
However, the fast acid production may not be the only reason for the acid crash because WT strain 
also grew similar rate as the evolved mutant. The differences between WT and the evolved mutant 
were related to the acid reassimilation and solventogenic switch. Evolved strains failed to switch 
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their metabolism from acidogenesis to solventogenesis, resulting in the absence of solvent 
production and high accumulation of acids. The previous study also reported that delay of the 
solventogenic switch resulted in the acid crash phenotype [81]. Therefore, the evolved mutant may 
harbor genetic mutations exhibiting fast cell growth and acid production with a delay of the 
solventogenic switch. 
I performed batch fermentations in 20% MG hydrolysate medium which is the initial 
condition for directed evolution to check phenotypic differences of evolved mutants (Fig. 5.3). The 
WT strain produced 5.3 g/L acetone and 9.2 g/L butanol from co-consumption of 17 g/L glucose 
and 28.9 g/L xylose (Fig. 5.3A). Also, acetate present in the hydrolysate was assimilated together 
with sugars by WT strain. The evolved mutant DG1, DG2 and DG3 showed almost identical 
fermentation profiles exhibiting acid crash phenotype (Fig. 5.3B, C, and D). Butyrate was 
accumulated more than 2.8 g/L at the end of the fermentation of the evolved mutants while WT 
strain efficiently reassimilated butyrate thereby maintaining a low level of butyrate throughout the 
fermentation. Sugar uptake of the evolved mutant was also limited, and solvent production was 
not observed. Although overall cell growth of evolved mutant was limited, all three evolved 
mutants showed better growth at the early stage of fermentation when compared to WT strain. This 
may be the acquired phenotype from directed evolution because evolved strain was selected for 
better growth in the MG hydrolysate medium. The evolved mutant consistently showed the acid 
crash phenotype under both standard medium and hydrolysate medium, suggesting that the effect 
of mutations present in evolved mutants may not be specific to MG hydrolysate such as having 
tolerance to inhibitors despite being selected with MG hydrolysate as selection pressure. 
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5.3.4. Overcoming the acid crash phenotype of evolved mutant by pH control 
Acid crash can be prevented by alleviating acid toxicity in the culture using pH control 
strategy. Maintaining the culture pH at higher level decreases undissociated form of acids which 
are toxic to the cell. Therefore, I performed batch fermentations using an evolved mutant DG1 and 
WT strain in a bioreactor with pH control above 5.5 for further investigation (Fig. 5.4). In the 
P2YE5 control medium containing 60 g/L glucose, the WT strain demonstrated a typical ABE 
fermentation profile producing 3.6 g/L acetone, and 12 g/L butanol from 50 g/L consumed glucose 
(Fig. 5.4A). The glucose uptake and solvent production of the WT strain were enhanced compared 
to the previous batch result without pH control. The evolved mutant DG1 also showed enhanced 
glucose consumption when compared to the previous acid crash result without pH control (Fig. 
5.4B). Although butyrate accumulation increased over 7 g/L, considerable amounts of solvent were 
produced, indicating that solventogenic switch occurred in the presence of pH control. The results 
suggest that the reason for culture degeneration during the evolutionary engineering is a temporal 
failure of solventogenic transition rather than a permanent failure. The mismatch between 
acidogenesis and solventogenesis that occurred in the evolved mutant DG1 may have resulted in 
high acid accumulation which is toxic to the cell without pH control, thereby inhibiting sugar 
uptake and cell growth. This means that degeneration of the evolved culture of C. beijerinckii was 
not caused by loss of solventogenic genes, unlike C. acetobutylicum which harbors the 
solventogenesis operon (Sol operon) in the mega plasmid that is susceptible to loss. 
In batch fermentation using 20% MG hydrolysate medium with pH control above 5.5, the 
mutant DG1 showed higher sugar uptake rate than WT strain (Fig. 5.4C and D). The DG1 produced 
8.1 g/L butanol and 2.0 g/L acetone from co-consumption of 22.5 g/L glucose and 36.5 g/L xylose. 
These results suggested that evolved mutant DG1 showed superior phenotype once pH control 
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prevented acid crash phenotype in MG hydrolysate medium which was used for directed evolution. 
Although the evolved isolate has the capacity to ferment MG hydrolysate faster than WT strain, 
the culture always showed the degeneration during evolutionary engineering. The possible reason 
for this may be because the mutant was originally evolved to grow faster in MG hydrolysate 
medium, but at the certain point, the fast growing phenotype made the cell sick due to fast acid 
accumulation at a toxic level, resulting in culture degeneration without pH control. Another 
interesting observation was that DG1 accumulated butyrate and acetate to the same concentration 
with butanol with pH control. This result suggested that acid production pathway in the DG1 
mutant was still active after the solventogenic switch. In wild-type C. beijerinckii, acidogenesis 
was repressed after the onset of solventogenesis. The DG1 strain accumulating both butyrate and 
butanol at the same concentration may be a good host strain for butyl butyrate production from 
ABE fermentation[81]. Overall, pH control helped both strains to increase sugar consumption and 
solvent production by relieving acid toxicity.  
 
5.3.5. Genome sequencing and analysis 
To identify the genetic mutations responsible for the phenotypic change after directed 
evolution in MG hydrolysate medium, I performed genome sequencing of the evolved mutants 
(DG1, DG2, and DG3) and wild-type C. beijerinckii parental strain. Comparative genome analysis 
revealed that all three mutants contained two SNPs in the genome. One SNP was in Cbei_2852 
encoding isochorismatase hydrolase, and another SNP was upstream of Cbei_4885 encoding AbrB 
family transcriptional regulator (Fig. 5.1D). These two mutations were further confirmed to be 
positive by Sanger sequencing of PCR products of the genomic region. This result suggested that 
relatively short period of directed evolution without the use of mutagen generated a few point 
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mutations rather than making multiple genomic variations. The SNP at 213 bp of open reading 
frame of Cbei_2852 was a synonymous mutation which did not make a change in the encoded 
amino acid. Thus, another SNP in the promoter region of the Cbei_4885 gene which can alter the 
expression level is more likely responsible mutation for phenotypic change in evolved mutants.   
The AbrB regulator is well-known transition state regulator in the related species, Bacillus 
subtilis, controlling sporulation initiation by interacting with a master regulator Spo0A [158]. The 
previous studies reported that AbrB regulator prevents the premature onset of sporulation by 
repressing several sporulation-associated genes [159-161]. Since the solventogenic clostridia 
including C. beijerinckii have a close correlation between solventogenesis and sporulation, AbrB 
also regulated expression of genes related to acidogenesis and solventogenesis metabolisms [162, 
163]. If the cells enter the transition phase from acidogenesis to solventogenesis, the active form 
of Spo0A binds to the 0A box motif in abrB promoter region resulting in repression of abrB 
expression. The repressed abrB expression initiates the sporulation process and turns down 
acidogenic gene expression [164]. If the abrB expression is not repressed due to genetic mutation 
such as disruption of Spo0A binding site, acidogenesis will not be repressed, and cells cannot 
initiate sporulation as well as solventogenesis at the right timing. As a result, acids will be 
accumulated in the culture which causes acid toxicity without pH control. Considering the role of 
AbrB, the SNP at the 154 bp upstream of start codon in the evolved mutants may prevent repression 
of AbrB expression or may enhance the AbrB expression in addition to the native expression level 
in the cells, which could result in acid crash phenotype for the above reasons. To confirm the 
alteration of AbrB expression in the evolved mutants, transcriptional analysis using RT-Q-PCR 
can be performed.       
The AbrB family regulator is also known to modulate catabolite repression by elevating the 
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expression of enzymes that are required for cell growth in the medium containing slowly 
metabolized carbon sources such as xylose [165]. This makes good sense as to why the cell grown 
in MG hydrolysate resulted in the point mutation in the promoter region of the abrB gene. Since 
the strain needs to have higher expression of abrB to grow better in the presence of xylose, the 
SNP in the promoter region may work best for cells to increase the abrB expression.  
 
5.4. Conclusions 
In this study, I performed evolutionary engineering of C. beijerinckii in the Miscanthus 
hydrolysate medium to improve the cell growth. C. beijerinckii culture was consistently 
degenerated with typical acid crash phenotype including the limited cell growth, acid 
accumulation, and no solvent production. The evolved mutants isolated from the degeneration 
culture exhibited the acid crash phenotype in both P2YE5 glucose medium and P2YE5 hydrolysate 
medium without pH control. However, with pH control, the evolved mutants showed increased 
cell growth and sugar uptake in MG hydrolysate medium when compared to the wild-type strain. 
The evolved mutant still showed solvent production with a high amount of acid accumulation, 
indicating that the reason for the acid crash was acid toxicity by increased acid accumulation 
followed by decreased pH rather than a permanent failure of the solventogenic switch due to loss 
of solventogenic genes. Genome sequencing of evolved mutant isolates revealed the SNP in the 
promoter region of the AbrB gene (Cbei_4885) encoding the AbrB regulator involved in the sugar 
uptake, acid production, and solventogenic switch. The directed evolution selecting for increased 
cell growth rate could generate unintended mutations responsible for enhancing acidogenesis 
which has a positive correlation with cell growth, thereby resulting in the acid crash phenotype in 
batch fermentation without pH control.  
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5.5. Figures and tables 
 
 
Figure 5.1. Flow diagram for evolutionary engineering process and summary of the results 
in this study. (A) Investigation of growth tolerance of C. beijerinckii to Miscanthus giganteus 
hydrolysate (MGh), (B) Directed evolution process selecting for increased cell growth in MGh 
medium, (C) Characterization of fermentation phenotype of evolved mutants, (D) Genome 
sequencing and comparative analysis to identify genetic variations. *Cell growth (%) was 
calculated based on the control medium containing 0% MGh. **Hydrolysate concentration was 
increased once the OD value was no longer increased. 
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Figure 5.2. Batch fermentation profiles of the C. beijerinckii wild-type (A) and the evolved 
mutant isolates DG1, DG2, and DG3 (B, C, and D, respectively) in P2YE5 medium containing 
60 g/L glucose without a pH control, and growth comparison of the strains (E) and 
magnification at the early stage of fermentation (F).  
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Figure 5.3. Batch fermentation profiles of the C. beijerinckii wild-type (A) and the evolved 
mutant isolates DG1, DG2, and DG3 (B, C, and D, respectively) in P2YE5 medium containing 
20% (v/v) Miscanthus hydrolysate without a pH control, and growth comparison of the 
strains (E) with magnification at the early stage of fermentation (F).  
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Figure 5.4. Batch fermentation profiles of the C. beijerinckii wild-type and the evolved strain 
DG1 in P2YE5 control medium containing 60 g/L glucose and P2YE5 medium containing 
20% (v/v) Miscanthus giganteus hydrolysate (MGh) with the pH control above 5.5. (A) C. 
beijerinckii wild-type in the P2YE5 control medium, (B) C. beijerinckii DG1 in the P2YE5 control 
medium, (C) C. beijerinckii wild-type in the P2YE5 MGh medium, (D) C. beijerinckii DG1 in the 
P2YE5 MGh medium. 
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Figure 5.5. The promoter region of the abrB gene with different binding motifs: The asterisk 
indicates the SNP (C to A) at the 154 bp upstream of start codon found in evolved strains. The 
predicted and putative -35 and -10 promoter regions are highlighted in lower case, and a putative 
ribosome binding site is shown in italics. The promoters (P1 & P2) were predicted by BPROM 
(www.softberry.com). The binding motifs, PerR (wavelike underlined), SigA (dashed underlined) 
and Spo0A (solid underlined) were predicted based on that of Bacillus subtilis. 
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Table 5.1. Primers used in this study 
 
 
 
  
Name Description 
F_Cbei_2852_SNP CAGGTTCACCTCATTTAATGGAC 
R_Cbei_2852_SNP CTCTTGCTGTAGTATCAACTCC 
F_Cbei_4885_SNP GGACATATGCCTTATATTACTTTATTTGT 
R_Cbei_4885_SNP CTATCTGTTTGTTTTAATTTCGTCTAAAC 
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CHAPTER VI       PRODUCTION OF 2,3-BUTANEDIOL BY METABOLICALLY 
ENGINEERED SACCHAROMYCES CEREVISIAE 
 
The content of this chapter will be submitted to Journal of Biotechnology. I am the first author of the 
paper. I performed the research, and Dr. Yong-Su Jin was the director of the research. The latter part of 
this chapter will be submitted to Bioresource Technology Journal. 
 
6.1. Introduction 
Growing concerns over global climate change by greenhouse gas emissions have induced 
studies to produce fuels and chemicals from renewable biomass. Microbial fermentation has been 
applied for converting the biomass to many important chemicals in industries. 2,3-Butanediol (2,3-
BD) is one of the chemicals that can be produced from renewable biomass through fermentation 
and is attractive biochemical owing to its diverse applications. 2,3-BD can be directly used for 
pharmaceuticals and food additives [166] or converted into butadiene for the manufacture of 
polymers and plastics [167]. Also, the global market of 2,3-BD is growing over time with the 
potential use of other 2,3-BD derivatives [168].     
Many bacteria species including Bacillus, Klebsiella, and Enterobacter as well as its 
engineered strains have been used and optimized for the 2,3-BD production [169]. Compared to 
the native producers, metabolically engineered industrial yeast Saccharomyces cerevisiae can also 
produce 2,3-BD efficiently with a high titer and yield by enhancing pyruvate flux to 2,3-BD 
through the elimination of the pyruvate decarboxylation reaction and overexpression of the 
heterologous 2,3-BD biosynthesis pathway [48]. Recently, several breakthroughs have been made 
for the efficient production of 2,3-BD in S. cerevisiae through metabolic engineering of the Pdc-
103 
 
negative strains incapable of producing ethanol [168]. 
Previous studies revealed that the Pdc-negative strain requires two-carbon (C2) compound for 
the cytosolic acetyl-CoA synthesis which is essential for cell growth. Also, the Pdc-negative strain 
is sensitive to high glucose concentration probably due to severe redox imbalance problem. Thus, 
the Pdc-negative S. cerevisiae strains have been evolved on the glucose as a sole carbon source to 
have the C2-independent and high glucose-tolerant phenotype for further metabolic engineering 
[170]. The genetic mutation in the MTH1 gene encoding a negative regulator of glucose-sensing 
metabolism was consistently found in the evolved Pdc-negative strains, which allows the cell 
growth on glucose without the supply of the C2 compound.  
In this study, the 2,3-BD producing Pdc-negative S. cerevisiae incapable of producing ethanol 
was constructed by introducing the 2,3-BD production pathway that was previously employed to 
produce 2,3-BD in yeast [48, 53, 50, 52, 54]. Initially, the recombinant Pdc-negative strain was 
not able to grow on the high concentration of glucose as a sole carbon source. However, the strain 
was evolved to grow on high glucose and produced 2,3-BD at a high titer and yield without ethanol 
production. I identified the genetic mutation in HXK2 gene responsible for the increased glucose 
tolerance in the evolved strain by genome sequencing and validated the effect through reverse 
engineering of the non-evolved Pdc-negative strain harboring 2,3-BD pathway by the 
CRISPR/Cas9-based genome editing. 
The previous study reported that hxk2 deletion mutant of S. cerevisiae co-consumed sucrose 
and glucose due to glucose derepression phenotype and increased oxidative capacity. The mutation 
in HXK2 gene found in the 2,3-BD producing Pdc-negative strain may also have the benefit when 
a sucrose-containing substrate such as sugarcane juice is used for 2,3-BD production. For a large-
scale industrial 2,3-BD production, sugarcane is a desirable feedstock since it is the abundant, 
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inexpensive and easily-degradable. The sugarcane juice contains mainly sucrose, glucose, and 
fructose and can be easily consumed by S. cerevisiae through endogenous invertase activity by 
hydrolysis of sucrose to glucose and fructose. Therefore, I investigated the feasibility of producing 
2,3-BD from sugarcane juice by the 2,3-BD-producing Pdc-negative strain constructed in this 
study. 
For successful 2,3-BD production from sugarcane juice by engineered yeast strain, 
fermentation conditions need to be investigated as following reasons. First, mixed sugars derived 
from sugarcane juice can be easily utilized by other microbial contaminants present in crude 
sugarcane juice. Thus, crude sugarcane juice needs to be pretreated to prevent microbial 
contamination. Second, the additional nitrogen source is required for supporting yeast cell growth 
due to limited nitrogen content in crude sugarcane juices [171, 172]. Third, the amount of yeast 
inoculum needs to be optimized for efficient 2,3-BD production against the stress condition caused 
by osmotic pressure from high initial sugar concentrations in sugarcane juice medium. Considering 
these factors, I successfully produce 2,3-BD at high yield and productivity from sugarcane juice 
by engineered S. cerevisiae in batch and fed-batch fermentations. 
 
6.2. Materials and methods 
6.2.1. Strains and plasmids 
Escherichia coli TOP10 (Invitrogen, CA, USA) was used for gene cloning and plasmid 
amplification. The Pdc-negative S. cerevisiae SOS5 (D452-2: MATα, leu2, his3, ura3, can1, 
Δpdc1, Δpdc5, ∆pdc6) was used as a host strain for introducing the 2,3-BD production pathway. 
The heterologous 2,3-BD biosynthetic genes, alsS and alsD from Bacillus subtilis and the 
endogenous BDH1 gene were constitutively expressed under the GPD promoter and CYC1 
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terminator in pRS426, pRS423 and pRS425 plasmids, respectively in the SOS5 strain. A list of 
strains and plasmids used in this study can be found in Table 1. 
 
6.2.2. Culture conditions and yeast transformation 
Lysogeny Broth (LB) medium (5 g/L yeast extract, 10 g/L tryptone, and 10 g/L NaCl) with 50 
μg/mL ampicillin was used for plasmid preparation from E. coli TOP10. Synthetic complete (SC) 
minimal medium (6.7 g/L yeast nitrogen base without amino acids and 0.6 g/L complete 
supplement mixture without histidine, leucine, tryptophan, and uracil; adjusted to pH 5.8) with 20 
g/L ethanol and addition of necessary amino acids/nucleotide was used for culturing the SOS5 and 
SOS5-SDB-PI strain. The YP complex medium (10 g/L yeast extract and 20 g/L peptone) was used 
for cultivation of the recombinant yeast strains. Transformation of plasmid(s) into the SOS5 strain 
was performed using the high-efficiency yeast transformation method previously described [173]. 
After the transformation, the SOS5-SDB-PI strain was selected on the SC medium agar (20 g/L 
Bacto agar) plates with 5 g/L glucose and 2 g/L ethanol and the addition of necessary amino acids. 
Transformants were then cultivated in minimal medium with 5 g/L glucose and 2 g/L ethanol with 
supplementation of necessary amino acids before inoculation into the main fermentations in the 
YP medium.  
 
6.2.3. Laboratory evolution of the 2,3-BD producing Pdc-negative strain 
The SOS5-SDB-PI strain was grown overnight in the SC medium containing 5 g/L and 2 g/L 
ethanol. The cells were harvested at mid-exponential phase by centrifugation and washed with the 
50 mM potassium phosphate buffer (pH=6.8) twice after removing the supernatant. The washed 
cells were incubated in the YP medium containing 110 g/L of glucose as a sole carbon source under 
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oxygen-limited condition until the cell growth and glucose uptake were observed.  
 
6.2.4. Batch and fed-batch fermentation experiments 
Main fermentations with were performed in 250 mL flasks containing 50 mL of the YP 
medium with 110 g/L glucose or 300 g/L. Pre-cultured cells were inoculated at OD600=1 for the 
main fermentation and cultivated at 30°C under a microaerobic condition with an agitation speed 
of 80 rpm. Fed-batch fermentations in the flask were performed in 250 mL flasks containing 50 
mL of the YP medium with 110 g/L glucose. 500 g/L of glucose was used for feeding solution and 
added to the flask. The Fed-batch fermentation in a bioreactor with 1 L working volume was 
performed at 30°C with pH control at 5.5 using 2M NaOH solution. For oxygen-limited condition, 
agitation was employed at 100 rpm without purging air into the reactor. 800 g/L glucose was used 
for feeding solution and intermittently fed into the reactor at the concentration of 100 g/L when 
glucose was depleted. During the fermentation, 5 ml of samples were taken from the reactor for 
measurement of cell growth and fermentation products.  
Main fermentations of SOS5-SDB-PII in sugar cane juice were performed in 250 mL flasks 
containing 50 mL of sugarcane juice medium adjusted to pH 6.0. Pre-cultured cells were harvested 
at around optical density OD600=5.0 and inoculated at OD600=1 for the main fermentation. The 
cultures were incubated at 30°C under a microaerobic condition with an agitation speed of 80 rpm. 
For high cell density culture, initial OD600=55 was used. For fed-batch fermentation, 500 g/L 
sucrose solution was used as feeding solution. 
 
6.2.5. Analytical methods 
Cell growth was measured by optical density (OD) in the fermentation broth at A600 using a 
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BioMate3 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA) and converted to dry cell 
weight (DCW) by DCW(g/L)=OD600*0.345. Metabolite concentrations were determined by a 
high-performance liquid chromatography (HPLC) system (Agilent Technologies 1200 Series) 
equipped with the Rezex ROA Organic Acid H+ column (Phenomenex Inc., Torrance, CA) and a 
refractive index (RI) detector (Agilent Technologies, Palo Alto, CA). The column was eluted by 
0.005 N H2SO4 at a flow rate of 0.6 mL/min at 50°C. Sucrose, glucose, and fructose were 
determined by HPLC with Bio-Rad Aminex HPX-87C column. The column was eluted with water 
at a flow rate of 0.6 mL/min at 80°C. 
 
6.3. Results and discussion 
6.3.1. Construction of 2,3-butanediol producing Pdc-negative S. cerevisiae 
The 2,3-BD biosynthesis pathway overexpressing the acetolactate synthase (AlsS) and 
acetolactate decarboxylase (AlsD) from B. subtilis and the endogenous 2,3-butanediol 
dehydrogenase (BDH1) was introduced into the pdc1, pdc5, and pdc6 triple deletion S. cerevisiae 
(SOS5) to produce 2,3-BD without ethanol production. The resulting strain SOS5-SDB-PI 
exhibited the growth defect in the SC selective medium containing 110 g/L glucose as a sole carbon 
source (Fig. 2A). To produce 2,3-BD efficiently from glucose with a high titer, the growth defect 
on high glucose needs to be overcome. For this purpose, laboratory evolution of the SOS5-SDB-
PI strain was performed by prolonged cultivation in the YP medium containing 110 g/L glucose 
under oxygen-limited condition. The evolved strain SOS5-SDB-PII which showed cell growth on 
high glucose was isolated and further evaluated for 2,3-BD production from glucose. 
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6.3.2. Characterization of the phenotype of the evolved SOS5-SDB-PII strain in batch and 
fed-batch fermentation 
In the batch fermentation, the evolved SOS5-SDB-PII strain was able to grow in the YP 
medium containing 110 g/L glucose and completely consumed all supplied glucose within 84 h 
(Fig. 2B). As results, the SOS5-SDB-PII strain produced 39.1 g/L of 2,3-BD and 25.2 g/L of 
glycerol without ethanol production. Also, pyruvate was accumulated up to 3.5 g/L at the end of 
the fermentation. I further investigated the 2,3-BD production by SOS5-SDB-PII strain in the fed-
batch fermentation by feeding additional glucose into the flask (Fig. 3A). The 2,3-BD production 
was increased up to 47.6 g/L from, but the rates of glucose uptake and 2,3-BD production were 
gradually reduced after feeding glucose. Thus, instead of feeding glucose, I performed the batch 
fermentation with high initial glucose concentration (280 g/L). The SOS5-SDB-PII strain also 
stopped the fermentation after consuming 150 g/L glucose. In the end, the 2,3-BD was produced 
by 54 g/L with 43 g/L glycerol. I speculated that the reason for the incomplete glucose consumption 
might be because of the decrease in the culture pH by the accumulation of acid intermediates since 
the measured pH value at the end of the fed-batch and batch fermentation in flasks were between 
3.58 and 3.65. Therefore, I performed another fed-batch fermentation of the SOS5-SDB-PII strain 
with a pH control at 5.5 in a bioreactor to see if fed glucose can be continuously consumed by the 
strain (Fig. 3B). As a result, the SOS5-SDB-PII strain was able to produce 120 g/L 2,3-BD after 
continuously consuming fed glucose. Excessive amounts of glycerol and pyruvate were also 
accumulated by 104 g/L and 8.6 g/L, respectively. However, after the fourth glucose feeding, 
glucose uptake was reduced and eventually stopped probably due to cell death caused by high 
osmotic pressure (total 220 g/L of 2,3-BD and glycerol accumulation) as well as accumulation of 
pyruvate over the long period of culture at a toxic level at pH=5.5.  
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 6.3.3. Genome sequencing of the SOS5-SDB-PII strain to identify the genetic mutation  
The SOS5-SDB-PII strain significantly produced 2,3-BD from a high concentration of 
glucose as a sole carbon source. Thus, the SOS5-SDB-PII strain may have the mutation in the 
MTH1 gene that was previously found in the evolved Pdc-negative strains exhibiting the C2-
independent and high glucose-tolerant phenotype. To identify the genetic mutation allowing the 
evolved SOS5-SDB-PII strain grow on the high glucose medium, I performed genome sequencing 
and comparative genome analysis. Compared to the SOS5-SDB-PI strain, the SOS5-SDB-PII 
strain contained one single nucleotide polymorphism (SNP) in the HXK2 gene (G to A) at the 
position of 920 bp (Fig. 5A). Interestingly, the expected mutation in the MTH1 gene was not 
detected in the SOS5-SDB-PII strain and checked again by Sanger sequencing. The result suggests 
that the SNP in HXK2 gene may cause the C2-independent and high glucose-tolerance phenotype 
of the Pdc-negative strain harboring the 2,3-BD biosynthesis pathway. The reason why the SOS5-
SDB-PII strain made different mutation may be because this Pdc-negative strain was evolved on 
high glucose condition after introducing the 2,3-BD biosynthetic pathway. In the previous studies 
reporting the mutations in the MTH1 gene, the Pdc-negative strains were evolved on glucose as a 
sole carbon source without introducing other metabolic pathways into the strain. Also, the previous 
study reported that introducing the 2,3-BD pathway into the Pdc-negative S. cerevisiae could allow 
the cell growth on glucose without a supply of C2 compound [54]. Thus, high glucose influx may 
be the only bottleneck for the SOS5-SDB-PII strain to grow on the high glucose medium without 
the C2 compound. This different selection pressure for directed evolution may have also resulted 
in the generation of the SNP in HXK2 gene rather than in the MTH1 gene.  
The HXK2 gene in S. cerevisiae encodes the hexokinase isozyme 2 which phosphorylates 
glucose in the cytosol and has known as “intracellular glucose sensor” involved in glucose 
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repression [174]. The SNP in the HXK2 gene in the SOS5-SDB-PII strain caused the amino acid 
change from glycine to aspartic acid at the position of 307th (G307D) which is the highly 
conserved ATP-binding domain (Fig. 5B) [175, 176]. The ATP is the second substrate of the 
hexokinase, and the interruption of the ATP binding domain might reduce the phosphorylation 
capacity of hexokinase. The decreased hexokinase activity is known to relieve the glucose 
repression in S. cerevisiae [177]. Also, the level of glucose repression correlates well with the rate 
of glucose transport and phosphorylation [178, 174]. These findings suggested the SNP in the 
HXK2 gene in the SOS5-SDB-PII strain could slow down the glucose transport rate that helps to 
minimize the redox imbalance problem of the Pdc-negative strains [179, 48]. Also, glucose 
derepression can increase the carbon flux to the TCA cycle and oxidative phosphorylation in the 
presence of excess glucose [180, 181]. The increased flux to respiration may help to overcome the 
high glucose sensitivity of the Pdc-negative strain by reducing accumulation of toxic intermediates 
from high glucose influx as the MTH1 mutant also suggested [179, 48].  
 
6.3.4. Validation of the effect of the point mutation in the HXK2 gene  
To determine whether the SNP (G to A at 920 bp) in the HXK2 gene is the direct reason for 
the high glucose-tolerant phenotype of the Pdc-negative S. cerevisiae containing the 2,3-BD 
biosynthesis pathway, the point mutation was reintroduced into the SOS5-SDB-PI strain incapable 
of growing on glucose as a sole carbon source by the CRISPR/Cas9-based genome editing. The 
single nucleotide substitution (G to A) at 920 bp in the resulting strain SOS5-SDB-PIII was 
confirmed by Sanger sequencing (Fig. 5A). During CRISPR/Cas9-based nucleotide substitution, 
the PAM sequence (TGG) recognized by Cas9 nuclease was modified by introducing the additional 
synonymous nucleotide change (G to A) at 948 bp that does not cause the amino acid change to 
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prevent further double strand breakage by Cas9 after introducing the point mutation at 920 bp in 
the HXK2 (Fig. 5A and 5B). The engineered SOS5-SDB-PIII strain harboring the mutant HXK2 
was able to grow in YP medium containing 100 g/L glucose at the similar growth rate with the 
evolved SOS5-SDB-PII strain and completely consumed all the glucose within 91 h. Also, the 
SOS5-SDB-PIII strain showed the similar 2,3-BD yield (0.332 g/g) when compared to the SOS5-
SDB-PII strain (0.341 g/g) (Fig. 5C). These results suggest that the SNP in the HXK2 gene is the 
reason for the high glucose-tolerant phenotype of the Pdc-negative S. cerevisiae harboring the 2,3-
BD pathway. 
 
6.3.5. Preparation of sugarcane juice medium for yeast fermentation 
The mixed sugars derived from sugarcane juice can be easily utilized by other microbial 
contaminants present in the sugarcane juice. Thus, the sugarcane juice needs to be treated before 
inoculating the 2,3-BD producing yeast to prevent the microbial contamination. Several 
preparation methods were tested to prevent the contamination and support the cell growth by 
providing nitrogen source (Fig. 6.6). The sugarcane juice media treated with five different 
preparation methods were incubated at 30oC without any inoculation and compared to the original 
sugarcane juice without treatment as a control. The first method (centrifugation and filtration) and 
second method (centrifugation and autoclave) did not show the sign of microbial cell growth (Fig. 
6.6). However, the other methods as well as the original sugarcane juice showed a significant 
increase in the OD indicating a microbial cell growth. This result suggested that microbial 
contamination of the sugarcane juice can be prevented by either filtration or autoclaving. Since the 
filtration method required long period and not optimal for the large-scale preparation, the second 
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method with autoclave was used for preparing sugarcane juice medium to test 2,3-BD production 
by engineered yeast. 
  
6.3.6. Production of 2,3-BD from sugarcane juice by metabolically engineered S. cerevisiae 
The evolved strain SOS5-SDB-PII grown on glucose attained a genetic mutation in HXK2 
gene encoding hexokinase. Since mutants in hexokinase could result in glucose de-repression 
phenotype in S. cerevisiae, the SOS5-SDB-PII strain may be beneficial to produce 2,3-BD from 
sugar mixture derived from sugarcane juice including sucrose, fructose, and glucose. Thus, I 
employed the SOS5-SDB-PII strain to produce 2,3-BD from sugarcane juice. The SOS5-SDB-PII 
strain was inoculated into sugarcane juice medium that was prepared by centrifugation and 
autoclave with initial OD=8.0. At 145 h of culture, the strain produced 47.6 g/L of 2,3-BD and 
19.5 g/L glycerol starting from 234 g/L sucrose, 14.6 g/L glucose, and 12.8 g/L fructose (Fig. 
6.7A). Both glucose and fructose were continuously generated from hydrolysis of sucrose but 
accumulated in the medium over time by 15.5 g/L and 35.5 g/L, respectively. The previous study 
reported that sugar metabolism and cell growth of yeast in crude sugarcane juice were limited due 
to the lack of nitrogen source [171]. Thus, I supplemented yeast extract into sugarcane juice 
medium to provide additional nitrogen source. As a result, the SOS5-SDB-PII strain produced 68.6 
g/L 2,3-BD and 44.8 g/L glycerol by co-consuming 197 g/L sucrose, 11.4 g/L glucose, and 10.1 
g/L fructose efficiently (Fig. 6.7B). The yield and productivity of 2,3-BD were 0.342 (g/g sugar) 
and 0.473 (g/L·h). Glycerol production was two-third of 2,3-BD production which is consistent 
with previous report [48]. The flux to glycerol is caused by redox imbalance between glycolysis 
pathway generating 2 moles of NADH from 1 mole of glucose and 2,3-BD biosynthetic pathway 
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oxidizing 1 mole of NADH (Fig. 1). However, glycerol production can be further minimized 
through bioprocess optimization and metabolic engineering [50, 52].  
 
6.3.7. Fed-batch fermentation of sugarcane juice with additional sucrose 
To increase 2,3-BD titer, I performed fed-batch fermentation by feeding additional sucrose. 
During the first batch period shown in Fig. 6.8A, the SOS5-SDB-PII strain produced 69.7 g/L 2,3-
BD and 45.3 g/L glycerol which is similar with that of previous batch fermentation. Also, the 2,3-
BD yield was 0.344 (g/g sugar) with no significant difference when compared to the previous run 
(0.342 g/g sugar). However, after feeding additional sucrose to medium, sugar uptake rate of the 
SOS5-SDB-PII strain was significantly reduced, thereby accumulating glucose and fructose 
generated from hydrolysis of sucrose. Compared to glucose and fructose uptake rates, sucrose 
hydrolysis rate was enhanced after feeding. This result indicated that more invertase was released 
to the medium after feeding probably due to disruption of cells by a drastic increase in osmotic 
pressure caused by high concentration of sucrose feeding. From the feeding point, only 6.6 g/L of 
2,3-BD was additionally produced, thereby accumulating total 76.6 g/L of 2,3-BD in 248 h (Fig. 
6.8A). At this point, polyols (2,3-BD and glycerol) and sugars (sucrose, fructose, glucose) were 
already accumulated at high concentrations total over 280 g/L in the medium causing a significant 
osmotic stress to the cell. 
 
6.3.8. Batch fermentation of sugarcane juice with high OD inoculum  
High cell density fermentation can increase sucrose hydrolysis rate as well as sugar 
consumption rate [182]. The increased sugar uptake rate results in improved 2,3-BD productivity 
from sugarcane juice. Also, fast sugar consumption by the high amount of yeast cells can minimize 
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contamination of other microbes in the reactor by competing with them. Therefore, I performed 
batch fermentation with a high initial cell density of SOS5-SDB-PII strain. With an initial OD at 
55, SOS5-SDB-PII strain consumed all the sugars within 75 h in sugarcane juice medium with 
yeast extract and produced 87.6 g/L 2,3-BD, 14.2 g/L acetoin, and 35.3 g/L glycerol (Fig. 6.8B). 
Considering that acetoin is an intermediate product which can be converted to 2,3-BD with 
controlling aeration, over the 100 g/L of products was produced from the 2,3-BD biosynthetic 
pathway in SOS5-SDB-PII strain. The productivity of 2,3-BD increased from 0.473 to 1.17 (g/L·h) 
when compared to previous batch fermentation with low initial OD. The yield of 2,3-BD was 0.363 
(g/g sugar). This result suggested that high cell density inoculation improved 2,3-BD productivity 
without loss in the yield of 2,3-BD. For industrial production of 2,3-BD, repeating batch 
fermentation with high cell density might be a better option than fed-batch fermentation with the 
additional feeding of sugars. Recycling the cells from the previous batch may help to achieve 
economically feasible production of 2,3-BD from sugarcane juice. 
 
6.4. Conclusions 
An engineered 2,3-BD producing S. cerevisiae strain was constructed through the introduction 
of acetolactate synthase and acetolactate decarboxylase from B. subtilis, and endogenous 2,3-
butanediol dehydrogenase in the pdc1, pdc5, and pdc6 triple deletion strain (SOS5). The resulting 
strain (SOS5-SDB) was evolved to grow on high glucose as a sole carbon source. The evolved 
strain (SOS5-SDB-PII) produced 120 g/L of 2,3-BD in the glucose fed-batch fermentation. 
Genome sequencing identified the SNP in the HXK2 gene in SOS5-SDB-PII strain, resulting in 
amino acid change (G307D) of hexokinase 2. The introduction of the SNP in HXK2 gene into 
SOS5-SDB strain by the CRISPR/Cas9-based nucleotide substitution successfully generated the 
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high-glucose tolerant phenotype. Furthermore, I tested the feasibility of producing 2,3-BD from 
sugarcane juice by an engineered 2,3-BD-producing Pdc-negative S. cerevisiae without ethanol 
production. For the preparation of sugarcane juice medium, centrifugation followed by autoclaving 
method successfully prevented microbial contamination. In batch fermentation of the sugarcane 
juice, the SOS5-SDB-PII strain produced 48 g/L 2,3-BD in 145 h with incomplete sugar 
consumption. With yeast extract supplementation, 2,3-BD production increased by 69 g/L with 
improved sugar consumption, yield, and productivity (0.472 g 2,3-BD/L·h). In fed-batch 
fermentation, the SOS5-SDB-PII strain produced 76 g/L 2,3-BD with the additional feeding of 
sucrose with decreased productivity (0.308 g 2,3-BD/L·h). High cell density fermentation of 
sugarcane juice medium containing yeast extract resulted in increased titer (87.6 g/L), yield (0.381 
g/g sugar), and productivity (1.17 g/L·h) of 2,3-BD. Industrial 2,3-BD production from sugarcane 
juice by repeated batch fermentation with high cell density might be a feasible option. 
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6.5. Figures and tables 
 
Figure 6.1. Production of 2,3-BD from sugarcane juice by metabolically engineered and 
evolved 2,3-BD producing Pdc-negative S. cerevisiae (SOS5-SDB-PII). The Pdc-negative S. 
cerevisiae (SOS5) harboring the 2,3-BD biosynthetic pathway (alsS, alsD, and BDH1) was 
evolved to grow on high glucose concentration. The evolved strain SOS5-SDB-PII gained a 
mutation in hexokinase 2 (HXK2) gene. 
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Figure 6.2. Batch fermentation profile of the SOS5-SDB-PI strain (A) and the evolved SOS5-
SDB-PII strain (B) in YP medium containing 110 g/L glucose.  
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Figure 6.3. Fed-batch fermentation profile of the evolved SOS5-SDB-PII strain in YP 
medium containing 110 g/L glucose (A) and batch fermentation profile in YP medium 
containing 300 g/L glucose (B).  
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Figure 6.4. Fed-batch fermentation profile of the SOS5-SDB-PII strain in YP medium with 
pH control at 5.5. 
  
120 
 
 
Figure 6.5. Partial nucleotide sequence (A) and its corresponding protein sequence (B) of the 
hexokinase isozyme 2 (HXK2) gene in the 2,3-BD producing Pdc-negative S. cerevisiae 
recombinants used in this study. The point mutation (G to A) at 902 bp of the HXK2 gene causes 
the amino acid change from glycine (G) to Aspartic acid (D) in the evolved SOS5-SDB-PII strain. 
For reverse engineering, the point mutation at 920 bp was introduced into SOS5-SDB-PI strain by 
CRISPR/Cas9 genome editing tool, resulting in the SOS5-SDB-PIII strain. To prevent continuous 
double strand breakage by a Cas9 nuclease, the additional synonymous nucleotide substitution (G 
to A) at 948 bp was introduced to modify the PAM sequence (-TGG) recognized by a Cas9 
nuclease. 
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Figure 6.6. Investigation of the preparation method for sugarcane juice medium. Five 
different methods were tested. 1: Centrifugation with filtration, 2: Centrifugation with an 
autoclave, 3: Centrifugation with antibiotics (500 mg/L of ampicillin and erythromycin), 4: 
Centrifugation, 5: Original with antibiotics (500 mg/L of ampicillin and erythromycin), 6: Original 
sugarcane juice. Several methods (3,4,5 and 6) showed sign of microbial growth (increased OD) 
after 24 h of incubation at 30oC without any inoculation. 
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Figure 6.7. Batch fermentation profiles of the 2,3-BD producing Pdc-negative S. cerevisiae SOS5-
SDB-PII strain in sugarcane juice without yeast extract (A) and with yeast extract (B). Symbols: 
sucrose (yellow square), glucose (gray hexagon), fructose (brown star), glycerol (green circle), acetoin 
(cyan triangle down), 2,3-BD (pink diamond), ethanol (blue triangle up), dry cell weight (red X) 
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Figure 6.8. Fed-batch fermentation profile (A) and high cell density batch fermentation profile (B) of 
the 2,3-BD producing Pdc-negative S. cerevisiae SOS5-SDB-PII strain in sugarcane juice with yeast 
extract. Symbols: sucrose (yellow square), glucose (gray hexagon), fructose (brown star), glycerol (green 
circle), acetoin (cyan triangle down), 2,3-BD (pink diamond), ethanol (blue triangle up), dry cell weight 
(red X) 
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CHAPTER VII       PRODUCTION OF ISOBUTANOL BY METABOLICALLY 
ENGINEERED SACCHAROMYCES CEREVISIAE 
 
The content of this chapter will be submitted to Applied Environmental Microbiology Journal. I am the 
first author of the paper. Dr. Yong-Su Jin was the director of the research. 
 
7.1. Introduction 
Production of fuels and chemicals from renewable biomass is a desirable way to ensure energy 
sustainability and reduce greenhouse gas emission. Isobutanol that can be produced from microbial 
cells is considered as a promising renewable chemical due to its advanced properties and diverse 
applications as a fuel additive and polymer such as poly-isobutylene. While bacterial production 
of isobutanol with a high yield and productivity has been reported, there is no previous study that 
achieves such a high yield and titer by the engineered yeast.  
Many previous studies to increase isobutanol production in S. cerevisiae have been performed 
through metabolic engineering strategies including overexpression of isobutanol biosynthetic 
pathway, pathway localization, and pathway optimization (reviewed in [59]). However, the 
maximum isobutanol titer that was produced by the engineered yeast was 1.62 g/L, and the highest 
isobutanol yield was 16 mg/g glucose, which is far below the maximum theoretical yield. Recently, 
a pyruvate decarboxylase (PDC) deletion mutant of S. cerevisiae was employed to increase 
isobutanol production in yeast by eliminating ethanol production [183]. Even though the Pdc-
deficient mutant was utilized for isobutanol production, the resulting strain only achieved a low 
yield of isobutanol 7.4 mg isobutanol/g glucose (0.018 mol/mol glucose) and accumulated 
byproducts including 2,3-dihydroxyisovalerate, ketoisovalerate, diacetyl, and acetoin. In contrast, 
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the Pdc-negative S. cerevisiae containing a heterologous 2,3-BD biosynthetic pathway exhibited 
a high yield of 2,3-BD without ethanol production. Thus, I investigated the metabolic limitations 
of producing isobutanol in a Pdc-negative S. cerevisiae and performed metabolic engineering of 
Pdc-negative strain to increase isobutanol production. 
In this chapter, I first introduced isobutanol biosynthetic pathway into the Pdc-negative S. 
cerevisiae SOS4 that was previously used for the high yield 2,3-BD production [48]. Specifically, 
the cytosolic isobutanol producing pathway consisting of the upstream pathway related to amino 
acid biosynthesis and the downstream pathway associated with the Ehrlich pathway for fusel 
alcohol production were introduced as the previous study successfully employed [184] (Fig. 1). 
The upstream pathway utilized the truncated ILV2, ILV5 and ILV3 genes from S. cerevisiae that 
were constructed by removing the mitochondrial localization peptides for cytosolic expression. 
The downstream pathway was enhanced by overexpressing 2-ketoisovalerate decarboxylase 
(Kivd) from Lactococcus lactis KACC 13877 for isobutanol production. Both the upstream and 
downstream pathways were introduced into a Pdc-negative S. cerevisiae strain SOS4.  
The SOS4 strain was constructed by deleting both PDC1 and PDC5 genes encoding major 
pyruvate decarboxylase involved in ethanol production and was evolved for glucose fermentation. 
The SOS4 strain gained a genetic mutation in the MTH1 gene that allowed cell growth in glucose 
medium. After the introduction of the cytosolic isobutanol pathway into the SOS4 strain, batch 
fermentations under many different conditions were carried out to investigate isobutanol 
production from glucose.  
 
7.2. Materials and methods 
7.2.1. Strains and Plasmids  
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Escherichia coli TOP10 (Invitrogen, CA, USA) was used for cloning experiments and 
plasmid DNA amplification. S. cerevisiae D452-2 (MATα, his3, leu2, ura3, can1) was used as a 
host tolerance assay. The Pdc-negative S. cerevisiae SOS4 (D452-2: MATα, leu2, his3, ura3, can1, 
Δpdc1, Δpdc5) [185] was used as a host strain for isobutanol production. Plasmids used in the 
previous study [184] for isobutanol production in S. cerevisiae were also utilized in this study. The 
LEU4 gene was deleted using the CRISPR/Cas9-based genetic engineering tool [186]. A complete 
list of strains and plasmids can be found in Table 7.1. The list of primers used in this study can be 
found in Table 7.2. 
 
7.2.2. Growth conditions and yeast transformation 
Lysogeny Broth (LB) medium (5 g/L yeast extract, 10 g/L tryptone, and 10 g/L NaCl) with 
50 μg/mL ampicillin was used for plasmid preparation from E. coli TOP10. Complex medium (10 
g/L yeast extract and 20 g/L peptone) with 20 g/L glucose was used for cultivation of yeast strains. 
Minimal (SC) medium (6.7 g/L yeast nitrogen base without amino acids and 0.6 g/L complete 
supplement mixture without histidine, leucine, tryptophan, and uracil; adjusted to pH 5.8) with 1 
g/L ethanol and amino acids if necessary. Transformation of plasmids into the SOS4 strain was 
accomplished using high-efficiency transformation methods [173]. Main fermentations were 
performed in 250 mL flasks containing 50 mL of minimal medium and complex medium. 
Fermentations were carried out at 30°C under a microaerobic condition with an agitation speed of 
80 rpm.  
 
7.2.3. Decarboxylase activity assay  
Cells from the cultivation were harvested and adjusted to OD at 20. The cells were re-
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suspended in reaction buffer (50 mM potassium phosphate buffer containing 2.5 mM MgSO4, at 
pH=6.5) and disrupted by vortexing with acid-washed glass beads (0.5 mm, Sigma, St Louis, 
USA). To prevent degradation of enzymes, protease inhibitor (Invitrogen) was added. After 
centrifugation at 13,000 rpm for 10 min, the supernatant was harvested and used as crude enzyme 
solution for decarboxylase activity assay. Measurements of decarboxylase activity were performed 
using the method described previously [184]. Either pyruvate and 2-KIV were added into a 
reaction mixture containing the crude extract, NADH and ADH (MP Biomedical). The absorbance 
of NADH at 340 nm was monitored in a 1 mL cuvette using spectrophotometer (Biomate3, Thermo 
Fisher Scientific, Waltham, MA, USA). One unit of decarboxylase activity was defined as the 
amount of an enzyme that can oxidize one micromole of NADH per minute. Specific KDC activity 
(U/mg cellular protein) was estimated by dividing enzyme activity by the total intracellular protein 
concentration. 
 
7.2.4. Analytical methods  
Cell growth was measured by optical density (OD) of cell culture at A600 using a BioMate3 
Spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA). Sugars and acids 
concentrations were measured by a high-performance liquid chromatography (HPLC) system 
(Agilent Technologies 1200 Series) equipped with a refractive index (RI) detector using a 
refractive index detector (RID) using Biorad Aminex HPX-87H column (300 x 7.8 mm). The 
column was eluted with 0.005 N of H2SO4 at a flow rate of 0.6 mL/min at 30°C. Other acid 
intermediates and alcohols including ethanol, isobutanol, and 3-MB were analyzed by a gas 
chromatography (GC) (Agilent Technologies 7890A) equipped with a flame ionization detector 
(FID) and auto-injector. An HP-INNOWax (30 m length, 0.53 mm diameter, 1.00 µm film 
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thickness) (Agilent Technologies) column was used for this purpose. Helium was used as the 
carrier gas.  
 
7.3. Results 
7.3.1. Introduction of cytosolic isobutanol biosynthetic pathway into Pdc-deficient 
Saccharomyces cerevisiae  
The previous study reported that the introduction of cytosolic isobutanol pathway could 
successfully increase isobutanol production in the wild-type S. cerevisiae [184] (Fig. 7.1). 
Therefore, I introduced the same plasmids into the Pdc-negative S. cerevisiae strain (SOS4) to 
increase isobutanol production by eliminating ethanol production. The resulting strain (S4-I253K) 
contained the plasmid expressing the truncated ILV2, ILV5 and ILV3 genes for cytosolic expression 
and the kivd gene from L. lactic. In the batch fermentation using a minimal medium containing 2% 
glucose, the S4-I253K strain produced only 205 mg/L isobutanol that was the similar amount (151 
mg/L) from the wild-type strains containing the same plasmids (Fig. 7.2). Unexpectedly, the S4-
I253K strain produced a significant amount of ethanol up to 3.92 g/L after complete glucose 
consumption at 72 h, while the parental strain SOS4 containing the empty plasmids (S4-p56) or 
only the upstream pathway (S4-I253) did not produce either ethanol or isobutanol (Fig. 7.2). This 
result indicated that only when the Kivd was introduced into the Pdc-negative strain, both ethanol 
and isobutanol were produced. According to the previous study, the parental strain SOS4 could not 
restore the ethanol production phenotype even after the long period of laboratory evolution with 
glucose [48]. This result suggested that the Kivd enzyme introduced into the S4-I253K was 
involved in the production of ethanol and isobutanol through decarboxylase activities for both 
pyruvate and 2-ketoisovalerate (2-KIV). The S4-I253K strain producing both isobutanol and 
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ethanol exhibited significant increases in glucose consumption and cell growth when compared to 
the other two strains, S4-p56 and S4-I253 (Fig. 7.2). This result suggested that production of 
alcohols including ethanol and isobutanol by the Kivd enzyme could overcome the growth defect 
on glucose of the Pdc-negative strain through the conversion of the surplus NADH to NAD+. (Fig. 
7.1). This result agreed with the previous report that introducing 2,3-butanediol production 
pathway into the Pdc-negative strain SOS4 rescued the growth defect of the strain and improved 
the sugar uptake. Thus, the Kivd is a key enzyme for isobutanol production in the Pdc-negative S. 
cerevisiae that has two functions; 1) producing isobutanol and 2) improving the cell growth of the 
Pdc-negative S. cerevisiae by restoring ethanol production. 
 
7.3.2. Confirmation of decarboxylase activities and nucleotide sequence of Kivd introduced 
into the Pdc-negative strain 
The S4-I253K strain produced ethanol as a major product even though endogenous PDCs 
were removed. Thus, I hypothesized that the Kivd might acquire the mutation which changes 
substrate specificity of the enzyme from 2-KIV to pyruvate. To confirm the possibility of the 
change in substrate specificity of the Kivd enzyme, I measured decarboxylase activities for 
pyruvate as well as 2-KIV using the cell extracts from the recombinant strains. When the cell 
extract from the wild-type D452-2 strain was used, there was a significant decarboxylase activity 
for pyruvate (Fig. 7.3). The control strain S4-p56 exhibited negligible levels of activity for both 
pyruvate and 2-KIV. The S4-I253K strain exhibited a significantly higher decarboxylase activity 
for 2-KIV than pyruvate. The PDC activity in the S4-I253K could be only detected by increasing 
concentrations of the crude extract and pyruvate at 10-fold in the assay reaction. This agreed with 
the previous report characterizing the same Kivd enzyme from L. lactis IFPL730 [187]. The 
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nucleotide sequence of kivd gene from L. lactic KACC 13877 used in this study was identical with 
the kivd in L. lactis IFPL730. The Kivd enzyme in L. lactis IFPL730 showed promiscuous 
decarboxylase activity for pyruvate when compared to that for 2-KIV [187].  
To confirm whether or not the Kivd gained a genetic mutation involved in the high ethanol 
production in the S4-I253K strain, I isolated the colonies of the S4-I253K strain after fermentation 
to confirm the sequence of the kivd gene in the plasmid. The plasmid DNA was extracted from the 
isolated colonies and sequenced for the kivd gene. The kivd sequences from the nine different S4-
I253K isolates did not contain any genetic mutation. This result confirmed that the ethanol 
production in S4-I253K was not due to the mutation in kivd gene which affects its substrate 
specificity.  
The reason for the ethanol production is more likely due to enzyme kinetics related with 
substrate concentration in the cell. The parental Pdc-negative strain SOS4 used in this study 
accumulated pyruvate as a major product up to 4.5 g/L from 20 g/L glucose under the similar 
condition (Ref). Also, pyruvate is first produced from glycolysis and then is converted to 2-KIV 
by the several enzymes involved in amino acid biosynthetic pathway that is tightly regulated and 
limited (Fig. 7.1). Regarding the order of biosynthesis and concentration difference between 
pyruvate and 2-KIV in the cell, the promiscuous PDC activity of the Kivd enzyme in the S4-I253K 
strain might mainly catalyze the accumulated pyruvate and produce ethanol. 
 
7.3.3. Optimization of fermentation condition to increase isobutanol production by the Pdc-
negative S. cerevisiae 
In the S4-I253K strain, pyruvate produced from glycolysis can be used for ethanol production 
by Kivd, but also used for other pathways such as the TCA cycle and other chemical and amino 
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acid synthesis required for the cell growth. The metabolic pathway distribution in the cell could be 
affected by the environmental condition. Thus, I tested different fermentation conditions to 
investigate the isobutanol production by the S4-I253K strain (Fig 7.4A). The SC minimal medium 
was used for test the different conditions for amino acid supplement and sugar concentration, and 
the complex medium was also used. Through the investigation, I found that the complex medium 
and high concentration of glucose increased isobutanol titer by the S4-I253K strain under the 
microaerobic condition. Thus, I used the YP complex medium and increase glucose concentration 
to 12% for the next investigation into the effect of an initial cell density. The S4-I253K strain 
produced 335 mg/L isobutanol in low cell density culture (initial OD=0.1). With increased cell 
density (initial OD=5), isobutanol production was improved by 481 mg/L (Fig. 7.4A). The result 
suggests that increased initial cell density has a beneficial effect on isobutanol production. Also, 
the cell growth of the S4-I253K strain showed a positive correlation with the isobutanol production 
(Fig. 7.4B). When 12% glucose was used for the fermentation, cell growth was decreased probably 
due to high osmotic stress. Thus, I decreased glucose concentration from 12% to 8% in the YP 
medium. In the YP medium containing 8% glucose and 1% ethanol with a high initial cell density, 
the S4-I253K strain produced isobutanol up to 1.24 g/L (Fig. 7.4C). Noticeably, 3-methyl-2-
butanol (3-MB) was also produced by 1.02 g/L. The production of 3-MB could decrease isobutanol 
yield since the 3-MB biosynthesis pathway is competitive with the isobutanol pathway (Fig. 7.1). 
Thus, I attempted to decrease the 3-MB production to increase isobutanol yield. 
 
7.3.4. Identification of the problem of an auxotrophic marker plasmid involved in the 3-MB 
production 
In the S4-I253K strain, the pRS425 plasmid was introduced for the overexpression of Kivd. 
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The pRS425 plasmid contains the LEU2 gene as a selection marker for the auxotrophic yeast strain 
to grow on the leucine-deficient medium. Therefore, the plasmid pRS425GPD-Kivd introduced 
into the S4-I253K strain could result in the overexpression of both Kivd and LEU2 in the cell. 
Considering that 3-MB production is from leucine biosynthetic pathway, I hypothesized that 
pRS425GPD-Kivd plasmid might cause the increased flux of leucine biosynthetic pathway, 
thereby accumulating 3-MB in the S4-I253K strain. 
To check whether or not the pRS425 plasmid contributes the unintended metabolic flux to 3-
MB, I transferred the Kivd expression cassette from the pRS425 plasmid to pRS423 plasmid that 
contains the HIS3 gene as an auxotrophic marker for histidine. Since the histidine biosynthetic 
pathway is not related to the isobutanol production pathway, introducing the pRS423 plasmid for 
Kivd overexpression may not affect the isobutanol and 3-MB production in the S4-I253K strain. 
The resulting strain containing pRS423GPD-Kivd was named as S4-I253KH. Batch fermentation 
of the S4-I253KH strain was performed in the minimal medium containing 2% glucose and 0.1% 
ethanol. As I expected, isobutanol production by the S4-I253KH strain increased from 196 mg/L 
to 254 mg/L, and 3-MB production decreased from 416 mg/L to 123 mg/L when compared to the 
S4-I253K strain under the same condition (Fig 7.5A and B). This result suggested that replacing 
the pRS425 plasmid with the pRS423 plasmid could minimize the 3-MB production in the 
isobutanol producing Pdc-deficient strain. Also, the results confirmed that the leucine biosynthetic 
pathway employed for 3-MB production is competitive with the isobutanol production pathway 
because both pathways start with the same substrate, 2-KIV. (Fig. 7.1). 
 
7.3.5. Deletion of the leucine biosynthetic pathway for 3-MB is competitive with the 
isobutanol pathway for 2-KIV 
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To further increase isobutanol production by decreasing 3-MB production, I completely 
blocked the downstream of leucine biosynthesis pathway by deleting the LEU4 gene in the S4-
I253KH strain. The LEU4 enzyme converts 2-KIV into 2-IPM which is directly competing with 
Kivd enzyme involved in isobutanol production. The resulting strain S4L-I253KH produced 274 
mg/L isobutanol and 102 mg/L 3-MB in a minimal medium containing 2% glucose and 0.1% 
ethanol (Fig. 7.5A and B). The isobutanol titer was increased in the minimal medium compared to 
the previous strain S4-I253KH, but the difference was not significant. When I used the customized 
complex medium to maximize the effect of LEU4 deletion, the S4L-I253KH produced 1.48 g/L 
isobutanol (Fig. 7.5C). The production of 3-MB by the S4L-I253KH strain (0.63 g/L) is much less 
than that of the S4-I253K strain (0.9 g/L) under the same condition (Fig. 7.5D). However, the S4L-
I253KH strain still could not completely consume glucose in the medium probably due to the 
toxicities of keto acid intermediates. 
 
7.3.6. Overexpression of upstream isobutanol pathway in cytosol inhibits the cell growth of 
the Pdc-negative S. cerevisiae  
The accumulation of keto acid intermediates might be involved in the incomplete glucose 
consumption and the slow growth of the Pdc-negative strain overexpressing the isobutanol 
biosynthetic pathway. The previous study also confirmed the accumulation of keto acid 
intermediates as excessive byproducts during the fermentation of the Pdc-negative strain 
containing the isobutanol biosynthesis pathway [183]. The reason might be because the upstream 
isobutanol pathway involved in valine biosynthesis was not balanced, thereby accumulating the 
keto acids at toxic levels. To solve this problem, I simply eliminated the overexpression of the 
upstream pathway by removing the plasmid containing cytosolic ILV2, ILV5, and ILV3 expression 
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cassette. The resulting strain containing only the pRS423GPD-Kivd plasmid was constructed 
based on the leu4 deletion strain (S4L) and named as S4L-KH. In batch fermentation, the S4L-KH 
strain produced 589 mg/L isobutanol in the minimal medium containing 2% glucose and 0.1% 
ethanol which is much higher yield than that of the S4L-I253KH strain overexpressing both 
upstream and downstream pathways (Fig. 7.5). Also, the cell growth and glucose consumption rate 
of the S4L-KH were enhanced when compared to the S4L-I253KH strain. This result suggested 
that reducing the overflow of keto acid intermediates enhances the glucose uptake and cell growth, 
thereby increasing the titer, rate, and yield of isobutanol. When the complex medium was used, the 
S4L-KH strain produced the maximum 2.1 g/L isobutanol that is the highest titer from glucose in 
yeast that has ever been reported (Fig 7.5). 
   
7.4. Discussion   
In the previous study, when I used the wild-type S. cerevisiae to produce isobutanol, I did not 
notice that the Kivd has the PDC activity for producing ethanol since the wild-type strain already 
produced ethanol as a major product. In this study, I used the evolved Pdc-negative S. cerevisiae 
that could not produce ethanol but could grow on glucose medium. After introducing the isobutanol 
producing pathway, the strain surprisingly produced ethanol again as a major product. I found that 
the introduced Kivd did not have a genetic mutation increasing pyruvate decarboxylase activity 
that converts pyruvate to acetaldehyde followed by ethanol production. Rather than the genetic 
mutation, the promiscuous PDC activity of the Kivd enzyme toward pyruvate can recover the 
growth defect of the PDC deletion in S. cerevisiae by restoring the ethanol production. However, 
the ethanol production by the Kivd will be eventually a limiting factor for isobutanol production 
by decreasing the yield of isobutanol. The inevitable production of ethanol by the Kivd which is 
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an essential enzyme for the Ehrlich pathway might be a big concern for the production of branch-
chain higher alcohol using the Pdc-negative yeast.  
The metabolic pathway from pyruvate to 2-KIV is more complex and inefficient than the 
alcohol production pathway from 2-KIV to isobutanol. Also, the upstream pathway for isobutanol 
production is difficult to be optimized due to limiting the activity of several enzymes in the cytosol. 
Specifically, the ILV2 encoding 2-acetolactate synthase has a promiscuous activity for other 
substrates than pyruvate. The ILV5 has a cofactor imbalance problem using NADPH as a cofactor 
that is less available than NADH in the cell. The ILV3 encoding DHIV dehydratase which is iron-
sulfur cluster enzyme. The iron-sulfur cluster unit mainly presents in the mitochondria, thereby the 
enzyme activity of ILV3 in the cytosol is limited. As a result, the accumulation of keto acid 
intermediates was observed during the fermentation of the Pdc-negative strain containing the 
complete isobutanol pathway, resulting in the inhibition of the cell growth and sugar uptake. 
Therefore, instead of overexpressing the upstream pathway which accumulated keto acid 
intermediates, overexpression of the downstream pathway with blocking the competitive amino 
acid biosynthetic pathway may be beneficial for increasing isobutanol titer in the Pdc-negative S. 
cerevisiae. However, the endogenous flux of the valine biosynthetic pathway may be not sufficient 
to further increase the isobutanol titer, and it is tightly regulated by the cell. Therefore, the 
optimization of enzyme activities in the upstream pathway needs to be performed to enhance the 
flux toward 2-KIV and isobutanol.  
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7.5. Figures and tables 
 
Figure 7.1. Introduction of the cytosolic isobutanol biosynthetic pathway into the Pdc-
negative S. cerevisiae SOS4. The cytosolic isobutanol pathway consists of the upstream pathway 
for keto acid production (the truncated ILV2, ILV5 and ILV3 enzyme for cytosolic expression) 
and the downstream pathway for alcohol production (the Kivd enzyme).   
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Figure 7.2. Fermentation profiles of the Pdc-negative recombinant strains in minimal 
medium containing 20 g/L glucose and 1 g/L ethanol. Symbols: S4-p56 (cyan triangle), S4-I253 
(purple square), S4-I253K (blue circle). Results are the averages of duplicate experiments with 
error bars.  
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Figure 7.3. Decarboxylase activity of the S. cerevisiae wild type and the Pdc-negative 
recombinant expressing a-ketoisovalerate decarboxylase (Kivd) from L. lactis KACC 13877. 
Pyruvate and 2-ketoisovalerate were used as substrates for the PDC activity and the KIVD activity, 
respectively. Results are the averages of duplicate experiments with error bars.  
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Figure 7.4. Isobutanol production by the Pdc-negative recombinant strain S4-I253K under 
the different conditions. (A) Isobutanol titer under the different conditions, (B) Cell growth under 
the different conditions, (C) Fermentation profile of the S4-I253K strain under the customized YP 
medium containing 80 g/L glucose and 8 g/L ethanol with high cell density (HCD) inoculum. The 
bar graph shows the averages of duplicate experiments with error bars. 
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Figure 7.5. Increased isobutanol production by eliminating the competitive leucine pathway 
and the overexpression of the upstream isobutanol pathway. (A) Isobutanol titer and (B) 3-
Methyl-1-butanol (3-MB) titer in SC selective medium containing 20 g/L glucose and 1 g/L 
ethanol, (C) Isobutanol titer and (D) 3-MB titer in YP customized medium containing 80 g/L 
glucose and 8 g/L ethanol. Results are the averages of duplicate experiments with error bars. 
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Table 7.1. Strains and plasmids used in this study 
Name Description Reference 
Strains   
D452-2 Saccharomyces cerevisiae, MATa, leu2, his3,ura3,can1 Hosaka et al., 1992 
SOS4 D452-2 Δpdc1, Δpdc5 (C2-independent and glucose-tolerant) Kim et al., 2013 
S4-p56 SOS4 (pRS426GPD and pRS425GPD) In this study 
S4-I253 SOS4 (pRS426_ILV253, pRS425GPD) In this study 
S4-I253K SOS4 (pRS426_ILV253, pRS425_Kivd13877) In this study 
S4-I253KH SOS4 (pRS426_ILV253, pRS423_Kivd13877) In this study 
S4L SOS4 Δleu4 In this study 
S4L-I253KH S4L (pRS426_ILV253, pRS423_Kivd13877) In this study 
S4L-KH S4L (pRS423_Kivd13877) In this study 
Plasmids   
pRS426GPD URA3, GPD promoter, CYC terminator, 2μ origin, Ampr 
Christianson et al., 
1992 
pRS423GPD HIS3, GPD promoter, CYC terminator, 2μ origin, Ampr 
Christianson et al., 
1992 
pRS425GPD LEU2, GPD promoter, CYC terminator, 2μ origin, Ampr 
Christianson et al., 
1992 
pRS426_ILV253 pRS426GPD harboring the truncated ILV2, ILV5, ILV3 genes 
from S. cerevisiae D452-2 Lee et al., 2012 
pRS425_Kivd13877 pRS425GPD harboring the kivd gene from L. lactis KACC13877 Lee et al., 2012 
pRS423_Kivd13877 pRS423 harboring the kivd gene expression cassette from 
pRS425_Kivd13877 In this study 
Cas9-NAT Cas9 expression plasmid Zhang et al., 2014 
pRS42H_LEU4-
gRNA 
pRS42H harboring the gRNA for CRISPR/Cas9-associated 
deletion of LEU4 gene In this study 
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Table 7.2. List of primers used in this study 
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CHAPTER VIII       SUMMARY AND FUTURE STUDIES 
 
8.1. Summary 
Throughout the six research chapters in the thesis, systematic investigation, bioprocess 
optimization, evolutionary engineering, and metabolic engineering were successfully applied to 
produce 1-butanol and butanol isomers by C. bejerinckii and S. cerevisiae. Specifically, 
fermentation conditions were optimized for increased butanol production from ABE fermentation 
by C. beijerinckii wild-type and mutant. The ABE fermentation process was modified to produce 
butyl esters by metabolically engineered C. beijerinckii. The oxygen-independent fluorescence 
reporter was developed and utilized for evaluating protein expression, cell analysis, isolation of 
mutant cells and metabolic engineering of C. beijerinckii. Evolutionary engineering of C. 
beijerinckii on lignocellulosic hydrolysate isolated the evolved mutant strain and revealed the 
important role of the transcriptional regulator on increased cell growth. Beside 1-butanol, 2,3-
butanediol was produced from glucose and sugarcane juice without ethanol production by 
metabolically engineered Pdc-negative S. cerevisiae. Isobutanol production was significantly 
increased through identification of metabolic limitations and optimization of metabolic pathways 
of Pdc-negative S. cerevisiae harboring a cytosolic isobutanol biosynthetic pathway. The most 
important findings from each chapter are summarized below. 
First, I performed the investigation of environmental and genetic factors influencing the 
acetone-butanol-ethanol (ABE) fermentation by a hyper-butanol producing mutant of Clostridium 
beijerinckii BA101 and wild-type strain. Under certain conditions, the BA101 did not show the 
increased butanol production and sometimes exhibited the acid crash phenotype. To investigate 
environmental factors influencing the ABE fermentation by BA101 mutant, I investigated three 
variable factors including agitation, inoculum age, and yeast extract supplement that may provide 
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great influences on the ABE fermentation profile. First of all, the agitation of the culture was 
beneficial to the wild-type strain, while it was detrimental to BA101 in the P2 medium containing 
60 g/L glucose. For the effect of inoculum age, a shorter period of the pre-culture was beneficial 
to BA101, while a longer period of the pre-culture was beneficial to the wild-type strain. For the 
effect of yeast extract supplementation, cell growth and sugar uptake of both the wild-type and 
BA101 strains were enhanced by increasing the amount of yeast extract in the medium. Initially, 
both BA101 and the wild-type strains produced a similar amount of butanol around 9 g/L. 
However, under the optimized conditions which is the 12 h-old inoculum and 5 g/L yeast extract 
without agitation, BA101 achieved a higher butanol production up to 14 g/L butanol that was a 
55% improvement compared to the initial condition. For the wild-type strain, higher solvent 
production was achieved with the 48 h-old inoculum and 5 g/L yeast extract in the presence of 
agitation. Under the optimization conditions for each strain, the pH control enhanced butanol 
production by both strains. Overall, the responses to environmental factors by BA101 were quite 
different than that of the wild-type strain. Both strains have their desirable conditions for 
maximizing solvent production. The results suggest that it is necessary to understand the 
characteristics of mutants after the strain development by evaluation and optimization processes 
for guiding them toward their best performance rather than using standard fermentation conditions.  
Second, I characterized the C. beijerinckii spo0A disruption mutant constructed by 
CRISPR/Cas9-based genome engineering. In batch fermentation with pH control, the spo0A 
mutant accumulated both butyrate and butanol up to 8.96 g/L and 3.32 g/L. Considering the unique 
phenotype accumulating both butyrate and butanol, I employed the spo0A mutant for the 
production of butyl butyrate that can be formed by the esterification of butyrate and butanol during 
the ABE fermentation with lipase enzyme. In an initial trial of small-scale extractive batch 
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fermentation using hexadecane layer with lipase CalB, the spo0A mutant was subjected to acid 
crash due to the butyrate accumulation, thereby producing only 98 mg/L butyl butyrate. To 
alleviate butyrate toxicity, the medium was supplemented with 10 g/L CaCO3 and 5 g/L butanol. 
The butyl butyrate production was then increased up to 2.73 g/L. When continuous agitation was 
performed to enhance the esterification and extraction of butyl butyrate, 3.32 g/L butyl butyrate 
was obtained in the hexadecane layer. In this chapter, I successfully demonstrated butyl butyrate 
production by metabolically engineered C. beijerinckii through the simultaneous ABE 
fermentation, condensation, and extraction. 
For further metabolic engineering, I developed in vivo fluorescence reporter system for 
collecting genetic information of C. beijerinckii such as promoter strength, regulation of gene 
expression and metabolic pathways, which is a prerequisite for rational engineering. The 
fluorescence reporter can also be used as a selection tool for screening a desirable mutant strain or 
plasmid among libraries. Since GFP-family proteins require molecular oxygen for fluorescence 
maturation, I employed an oxygen-independent flavin mononucleotide-based fluorescent protein 
(FbFP) system as an alternative fluorescence reporter under a strict anaerobic growth condition of 
clostridia. The expression of the reporter protein and in vivo fluorescence in C. beijeirnckii were 
confirmed under anaerobic growth condition after introducing the plasmid expressing the codon-
optimized FbFP gene for C. beijerinckii (CbFbFP). During microscopic observation, I identified a 
heterogeneity of the cell population exhibiting a variety range of fluorescence intensity. Thus, 
FACS was employed to sort the brightest cell population (5%) from the heterogeneous population 
and revealed several mutations in the plasmid backbone and the introduced CbFbFP expression 
cassette which may be responsible for the high level and stable expression of CbFbFP in C. 
beijerinckii. The isolated oxygen-independent CbFbFP reporter cassette and plasmid were further 
146 
 
applied for strain selection, population analysis, and metabolic engineering. The secondary alcohol 
dehydrogenase operon was introduced into the mutant plasmid isolated by CbFbFP reporter. The 
resulting strains successfully demonstrated isopropanol production. 
For the cost-effective and sustainable production of butanol through fermentation, 
lignocellulosic biomass is an attractive renewable feedstock. Although the wild-type C. 
beijerinckii can naturally utilize a wide range of sugars present in the lignocellulosic biomass 
hydrolysate, the cell growth is generally limited due to potential toxic inhibitors generated during 
hydrolysis. To overcome the inhibitor problem, I performed evolutionary engineering of C. 
beijerinckii in the Miscanthus hydrolysate medium to improve the cell growth. After several serial 
transfers, the C. beijerinckii culture was repeatedly degenerated with typical acid crash phenotype 
including the limited cell growth, high acid accumulation and no sign of solventogenesis. I isolated 
the evolved strain exhibiting the acid crash phenotype and further characterized its fermentation 
phenotypes, but the strain still showed the acid crash phenotype in both standard medium and 
hydrolysate medium. Three single colony isolates were sequenced to elucidate the mechanism of 
the acid crash phenotype generated by directed evolution in the hydrolysate medium. Comparative 
genome analysis revealed that the SNP in the promoter region of the AbrB gene (Cbei_4885) 
encoding the AbrB regulator involved in the sugar uptake, acid production, and solventogenic 
switch. The findings suggested that the directed evolution selecting for increased cell growth rate 
could generate a mutation responsible for enhancing the acidogenesis which is closely related to 
cell growth. The increased cell growth rate and acid production rate result in the acid crash 
phenotype in batch fermentation without pH control.  
2,3-Butanediol (2,3-BD) is attractive biochemical due to its diverse applications. To produce 
2,3-BD by industrial yeast, the heterologous 2,3-BD biosynthesis pathway consisting of alsS and 
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alsD from B. subtilis and endogenous BDH1 was introduced into the pdc1, pdc5 and pdc6 triple 
deletion strain (SOS5) incapable of producing ethanol. The resulting strain was then evolved to 
grow on high glucose as a sole carbon source since the Pdc-negative S. cerevisiae requires a C2 
compound for cell growth and is also sensitive to high glucose concentration. The evolved strain 
grown on high glucose concentration was isolated for investigating 2,3-BD production capacity. 
In batch fermentation, the evolved strain SOS5-SDB-PII produced 39.1 g/L 2,3-BD and 25.2 g/L 
glycerol from 110 g/L glucose as a sole carbon source without ethanol production. In fed-batch 
fermentation with pH control, the SOS5-SDB-PII strain produced 2,3-BD up to 120 g/L by 
intermittently feeding high concentration of glucose. To identify genetic mutations involved in the 
phenotypic change of SOS5-SDB-PII, genome sequencing was performed. Comparative genome 
analysis of the SOS5-SDB-PII strain revealed the SNP (G to A at 920 bp) in the HXK2 gene, 
resulting in the amino acid change (G307D) in the ATP-binding domain of hexokinase isozyme 2. 
The point mutation was re-introduced into the initial strain SOS5-SDB incapable of growing on 
high glucose condition by CRISPR/Cas9 system and successfully generated the high glucose-
tolerant phenotype. 
For industrial 2,3-BD production, sugarcane is a desirable feedstock since it is the abundant, 
inexpensive and easily-degradable. Sugarcane juice containing sucrose, glucose, and fructose can 
be consumed by S. cerevisiae through native invertase activity without additional engineering. 
Thus, I tested the feasibility of using sugarcane juice as a feedstock to produce 2,3-BD by 
engineered S. cerevisiae. For the preparation of sugarcane juice medium for yeast fermentation, 
several pretreatment methods were investigated. Centrifugation followed by autoclaving method 
successfully prevented contamination of other microorganisms existed in crude sugarcane juice. 
To provide the nitrogen source for yeast cell growth, yeast extract was additionally supplemented 
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into sugarcane juice. In batch fermentation with yeast extract, 2,3-BD producing Pdc-negative S. 
cerevisiae strain SOS5-SDB-PII produced 68.6 g/L in 145 h, which was 20% increase in cell 
growth and 30% increase in total sugar consumption when compared to the medium without yeast 
extract. In fed-batch fermentation with additional sucrose, the SOS5-SDB-PII strain produced 76.6 
g/L 2,3-BD. Next, I performed high cell density fermentation which has been used for industrial 
fermentation setting to increase 2,3-BD productivity. With high initial OD at 55, SOS5-SDB-PII 
strain consumed all the sugars in the sugarcane juice medium within 75 h and produced 87.6 g/L 
2,3-BD, which is a significant increase in productivity.  
Isobutanol is a compound of interest due to its diverse applications for fuel additive and 
polymers. While bacterial production of isobutanol with a high yield and productivity has been 
reported, there is no previous academic research reporting such a high yield and titer from the 
engineered yeast. To address the limitation on isobutanol production in yeast, I engineered S. 
cerevisiae to produce isobutanol. Specifically, I utilized the isobutanol production pathway 
overexpressing the endogenous ILV2, ILV5, and ILV3 and the heterologous Kivd from L. lactis in 
the cytosol that was previously used for isobutanol production in yeast. The cytosolic isobutanol 
pathway was introduced into a Pdc-negative S. cerevisiae incapable of producing ethanol to 
increase a titer and yield of isobutanol. Under the oxygen-limited condition, the resulting strain 
S4-I253K produced 205 mg/L isobutanol, but also accumulated 3.4 g/L ethanol from 20 g/L 
glucose in the minimal medium. I confirmed that the reason for the restoration of ethanol 
production phenotype of the Pdc-negative S. cerevisiae was the introduction of Kivd which has a 
promiscuous decarboxylase activity for pyruvate accumulated in the cell. When the fermentation 
conditions were customized for increasing cell growth and isobutanol production, the S4-I253K 
strain produced 1.24 g/L isobutanol and simultaneously produced 3-methyl-2-butanol (3-MB) up 
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to 0.98 g/L. I identified the reason for the high 3-MB production in the S4-I253K strain which 
used the pRS425 plasmid containing the leucine auxotrophic marker gene (LEU2) involved in the 
3-MB production pathway. When I replaced the pRS425 plasmid with pRS423 containing histidine 
marker (HIS3), the resulting strain S4-I253KH reduced the production of 3-MB by 0.56 g/L 3-MB 
and increased the isobutanol production by 1.31 g/L under the customized condition. Furthermore, 
I deleted the LEU4 gene encoding the first enzyme for 3-MB production pathway and directly 
competitive with Kivd for 2-KIV. The resulting strain S4L-I253KH produced 1.83 g/L isobutanol 
and accumulated 0.57 g/L 3-MB. I also confirmed the high accumulation of keto acid intermediates 
such as 2-acetolactate and DHIV during the fermentation. Thus, I simply eliminated the plasmid 
overexpressing the cytosolic upstream pathway (ILV2, ILV5, and ILV3) to relieve the metabolic 
burden and acid accumulation. Under the customized condition, the resulting strain S4L-KH 
achieved maximum 2.1 g/L isobutanol from 80 g/L glucose with minimizing 3-MB production and 
acid accumulations.  
Overall, this thesis research has broad applications for the sustainable biological production 
of higher chain alcohols as advanced biofuels and chemicals which can replace the use of fossil 
fuel and petroleum. Moreover, findings and tools obtained in this study can be applied for 
engineering of other solventogenic clostridia and yeast strains for increased production of value-
added bioproducts. 
 
8.2. Future research directions 
In chapter II, I found that BA101 has the SNP in histidine kinase which is involved in a two-
component signaling pathway regulating many downstream metabolisms. More experiments can 
be performed to confirm the effect of SNP through reverse engineering. For example, the same 
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mutation can be introduced into the wild-type strain to confirm whether this is a strain-specific 
effect in BA101 or it can be generalized to other Clostridium strains. For this purpose, the 
CRISPR/Cas9-based nucleotide substitution can be employed to create the same point mutation in 
the genome of the wild-type strain.  
In chapter III, butyl butyrate was successfully produced in the batch fermentation of C. 
beijerinckii spo0A mutant with in situ esterification via lipase activity. To increase the butyl 
butyrate titer, fed-batch fermentation can be performed by feeding more glucose into the system. 
Also, for sustainable production, continuous culture can be employed with in situ recovery of butyl 
butyrate from hexadecane layer.  
In chapter IV, the isolated mutant plasmid expressing the CbFbFP can be used for 
overexpression of heterologous protein in C. beijerinckii with co-expression of CbFbFP reporter. 
For this purpose, another expression cassette harboring target gene can be introduced into the 
mutant plasmid expressing CbFbFP, resulting in the dual expression vector. This duet-vector can 
be used for screening of recombinant strain exhibiting a high expression level of target protein by 
simply monitoring the fluorescence intensity that is co-expressed in the same vector.  
In chapter V, I found that the mutation in the promoter region of the abrB gene in the evolved 
strain showing the acid crash phenotype in Miscanthus hydrolysate medium. To confirm whether 
this SNP causes the increase of AbrB expression or not, RT-qPCR can be performed to check the 
expression of AbrB during fermentation. To create the acid crash phenotype, AbrB regulator can 
also be directly overexpressed using the plasmid that I isolated in chapter IV. At the same time, 
the point mutation can be re-introduced into wild-type strain through the CRISPR/Cas9-based 
nucleotide substitution to evaluate the effect of the mutation. 
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In chapter VI, I successfully constructed the 2,3-BD producing Pdc-negative strain without 
production of ethanol which is a major product in yeast. However, the recombinant strain produced 
a high amount of glycerol rather than ethanol as a byproduct. Thus, further metabolic engineering 
can be performed to minimize glycerol production in the 2,3-BD producing Pdc-negative strain. 
Also, fed-batch fermentation was not effective to increase 2,3-BD from sugarcane juice. For long-
term operation, continuous culture system can be developed to keep low concentrations of sugars 
and products in the reactor which minimizes the osmotic stress.  
In chapter VII, I have achieved the highest titer of isobutanol from glucose by yeast reported 
in academic research. However, the isobutanol titer can be further increased by fed-batch 
fermentation with a pH control. Also, other non-glucose sugars which minimize a glucose 
repression can be used for isobutanol production to increase the titer in yeast. In the end, the 
upstream pathway which is the valine biosynthesis pathway should be optimized to eliminate the 
byproduct formations and increase the flux to isobutanol in yeast. 
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